Motif 69 (n=220)
Position-wise Probabilities
Download
uniprot | genes | site | source | protein | function |
---|---|---|---|---|---|
A6NC98 | CCDC88B | S1370 | ochoa | Coiled-coil domain-containing protein 88B (Brain leucine zipper domain-containing protein) (Gipie) (Hook-related protein 3) (HkRP3) | Acts as a positive regulator of T-cell maturation and inflammatory function. Required for several functions of T-cells, in both the CD4(+) and the CD8(+) compartments and this includes expression of cell surface markers of activation, proliferation, and cytokine production in response to specific or non-specific stimulation (By similarity). Enhances NK cell cytotoxicity by positively regulating polarization of microtubule-organizing center (MTOC) to cytotoxic synapse, lytic granule transport along microtubules, and dynein-mediated clustering to MTOC (PubMed:25762780). Interacts with HSPA5 and stabilizes the interaction between HSPA5 and ERN1, leading to suppression of ERN1-induced JNK activation and endoplasmic reticulum stress-induced apoptosis (PubMed:21289099). {ECO:0000250|UniProtKB:Q4QRL3, ECO:0000269|PubMed:21289099, ECO:0000269|PubMed:25762780}. |
A6NC98 | CCDC88B | S1410 | ochoa | Coiled-coil domain-containing protein 88B (Brain leucine zipper domain-containing protein) (Gipie) (Hook-related protein 3) (HkRP3) | Acts as a positive regulator of T-cell maturation and inflammatory function. Required for several functions of T-cells, in both the CD4(+) and the CD8(+) compartments and this includes expression of cell surface markers of activation, proliferation, and cytokine production in response to specific or non-specific stimulation (By similarity). Enhances NK cell cytotoxicity by positively regulating polarization of microtubule-organizing center (MTOC) to cytotoxic synapse, lytic granule transport along microtubules, and dynein-mediated clustering to MTOC (PubMed:25762780). Interacts with HSPA5 and stabilizes the interaction between HSPA5 and ERN1, leading to suppression of ERN1-induced JNK activation and endoplasmic reticulum stress-induced apoptosis (PubMed:21289099). {ECO:0000250|UniProtKB:Q4QRL3, ECO:0000269|PubMed:21289099, ECO:0000269|PubMed:25762780}. |
E7EW31 | PROB1 | S777 | ochoa | Proline-rich basic protein 1 | None |
O00443 | PIK3C2A | S259 | ochoa|psp | Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.137) (EC 2.7.1.153) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) | Generates phosphatidylinositol 3-phosphate (PtdIns3P) and phosphatidylinositol 3,4-bisphosphate (PtdIns(3,4)P2) that act as second messengers. Has a role in several intracellular trafficking events. Functions in insulin signaling and secretion. Required for translocation of the glucose transporter SLC2A4/GLUT4 to the plasma membrane and glucose uptake in response to insulin-mediated RHOQ activation. Regulates insulin secretion through two different mechanisms: involved in glucose-induced insulin secretion downstream of insulin receptor in a pathway that involves AKT1 activation and TBC1D4/AS160 phosphorylation, and participates in the late step of insulin granule exocytosis probably in insulin granule fusion. Synthesizes PtdIns3P in response to insulin signaling. Functions in clathrin-coated endocytic vesicle formation and distribution. Regulates dynamin-independent endocytosis, probably by recruiting EEA1 to internalizing vesicles. In neurosecretory cells synthesizes PtdIns3P on large dense core vesicles. Participates in calcium induced contraction of vascular smooth muscle by regulating myosin light chain (MLC) phosphorylation through a mechanism involving Rho kinase-dependent phosphorylation of the MLCP-regulatory subunit MYPT1. May play a role in the EGF signaling cascade. May be involved in mitosis and UV-induced damage response. Required for maintenance of normal renal structure and function by supporting normal podocyte function. Involved in the regulation of ciliogenesis and trafficking of ciliary components (PubMed:31034465). {ECO:0000269|PubMed:10766823, ECO:0000269|PubMed:10805725, ECO:0000269|PubMed:11239472, ECO:0000269|PubMed:12719431, ECO:0000269|PubMed:16215232, ECO:0000269|PubMed:21081650, ECO:0000269|PubMed:31034465, ECO:0000269|PubMed:9337861}. |
O00571 | DDX3X | S492 | ochoa | ATP-dependent RNA helicase DDX3X (EC 3.6.4.13) (CAP-Rf) (DEAD box protein 3, X-chromosomal) (DEAD box, X isoform) (DBX) (Helicase-like protein 2) (HLP2) | Multifunctional ATP-dependent RNA helicase (PubMed:17357160, PubMed:21589879, PubMed:31575075). The ATPase activity can be stimulated by various ribo-and deoxynucleic acids indicative for a relaxed substrate specificity (PubMed:29222110). In vitro can unwind partially double-stranded DNA with a preference for 5'-single-stranded DNA overhangs (PubMed:17357160, PubMed:21589879). Binds RNA G-quadruplex (rG4s) structures, including those located in the 5'-UTR of NRAS mRNA (PubMed:30256975). Involved in many cellular processes, which do not necessarily require its ATPase/helicase catalytic activities (Probable). Involved in transcription regulation (PubMed:16818630, PubMed:18264132). Positively regulates CDKN1A/WAF1/CIP1 transcription in an SP1-dependent manner, hence inhibits cell growth. This function requires its ATPase, but not helicase activity (PubMed:16818630, PubMed:18264132). CDKN1A up-regulation may be cell-type specific (PubMed:18264132). Binds CDH1/E-cadherin promoter and represses its transcription (PubMed:18264132). Potentiates HNF4A-mediated MTTP transcriptional activation; this function requires ATPase, but not helicase activity. Facilitates HNF4A acetylation, possibly catalyzed by CREBBP/EP300, thereby increasing the DNA-binding affinity of HNF4 to its response element. In addition, disrupts the interaction between HNF4 and SHP that forms inactive heterodimers and enhances the formation of active HNF4 homodimers. By promoting HNF4A-induced MTTP expression, may play a role in lipid homeostasis (PubMed:28128295). May positively regulate TP53 transcription (PubMed:28842590). Associates with mRNPs, predominantly with spliced mRNAs carrying an exon junction complex (EJC) (PubMed:17095540, PubMed:18596238). Involved in the regulation of translation initiation (PubMed:17667941, PubMed:18628297, PubMed:22872150). Not involved in the general process of translation, but promotes efficient translation of selected complex mRNAs, containing highly structured 5'-untranslated regions (UTR) (PubMed:20837705, PubMed:22872150). This function depends on helicase activity (PubMed:20837705, PubMed:22872150). Might facilitate translation by resolving secondary structures of 5'-UTRs during ribosome scanning (PubMed:20837705). Alternatively, may act prior to 43S ribosomal scanning and promote 43S pre-initiation complex entry to mRNAs exhibiting specific RNA motifs, by performing local remodeling of transcript structures located close to the cap moiety (PubMed:22872150). Independently of its ATPase activity, promotes the assembly of functional 80S ribosomes and disassembles from ribosomes prior to the translation elongation process (PubMed:22323517). Positively regulates the translation of cyclin E1/CCNE1 mRNA and consequently promotes G1/S-phase transition during the cell cycle (PubMed:20837705). May activate TP53 translation (PubMed:28842590). Required for endoplasmic reticulum stress-induced ATF4 mRNA translation (PubMed:29062139). Independently of its ATPase/helicase activity, enhances IRES-mediated translation; this activity requires interaction with EIF4E (PubMed:17667941, PubMed:22323517). Independently of its ATPase/helicase activity, has also been shown specifically repress cap-dependent translation, possibly by acting on translation initiation factor EIF4E (PubMed:17667941). Involved in innate immunity, acting as a viral RNA sensor. Binds viral RNAs and promotes the production of type I interferon (IFN-alpha and IFN-beta) (PubMed:20127681, PubMed:21170385, PubMed:31575075). Potentiate MAVS/RIGI-mediated induction of IFNB in early stages of infection (PubMed:20127681, PubMed:21170385, PubMed:33674311). Enhances IFNB1 expression via IRF3/IRF7 pathway and participates in NFKB activation in the presence of MAVS and TBK1 (PubMed:18583960, PubMed:18636090, PubMed:19913487, PubMed:21170385, PubMed:27980081). Involved in TBK1 and IKBKE-dependent IRF3 activation leading to IFNB induction, acts as a scaffolding adapter that links IKBKE and IRF3 and coordinates their activation (PubMed:23478265). Involved in the TLR7/TLR8 signaling pathway leading to type I interferon induction, including IFNA4 production. In this context, acts as an upstream regulator of IRF7 activation by MAP3K14/NIK and CHUK/IKKA. Stimulates CHUK autophosphorylation and activation following physiological activation of the TLR7 and TLR8 pathways, leading to MAP3K14/CHUK-mediated activatory phosphorylation of IRF7 (PubMed:30341167). Also stimulates MAP3K14/CHUK-dependent NF-kappa-B signaling (PubMed:30341167). Negatively regulates TNF-induced IL6 and IL8 expression, via the NF-kappa-B pathway. May act by interacting with RELA/p65 and trapping it in the cytoplasm (PubMed:27736973). May also bind IFNB promoter; the function is independent of IRF3 (PubMed:18583960). Involved in both stress and inflammatory responses (By similarity). Independently of its ATPase/helicase activity, required for efficient stress granule assembly through its interaction with EIF4E, hence promotes survival in stressed cells (PubMed:21883093). Independently of its helicase activity, regulates NLRP3 inflammasome assembly through interaction with NLRP3 and hence promotes cell death by pyroptosis during inflammation. This function is independent of helicase activity (By similarity). Therefore DDX3X availability may be used to interpret stress signals and choose between pro-survival stress granules and pyroptotic NLRP3 inflammasomes and serve as a live-or-die checkpoint in stressed cells (By similarity). In association with GSK3A/B, negatively regulates extrinsic apoptotic signaling pathway via death domain receptors, including TNFRSF10B, slowing down the rate of CASP3 activation following death receptor stimulation (PubMed:18846110). Cleavage by caspases may inactivate DDX3X and relieve the inhibition (PubMed:18846110). Independently of its ATPase/helicase activity, allosteric activator of CSNK1E. Stimulates CSNK1E-mediated phosphorylation of DVL2, thereby involved in the positive regulation of Wnt/beta-catenin signaling pathway. Also activates CSNK1A1 and CSNK1D in vitro, but it is uncertain if these targets are physiologically relevant (PubMed:23413191, PubMed:29222110). ATPase and casein kinase-activating functions are mutually exclusive (PubMed:29222110). May be involved in mitotic chromosome segregation (PubMed:21730191). {ECO:0000250|UniProtKB:Q62167, ECO:0000269|PubMed:16818630, ECO:0000269|PubMed:17095540, ECO:0000269|PubMed:17357160, ECO:0000269|PubMed:17667941, ECO:0000269|PubMed:18264132, ECO:0000269|PubMed:18583960, ECO:0000269|PubMed:18596238, ECO:0000269|PubMed:18628297, ECO:0000269|PubMed:18636090, ECO:0000269|PubMed:18846110, ECO:0000269|PubMed:19913487, ECO:0000269|PubMed:20127681, ECO:0000269|PubMed:20837705, ECO:0000269|PubMed:21170385, ECO:0000269|PubMed:21589879, ECO:0000269|PubMed:21730191, ECO:0000269|PubMed:21883093, ECO:0000269|PubMed:22323517, ECO:0000269|PubMed:22872150, ECO:0000269|PubMed:23413191, ECO:0000269|PubMed:23478265, ECO:0000269|PubMed:27736973, ECO:0000269|PubMed:27980081, ECO:0000269|PubMed:28128295, ECO:0000269|PubMed:28842590, ECO:0000269|PubMed:29062139, ECO:0000269|PubMed:29222110, ECO:0000269|PubMed:30256975, ECO:0000269|PubMed:30341167, ECO:0000269|PubMed:31575075, ECO:0000269|PubMed:33674311, ECO:0000305}.; FUNCTION: (Microbial infection) Facilitates hepatitis C virus (HCV) replication (PubMed:29899501). During infection, HCV core protein inhibits the interaction between MAVS and DDX3X and therefore impairs MAVS-dependent INFB induction and might recruit DDX3X to HCV replication complex (PubMed:21170385). {ECO:0000269|PubMed:21170385, ECO:0000269|PubMed:29899501}.; FUNCTION: (Microbial infection) Facilitates HIV-1 replication (PubMed:15507209, PubMed:18583960, PubMed:21589879, PubMed:22872150, PubMed:29899501). Acts as a cofactor for XPO1-mediated nuclear export of HIV-1 Rev RNAs (PubMed:15507209, PubMed:18583960, PubMed:29899501). This function is strongly stimulated in the presence of TBK1 and requires DDX3X ATPase activity (PubMed:18583960). {ECO:0000269|PubMed:15507209, ECO:0000269|PubMed:18583960, ECO:0000269|PubMed:21589879, ECO:0000269|PubMed:22872150, ECO:0000269|PubMed:29899501}.; FUNCTION: (Microbial infection) Facilitates Zika virus (ZIKV) replication. {ECO:0000269|PubMed:29899501}.; FUNCTION: (Microbial infection) Facilitates Dengue virus (DENV) replication. {ECO:0000269|PubMed:29899501}.; FUNCTION: (Microbial infection) Facilitates Venezuelan equine encephalitis virus (VEEV) replication. {ECO:0000269|PubMed:27105836}. |
O15061 | SYNM | S1163 | ochoa | Synemin (Desmuslin) | Type-VI intermediate filament (IF) which plays an important cytoskeletal role within the muscle cell cytoskeleton. It forms heteromeric IFs with desmin and/or vimentin, and via its interaction with cytoskeletal proteins alpha-dystrobrevin, dystrophin, talin-1, utrophin and vinculin, is able to link these heteromeric IFs to adherens-type junctions, such as to the costameres, neuromuscular junctions, and myotendinous junctions within striated muscle cells. {ECO:0000269|PubMed:11353857, ECO:0000269|PubMed:16777071, ECO:0000269|PubMed:18028034}. |
O15151 | MDM4 | S96 | psp | Protein Mdm4 (Double minute 4 protein) (Mdm2-like p53-binding protein) (Protein Mdmx) (p53-binding protein Mdm4) | Along with MDM2, contributes to TP53 regulation (PubMed:32300648). Inhibits p53/TP53- and TP73/p73-mediated cell cycle arrest and apoptosis by binding its transcriptional activation domain. Inhibits degradation of MDM2. Can reverse MDM2-targeted degradation of TP53 while maintaining suppression of TP53 transactivation and apoptotic functions. {ECO:0000269|PubMed:16163388, ECO:0000269|PubMed:16511572, ECO:0000269|PubMed:32300648}. |
O15523 | DDX3Y | S490 | ochoa | ATP-dependent RNA helicase DDX3Y (EC 3.6.4.13) (DEAD box protein 3, Y-chromosomal) | Probable ATP-dependent RNA helicase. During immune response, may enhance IFNB1 expression via IRF3/IRF7 pathway (By similarity). {ECO:0000250|UniProtKB:Q62095}. |
O43379 | WDR62 | S501 | ochoa | WD repeat-containing protein 62 | Required for cerebral cortical development. Plays a role in neuronal proliferation and migration (PubMed:20729831, PubMed:20890278). Plays a role in mother-centriole-dependent centriole duplication; the function also seems to involve CEP152, CDK5RAP2 and CEP63 through a stepwise assembled complex at the centrosome that recruits CDK2 required for centriole duplication (PubMed:26297806). {ECO:0000269|PubMed:20729831, ECO:0000269|PubMed:20890278, ECO:0000269|PubMed:26297806}. |
O60313 | OPA1 | S478 | ochoa | Dynamin-like GTPase OPA1, mitochondrial (EC 3.6.5.5) (Optic atrophy protein 1) [Cleaved into: Dynamin-like GTPase OPA1, long form (L-OPA1); Dynamin-like GTPase OPA1, short form (S-OPA1)] | Dynamin-related GTPase that is essential for normal mitochondrial morphology by mediating fusion of the mitochondrial inner membranes, regulating cristae morphology and maintaining respiratory chain function (PubMed:16778770, PubMed:17709429, PubMed:20185555, PubMed:24616225, PubMed:28628083, PubMed:28746876, PubMed:31922487, PubMed:32228866, PubMed:32567732, PubMed:33130824, PubMed:33237841, PubMed:37612504, PubMed:37612506). Exists in two forms: the transmembrane, long form (Dynamin-like GTPase OPA1, long form; L-OPA1), which is tethered to the inner mitochondrial membrane, and the short soluble form (Dynamin-like GTPase OPA1, short form; S-OPA1), which results from proteolytic cleavage and localizes in the intermembrane space (PubMed:31922487, PubMed:32228866, PubMed:33237841, PubMed:37612504, PubMed:37612506). Both forms (L-OPA1 and S-OPA1) cooperate to catalyze the fusion of the mitochondrial inner membrane (PubMed:31922487, PubMed:37612504, PubMed:37612506). The equilibrium between L-OPA1 and S-OPA1 is essential: excess levels of S-OPA1, produced by cleavage by OMA1 following loss of mitochondrial membrane potential, lead to an impaired equilibrium between L-OPA1 and S-OPA1, inhibiting mitochondrial fusion (PubMed:20038677, PubMed:31922487). The balance between L-OPA1 and S-OPA1 also influences cristae shape and morphology (By similarity). Involved in remodeling cristae and the release of cytochrome c during apoptosis (By similarity). Proteolytic processing by PARL in response to intrinsic apoptotic signals may lead to disassembly of OPA1 oligomers and release of the caspase activator cytochrome C (CYCS) into the mitochondrial intermembrane space (By similarity). Acts as a regulator of T-helper Th17 cells, which are characterized by cells with fused mitochondria with tight cristae, by mediating mitochondrial membrane remodeling: OPA1 is required for interleukin-17 (IL-17) production (By similarity). Its role in mitochondrial morphology is required for mitochondrial genome maintenance (PubMed:18158317, PubMed:20974897). {ECO:0000250|UniProtKB:P58281, ECO:0000269|PubMed:16778770, ECO:0000269|PubMed:17709429, ECO:0000269|PubMed:18158317, ECO:0000269|PubMed:20038677, ECO:0000269|PubMed:20185555, ECO:0000269|PubMed:20974897, ECO:0000269|PubMed:24616225, ECO:0000269|PubMed:28628083, ECO:0000269|PubMed:28746876, ECO:0000269|PubMed:31922487, ECO:0000269|PubMed:32228866, ECO:0000269|PubMed:32567732, ECO:0000269|PubMed:33130824, ECO:0000269|PubMed:33237841, ECO:0000269|PubMed:37612504, ECO:0000269|PubMed:37612506}.; FUNCTION: [Dynamin-like GTPase OPA1, long form]: Constitutes the transmembrane long form (L-OPA1) that plays a central role in mitochondrial inner membrane fusion and cristae morphology (PubMed:31922487, PubMed:32228866, PubMed:37612504, PubMed:37612506). L-OPA1 and the soluble short form (S-OPA1) form higher-order helical assemblies that coordinate the fusion of mitochondrial inner membranes (PubMed:31922487, PubMed:37612504, PubMed:37612506). Inner membrane-anchored L-OPA1 molecules initiate membrane remodeling by recruiting soluble S-OPA1 to rapidly polymerize into a flexible cylindrical scaffold encaging the mitochondrial inner membrane (PubMed:37612504, PubMed:37612506). Once at the membrane surface, the formation of S-OPA1 helices induce bilayer curvature (PubMed:37612504, PubMed:37612506). OPA1 dimerization through the paddle region, which inserts into cardiolipin-containing membrane, promotes GTP hydrolysis and the helical assembly of a flexible OPA1 lattice on the membrane, which drives membrane curvature and mitochondrial fusion (PubMed:28628083, PubMed:37612504, PubMed:37612506). Plays a role in the maintenance and remodeling of mitochondrial cristae, some invaginations of the mitochondrial inner membrane that provide an increase in the surface area (PubMed:32567732, PubMed:33130824). Probably acts by forming helical filaments at the inside of inner membrane tubes with the shape and dimensions of crista junctions (By similarity). The equilibrium between L-OPA1 and S-OPA1 influences cristae shape and morphology: increased L-OPA1 levels promote cristae stacking and elongated mitochondria, while increased S-OPA1 levels correlated with irregular cristae packing and round mitochondria shape (By similarity). {ECO:0000250|UniProtKB:G0SGC7, ECO:0000250|UniProtKB:P58281, ECO:0000269|PubMed:28628083, ECO:0000269|PubMed:31922487, ECO:0000269|PubMed:32228866, ECO:0000269|PubMed:32567732, ECO:0000269|PubMed:33130824, ECO:0000269|PubMed:37612504, ECO:0000269|PubMed:37612506}.; FUNCTION: [Dynamin-like GTPase OPA1, short form]: Constitutes the soluble short form (S-OPA1) generated by cleavage by OMA1, which plays a central role in mitochondrial inner membrane fusion and cristae morphology (PubMed:31922487, PubMed:32228866, PubMed:32245890, PubMed:37612504, PubMed:37612506). The transmembrane long form (L-OPA1) and the S-OPA1 form higher-order helical assemblies that coordinate the fusion of mitochondrial inner membranes (PubMed:31922487, PubMed:32228866, PubMed:37612504, PubMed:37612506). Inner membrane-anchored L-OPA1 molecules initiate membrane remodeling by recruiting soluble S-OPA1 to rapidly polymerize into a flexible cylindrical scaffold encaging the mitochondrial inner membrane (PubMed:32228866, PubMed:37612504, PubMed:37612506). Once at the membrane surface, the formation of S-OPA1 helices induce bilayer curvature (PubMed:37612504, PubMed:37612506). OPA1 dimerization through the paddle region, which inserts into cardiolipin-containing membrane, promotes GTP hydrolysis and the helical assembly of a flexible OPA1 lattice on the membrane, which drives membrane curvature and mitochondrial fusion (PubMed:28628083, PubMed:37612504, PubMed:37612506). Excess levels of S-OPA1 produced by cleavage by OMA1 following stress conditions that induce loss of mitochondrial membrane potential, lead to an impaired equilibrium between L-OPA1 and S-OPA1, thereby inhibiting mitochondrial fusion (PubMed:20038677). Involved in mitochondrial safeguard in response to transient mitochondrial membrane depolarization by mediating flickering: cleavage by OMA1 leads to excess production of S-OPA1, preventing mitochondrial hyperfusion (By similarity). Plays a role in the maintenance and remodeling of mitochondrial cristae, some invaginations of the mitochondrial inner membrane that provide an increase in the surface area (PubMed:32245890). Probably acts by forming helical filaments at the inside of inner membrane tubes with the shape and dimensions of crista junctions (By similarity). The equilibrium between L-OPA1 and S-OPA1 influences cristae shape and morphology: increased L-OPA1 levels promote cristae stacking and elongated mitochondria, while increased S-OPA1 levels correlated with irregular cristae packing and round mitochondria shape (By similarity). {ECO:0000250|UniProtKB:G0SGC7, ECO:0000250|UniProtKB:P58281, ECO:0000269|PubMed:20038677, ECO:0000269|PubMed:28628083, ECO:0000269|PubMed:31922487, ECO:0000269|PubMed:32228866, ECO:0000269|PubMed:32245890, ECO:0000269|PubMed:37612504, ECO:0000269|PubMed:37612506}.; FUNCTION: [Isoform 1]: Coexpression of isoform 1 with shorter alternative products is required for optimal activity in promoting mitochondrial fusion. {ECO:0000269|PubMed:17709429}.; FUNCTION: [Isoform 4]: Isoforms that contain the alternative exon 4b are required for mitochondrial genome maintenance, possibly by anchoring the mitochondrial nucleoids to the inner mitochondrial membrane. {ECO:0000269|PubMed:20974897}.; FUNCTION: [Isoform 5]: Isoforms that contain the alternative exon 4b are required for mitochondrial genome maintenance, possibly by anchoring the mitochondrial nucleoids to the inner mitochondrial membrane. {ECO:0000269|PubMed:20974897}. |
O60356 | NUPR1 | S58 | ochoa | Nuclear protein 1 (Candidate of metastasis 1) (Protein p8) | Transcription regulator that converts stress signals into a program of gene expression that empowers cells with resistance to the stress induced by a change in their microenvironment. Thereby participates in the regulation of many processes namely cell-cycle, apoptosis, autophagy and DNA repair responses (PubMed:11056169, PubMed:11940591, PubMed:16300740, PubMed:16478804, PubMed:18690848, PubMed:19650074, PubMed:19723804, PubMed:20181828, PubMed:22565310, PubMed:22858377, PubMed:30451898). Controls cell cycle progression and protects cells from genotoxic stress induced by doxorubicin through the complex formation with TP53 and EP300 that binds CDKN1A promoter leading to transcriptional induction of CDKN1A (PubMed:18690848). Protects pancreatic cancer cells from stress-induced cell death by binding the RELB promoter and activating its transcription, leading to IER3 transactivation (PubMed:22565310). Negatively regulates apoptosis through interaction with PTMA (PubMed:16478804). Inhibits autophagy-induced apoptosis in cardiac cells through FOXO3 interaction, inducing cytoplasmic translocation of FOXO3 thereby preventing the FOXO3 association with the pro-autophagic BNIP3 promoter (PubMed:20181828). Inhibits cell growth and facilitates programmed cell death by apoptosis after adriamycin-induced DNA damage through transactivation of TP53 (By similarity). Regulates methamphetamine-induced apoptosis and autophagy through DDIT3-mediated endoplasmic reticulum stress pathway (By similarity). Participates in DNA repair following gamma-irradiation by facilitating DNA access of the transcription machinery through interaction with MSL1 leading to inhibition of histone H4' Lys-16' acetylation (H4K16ac) (PubMed:19650074). Coactivator of PAX2 transcription factor activity, both by recruiting EP300 to increase PAX2 transcription factor activity and by binding PAXIP1 to suppress PAXIP1-induced inhibition on PAX2 (PubMed:11940591). Positively regulates cell cycle progression through interaction with COPS5 inducing cytoplasmic translocation of CDKN1B leading to the CDKN1B degradation (PubMed:16300740). Coordinates, through its interaction with EP300, the assiociation of MYOD1, EP300 and DDX5 to the MYOG promoter, leading to inhibition of cell-cycle progression and myogenic differentiation promotion (PubMed:19723804). Negatively regulates beta cell proliferation via inhibition of cell-cycle regulatory genes expression through the suppression of their promoter activities (By similarity). Also required for LHB expression and ovarian maturation (By similarity). Exacerbates CNS inflammation and demyelination upon cuprizone treatment (By similarity). {ECO:0000250|UniProtKB:O54842, ECO:0000250|UniProtKB:Q9WTK0, ECO:0000269|PubMed:11056169, ECO:0000269|PubMed:11940591, ECO:0000269|PubMed:16300740, ECO:0000269|PubMed:16478804, ECO:0000269|PubMed:18690848, ECO:0000269|PubMed:19650074, ECO:0000269|PubMed:19723804, ECO:0000269|PubMed:20181828, ECO:0000269|PubMed:22565310, ECO:0000269|PubMed:22858377, ECO:0000269|PubMed:30451898}. |
O60563 | CCNT1 | S22 | ochoa | Cyclin-T1 (CycT1) (Cyclin-T) | Regulatory subunit of the cyclin-dependent kinase pair (CDK9/cyclin-T1) complex, also called positive transcription elongation factor B (P-TEFb), which facilitates the transition from abortive to productive elongation by phosphorylating the CTD (C-terminal domain) of the large subunit of RNA polymerase II (RNA Pol II) (PubMed:16109376, PubMed:16109377, PubMed:30134174, PubMed:35393539). Required to activate the protein kinase activity of CDK9: acts by mediating formation of liquid-liquid phase separation (LLPS) that enhances binding of P-TEFb to the CTD of RNA Pol II (PubMed:29849146, PubMed:35393539). {ECO:0000269|PubMed:16109376, ECO:0000269|PubMed:16109377, ECO:0000269|PubMed:29849146, ECO:0000269|PubMed:30134174, ECO:0000269|PubMed:35393539}.; FUNCTION: (Microbial infection) In case of HIV or SIV infections, binds to the transactivation domain of the viral nuclear transcriptional activator, Tat, thereby increasing Tat's affinity for the transactivating response RNA element (TAR RNA). Serves as an essential cofactor for Tat, by promoting RNA Pol II activation, allowing transcription of viral genes. {ECO:0000269|PubMed:10329125, ECO:0000269|PubMed:10329126}. |
O60711 | LPXN | S267 | ochoa | Leupaxin | Transcriptional coactivator for androgen receptor (AR) and serum response factor (SRF). Contributes to the regulation of cell adhesion, spreading and cell migration and acts as a negative regulator in integrin-mediated cell adhesion events. Suppresses the integrin-induced tyrosine phosphorylation of paxillin (PXN). May play a critical role as an adapter protein in the formation of the adhesion zone in osteoclasts. Negatively regulates B-cell antigen receptor (BCR) signaling. {ECO:0000269|PubMed:17640867, ECO:0000269|PubMed:18451096, ECO:0000269|PubMed:18497331, ECO:0000269|PubMed:20543562}. |
O60716 | CTNND1 | S651 | ochoa | Catenin delta-1 (Cadherin-associated Src substrate) (CAS) (p120 catenin) (p120(ctn)) (p120(cas)) | Key regulator of cell-cell adhesion that associates with and regulates the cell adhesion properties of both C-, E- and N-cadherins, being critical for their surface stability (PubMed:14610055, PubMed:20371349). Promotes localization and retention of DSG3 at cell-cell junctions, via its interaction with DSG3 (PubMed:18343367). Beside cell-cell adhesion, regulates gene transcription through several transcription factors including ZBTB33/Kaiso2 and GLIS2, and the activity of Rho family GTPases and downstream cytoskeletal dynamics (PubMed:10207085, PubMed:20371349). Implicated both in cell transformation by SRC and in ligand-induced receptor signaling through the EGF, PDGF, CSF-1 and ERBB2 receptors (PubMed:17344476). {ECO:0000269|PubMed:10207085, ECO:0000269|PubMed:14610055, ECO:0000269|PubMed:17344476, ECO:0000269|PubMed:18343367, ECO:0000269|PubMed:20371349}. |
O75044 | SRGAP2 | S916 | ochoa | SLIT-ROBO Rho GTPase-activating protein 2 (srGAP2) (Formin-binding protein 2) (Rho GTPase-activating protein 34) | Postsynaptic RAC1 GTPase activating protein (GAP) that plays a key role in neuronal morphogenesis and migration mainly during development of the cerebral cortex (PubMed:20810653, PubMed:27373832, PubMed:28333212). Regulates excitatory and inhibitory synapse maturation and density in cortical pyramidal neurons (PubMed:22559944, PubMed:27373832). SRGAP2/SRGAP2A limits excitatory and inhibitory synapse density through its RAC1-specific GTPase activating activity, while it promotes maturation of both excitatory and inhibitory synapses through its ability to bind to the postsynaptic scaffolding protein HOMER1 at excitatory synapses, and the postsynaptic protein GPHN at inhibitory synapses (By similarity). Mechanistically, acts by binding and deforming membranes, thereby regulating actin dynamics to regulate cell migration and differentiation (PubMed:27373832). Promotes cell repulsion and contact inhibition of locomotion: localizes to protrusions with curved edges and controls the duration of RAC1 activity in contact protrusions (By similarity). In non-neuronal cells, may also play a role in cell migration by regulating the formation of lamellipodia and filopodia (PubMed:20810653, PubMed:21148482). {ECO:0000250|UniProtKB:Q91Z67, ECO:0000269|PubMed:20810653, ECO:0000269|PubMed:21148482, ECO:0000269|PubMed:22559944, ECO:0000269|PubMed:27373832, ECO:0000269|PubMed:28333212}. |
O75420 | GIGYF1 | S148 | ochoa | GRB10-interacting GYF protein 1 (PERQ amino acid-rich with GYF domain-containing protein 1) | May act cooperatively with GRB10 to regulate tyrosine kinase receptor signaling. May increase IGF1 receptor phosphorylation under IGF1 stimulation as well as phosphorylation of IRS1 and SHC1 (By similarity). {ECO:0000250, ECO:0000269|PubMed:12771153}. |
O75420 | GIGYF1 | S230 | ochoa | GRB10-interacting GYF protein 1 (PERQ amino acid-rich with GYF domain-containing protein 1) | May act cooperatively with GRB10 to regulate tyrosine kinase receptor signaling. May increase IGF1 receptor phosphorylation under IGF1 stimulation as well as phosphorylation of IRS1 and SHC1 (By similarity). {ECO:0000250, ECO:0000269|PubMed:12771153}. |
O75616 | ERAL1 | S173 | ochoa|psp | GTPase Era, mitochondrial (H-ERA) (hERA) (Conserved ERA-like GTPase) (CEGA) (ERA-W) (ERA-like protein 1) | Probable GTPase that plays a role in the mitochondrial ribosomal small subunit assembly. Specifically binds the 12S mitochondrial rRNA (12S mt-rRNA) to a 33 nucleotide section delineating the 3' terminal stem-loop region. May act as a chaperone that protects the 12S mt-rRNA on the 28S mitoribosomal subunit during ribosomal small subunit assembly. {ECO:0000269|PubMed:20430825, ECO:0000269|PubMed:20604745, ECO:0000269|PubMed:28449065}. |
O94762 | RECQL5 | S815 | ochoa | ATP-dependent DNA helicase Q5 (EC 5.6.2.4) (DNA 3'-5' helicase RecQ5) (DNA helicase, RecQ-like type 5) (RecQ5) (RecQ protein-like 5) | DNA helicase that plays an important role in DNA replication, transcription and repair (PubMed:20643585, PubMed:22973052, PubMed:28100692). Probably unwinds DNA in a 3'-5' direction (Probable) (PubMed:28100692). Binds to the RNA polymerase II subunit POLR2A during transcription elongation and suppresses transcription-associated genomic instability (PubMed:20231364). Also associates with POLR1A and enforces the stability of ribosomal DNA arrays (PubMed:27502483). Plays an important role in mitotic chromosome separation after cross-over events and cell cycle progress (PubMed:22013166). Mechanistically, removes RAD51 filaments protecting stalled replication forks at common fragile sites and stimulates MUS81-EME1 endonuclease leading to mitotic DNA synthesis (PubMed:28575661). Required for efficient DNA repair, including repair of inter-strand cross-links (PubMed:23715498). Stimulates DNA decatenation mediated by TOP2A. Prevents sister chromatid exchange and homologous recombination. A core helicase fragment (residues 11-609) binds preferentially to splayed duplex, looped and ssDNA (PubMed:28100692). {ECO:0000269|PubMed:20231364, ECO:0000269|PubMed:20348101, ECO:0000269|PubMed:20643585, ECO:0000269|PubMed:22013166, ECO:0000269|PubMed:22973052, ECO:0000269|PubMed:23715498, ECO:0000269|PubMed:23748380, ECO:0000269|PubMed:27502483, ECO:0000269|PubMed:28100692, ECO:0000269|PubMed:28575661, ECO:0000305|PubMed:28100692}. |
O94842 | TOX4 | S178 | ochoa | TOX high mobility group box family member 4 | Transcription factor that modulates cell fate reprogramming from the somatic state to the pluripotent and neuronal fate (By similarity). In liver, controls the expression of hormone-regulated gluconeogenic genes such as G6PC1 and PCK1 (By similarity). This regulation is independent of the insulin receptor activation (By similarity). Also acts as a regulatory component of protein phosphatase 1 (PP1) complexes (PubMed:39603239, PubMed:39603240). Component of the PNUTS-PP1 protein phosphatase complex, a PP1 complex that regulates RNA polymerase II transcription pause-release (PubMed:39603239, PubMed:39603240). PNUTS-PP1 also plays a role in the control of chromatin structure and cell cycle progression during the transition from mitosis into interphase (PubMed:20516061). {ECO:0000250|UniProtKB:Q8BU11, ECO:0000269|PubMed:20516061, ECO:0000269|PubMed:39603239, ECO:0000269|PubMed:39603240}. |
O94900 | TOX | S216 | ochoa | Thymocyte selection-associated high mobility group box protein TOX (Thymus high mobility group box protein TOX) | Transcriptional regulator with a major role in neural stem cell commitment and corticogenesis as well as in lymphoid cell development and lymphoid tissue organogenesis (By similarity). Binds to GC-rich DNA sequences in the proximity of transcription start sites and may alter chromatin structure, modifying access of transcription factors to DNA. During cortical development, controls the neural stem cell pool by inhibiting the switch from proliferative to differentiating progenitors. Beyond progenitor cells, promotes neurite outgrowth in newborn neurons migrating to reach the cortical plate. May activate or repress critical genes for neural stem cell fate such as SOX2, EOMES and ROBO2 (By similarity). Plays an essential role in the development of lymphoid tissue-inducer (LTi) cells, a subset necessary for the formation of secondary lymphoid organs: peripheral lymph nodes and Peyer's patches. Acts as a developmental checkpoint and regulates thymocyte positive selection toward T cell lineage commitment. Required for the development of various T cell subsets, including CD4-positive helper T cells, CD8-positive cytotoxic T cells, regulatory T cells and CD1D-dependent natural killer T (NKT) cells. Required for the differentiation of common lymphoid progenitors (CMP) to innate lymphoid cells (ILC) (By similarity). May regulate the NOTCH-mediated gene program, promoting differentiation of the ILC lineage. Required at the progenitor phase of NK cell development in the bone marrow to specify NK cell lineage commitment (By similarity) (PubMed:21126536). Upon chronic antigen stimulation, diverts T cell development by promoting the generation of exhaustive T cells, while suppressing effector and memory T cell programming. May regulate the expression of genes encoding inhibitory receptors such as PDCD1 and induce the exhaustion program, to prevent the overstimulation of T cells and activation-induced cell death (By similarity). {ECO:0000250|UniProtKB:Q66JW3, ECO:0000269|PubMed:21126536}. |
O95279 | KCNK5 | S385 | ochoa | Potassium channel subfamily K member 5 (Acid-sensitive potassium channel protein TASK-2) (TWIK-related acid-sensitive K(+) channel 2) | K(+) channel that conducts voltage-dependent outward rectifying currents upon membrane depolarization. Voltage sensing is coupled to K(+) electrochemical gradient in an 'ion flux gating' mode where outward but not inward ion flow opens the gate (PubMed:26919430, PubMed:36063992, PubMed:9812978). Homo- and heterodimerizes to form functional channels with distinct regulatory and gating properties (PubMed:36063992). {ECO:0000269|PubMed:26919430, ECO:0000269|PubMed:36063992, ECO:0000269|PubMed:9812978}. |
O95936 | EOMES | S596 | ochoa | Eomesodermin homolog (T-box brain protein 2) (T-brain-2) (TBR-2) | Functions as a transcriptional activator playing a crucial role during development. Functions in trophoblast differentiation and later in gastrulation, regulating both mesoderm delamination and endoderm specification. Plays a role in brain development being required for the specification and the proliferation of the intermediate progenitor cells and their progeny in the cerebral cortex (PubMed:17353897). Required for differentiation and migration of unipolar dendritic brush cells (PubMed:33488348). Also involved in the differentiation of CD8+ T-cells during immune response regulating the expression of lytic effector genes (PubMed:17566017). {ECO:0000269|PubMed:17353897, ECO:0000269|PubMed:17566017, ECO:0000269|PubMed:33488348}. |
O95985 | TOP3B | S788 | ochoa | DNA topoisomerase 3-beta-1 (EC 5.6.2.1) (DNA topoisomerase III beta-1) | Releases the supercoiling and torsional tension of DNA introduced during the DNA replication and transcription by transiently cleaving and rejoining one strand of the DNA duplex. Introduces a single-strand break via transesterification at a target site in duplex DNA. The scissile phosphodiester is attacked by the catalytic tyrosine of the enzyme, resulting in the formation of a DNA-(5'-phosphotyrosyl)-enzyme intermediate and the expulsion of a 3'-OH DNA strand. The free DNA strand than undergoes passage around the unbroken strand thus removing DNA supercoils. Finally, in the religation step, the DNA 3'-OH attacks the covalent intermediate to expel the active-site tyrosine and restore the DNA phosphodiester backbone (By similarity). Possesses negatively supercoiled DNA relaxing activity. {ECO:0000250}. |
P04049 | RAF1 | S29 | ochoa|psp | RAF proto-oncogene serine/threonine-protein kinase (EC 2.7.11.1) (Proto-oncogene c-RAF) (cRaf) (Raf-1) | Serine/threonine-protein kinase that acts as a regulatory link between the membrane-associated Ras GTPases and the MAPK/ERK cascade, and this critical regulatory link functions as a switch determining cell fate decisions including proliferation, differentiation, apoptosis, survival and oncogenic transformation. RAF1 activation initiates a mitogen-activated protein kinase (MAPK) cascade that comprises a sequential phosphorylation of the dual-specific MAPK kinases (MAP2K1/MEK1 and MAP2K2/MEK2) and the extracellular signal-regulated kinases (MAPK3/ERK1 and MAPK1/ERK2). The phosphorylated form of RAF1 (on residues Ser-338 and Ser-339, by PAK1) phosphorylates BAD/Bcl2-antagonist of cell death at 'Ser-75'. Phosphorylates adenylyl cyclases: ADCY2, ADCY5 and ADCY6, resulting in their activation. Phosphorylates PPP1R12A resulting in inhibition of the phosphatase activity. Phosphorylates TNNT2/cardiac muscle troponin T. Can promote NF-kB activation and inhibit signal transducers involved in motility (ROCK2), apoptosis (MAP3K5/ASK1 and STK3/MST2), proliferation and angiogenesis (RB1). Can protect cells from apoptosis also by translocating to the mitochondria where it binds BCL2 and displaces BAD/Bcl2-antagonist of cell death. Regulates Rho signaling and migration, and is required for normal wound healing. Plays a role in the oncogenic transformation of epithelial cells via repression of the TJ protein, occludin (OCLN) by inducing the up-regulation of a transcriptional repressor SNAI2/SLUG, which induces down-regulation of OCLN. Restricts caspase activation in response to selected stimuli, notably Fas stimulation, pathogen-mediated macrophage apoptosis, and erythroid differentiation. {ECO:0000269|PubMed:11427728, ECO:0000269|PubMed:11719507, ECO:0000269|PubMed:15385642, ECO:0000269|PubMed:15618521, ECO:0000269|PubMed:15849194, ECO:0000269|PubMed:16892053, ECO:0000269|PubMed:16924233, ECO:0000269|PubMed:9360956}. |
P04626 | ERBB2 | S1107 | ochoa | Receptor tyrosine-protein kinase erbB-2 (EC 2.7.10.1) (Metastatic lymph node gene 19 protein) (MLN 19) (Proto-oncogene Neu) (Proto-oncogene c-ErbB-2) (Tyrosine kinase-type cell surface receptor HER2) (p185erbB2) (CD antigen CD340) | Protein tyrosine kinase that is part of several cell surface receptor complexes, but that apparently needs a coreceptor for ligand binding. Essential component of a neuregulin-receptor complex, although neuregulins do not interact with it alone. GP30 is a potential ligand for this receptor. Regulates outgrowth and stabilization of peripheral microtubules (MTs). Upon ERBB2 activation, the MEMO1-RHOA-DIAPH1 signaling pathway elicits the phosphorylation and thus the inhibition of GSK3B at cell membrane. This prevents the phosphorylation of APC and CLASP2, allowing its association with the cell membrane. In turn, membrane-bound APC allows the localization of MACF1 to the cell membrane, which is required for microtubule capture and stabilization. {ECO:0000305}.; FUNCTION: In the nucleus is involved in transcriptional regulation. Associates with the 5'-TCAAATTC-3' sequence in the PTGS2/COX-2 promoter and activates its transcription. Implicated in transcriptional activation of CDKN1A; the function involves STAT3 and SRC. Involved in the transcription of rRNA genes by RNA Pol I and enhances protein synthesis and cell growth. {ECO:0000269|PubMed:10358079, ECO:0000269|PubMed:15380516, ECO:0000269|PubMed:21555369}. |
P06239 | LCK | S194 | ochoa|psp | Tyrosine-protein kinase Lck (EC 2.7.10.2) (Leukocyte C-terminal Src kinase) (LSK) (Lymphocyte cell-specific protein-tyrosine kinase) (Protein YT16) (Proto-oncogene Lck) (T cell-specific protein-tyrosine kinase) (p56-LCK) | Non-receptor tyrosine-protein kinase that plays an essential role in the selection and maturation of developing T-cells in the thymus and in the function of mature T-cells. Plays a key role in T-cell antigen receptor (TCR)-linked signal transduction pathways. Constitutively associated with the cytoplasmic portions of the CD4 and CD8 surface receptors. Association of the TCR with a peptide antigen-bound MHC complex facilitates the interaction of CD4 and CD8 with MHC class II and class I molecules, respectively, thereby recruiting the associated LCK protein to the vicinity of the TCR/CD3 complex. LCK then phosphorylates tyrosine residues within the immunoreceptor tyrosine-based activation motifs (ITAM) of the cytoplasmic tails of the TCR-gamma chains and CD3 subunits, initiating the TCR/CD3 signaling pathway. Once stimulated, the TCR recruits the tyrosine kinase ZAP70, that becomes phosphorylated and activated by LCK. Following this, a large number of signaling molecules are recruited, ultimately leading to lymphokine production. LCK also contributes to signaling by other receptor molecules. Associates directly with the cytoplasmic tail of CD2, which leads to hyperphosphorylation and activation of LCK. Also plays a role in the IL2 receptor-linked signaling pathway that controls the T-cell proliferative response. Binding of IL2 to its receptor results in increased activity of LCK. Is expressed at all stages of thymocyte development and is required for the regulation of maturation events that are governed by both pre-TCR and mature alpha beta TCR. Phosphorylates other substrates including RUNX3, PTK2B/PYK2, the microtubule-associated protein MAPT, RHOH or TYROBP. Interacts with FYB2 (PubMed:27335501). {ECO:0000269|PubMed:16339550, ECO:0000269|PubMed:16709819, ECO:0000269|PubMed:20028775, ECO:0000269|PubMed:20100835, ECO:0000269|PubMed:20851766, ECO:0000269|PubMed:21269457, ECO:0000269|PubMed:22080863, ECO:0000269|PubMed:27335501, ECO:0000269|PubMed:38614099}. |
P06241 | FYN | Y39 | psp | Tyrosine-protein kinase Fyn (EC 2.7.10.2) (Proto-oncogene Syn) (Proto-oncogene c-Fyn) (Src-like kinase) (SLK) (p59-Fyn) | Non-receptor tyrosine-protein kinase that plays a role in many biological processes including regulation of cell growth and survival, cell adhesion, integrin-mediated signaling, cytoskeletal remodeling, cell motility, immune response and axon guidance (PubMed:11536198, PubMed:15489916, PubMed:15557120, PubMed:16387660, PubMed:20100835, PubMed:7568038, PubMed:7822789). Inactive FYN is phosphorylated on its C-terminal tail within the catalytic domain (PubMed:15489916). Following activation by PKA, the protein subsequently associates with PTK2/FAK1, allowing PTK2/FAK1 phosphorylation, activation and targeting to focal adhesions (PubMed:15489916). Involved in the regulation of cell adhesion and motility through phosphorylation of CTNNB1 (beta-catenin) and CTNND1 (delta-catenin) (PubMed:17194753). Regulates cytoskeletal remodeling by phosphorylating several proteins including the actin regulator WAS and the microtubule-associated proteins MAP2 and MAPT (PubMed:14707117, PubMed:15536091). Promotes cell survival by phosphorylating AGAP2/PIKE-A and preventing its apoptotic cleavage (PubMed:16841086). Participates in signal transduction pathways that regulate the integrity of the glomerular slit diaphragm (an essential part of the glomerular filter of the kidney) by phosphorylating several slit diaphragm components including NPHS1, KIRREL1 and TRPC6 (PubMed:14761972, PubMed:18258597, PubMed:19179337). Plays a role in neural processes by phosphorylating DPYSL2, a multifunctional adapter protein within the central nervous system, ARHGAP32, a regulator for Rho family GTPases implicated in various neural functions, and SNCA, a small pre-synaptic protein (PubMed:11162638, PubMed:12788081, PubMed:19652227). Involved in reelin signaling by mediating phosphorylation of DAB1 following reelin (RELN)-binding to its receptor (By similarity). Participates in the downstream signaling pathways that lead to T-cell differentiation and proliferation following T-cell receptor (TCR) stimulation (PubMed:22080863). Phosphorylates PTK2B/PYK2 in response to T-cell receptor activation (PubMed:20028775). Also participates in negative feedback regulation of TCR signaling through phosphorylation of PAG1, thereby promoting interaction between PAG1 and CSK and recruitment of CSK to lipid rafts (PubMed:18056706). CSK maintains LCK and FYN in an inactive form (By similarity). Promotes CD28-induced phosphorylation of VAV1 (PubMed:11005864). In mast cells, phosphorylates CLNK after activation of immunoglobulin epsilon receptor signaling (By similarity). Can also promote CD244-mediated NK cell activation (PubMed:15713798). {ECO:0000250|UniProtKB:P39688, ECO:0000269|PubMed:11005864, ECO:0000269|PubMed:11162638, ECO:0000269|PubMed:11536198, ECO:0000269|PubMed:12788081, ECO:0000269|PubMed:14707117, ECO:0000269|PubMed:14761972, ECO:0000269|PubMed:15536091, ECO:0000269|PubMed:15557120, ECO:0000269|PubMed:15713798, ECO:0000269|PubMed:16387660, ECO:0000269|PubMed:16841086, ECO:0000269|PubMed:17194753, ECO:0000269|PubMed:18056706, ECO:0000269|PubMed:18258597, ECO:0000269|PubMed:19179337, ECO:0000269|PubMed:19652227, ECO:0000269|PubMed:20028775, ECO:0000269|PubMed:20100835, ECO:0000269|PubMed:22080863, ECO:0000269|PubMed:7568038, ECO:0000269|PubMed:7822789, ECO:0000303|PubMed:15489916}. |
P08237 | PFKM | S667 | ochoa | ATP-dependent 6-phosphofructokinase, muscle type (ATP-PFK) (PFK-M) (EC 2.7.1.11) (6-phosphofructokinase type A) (Phosphofructo-1-kinase isozyme A) (PFK-A) (Phosphohexokinase) | Catalyzes the phosphorylation of D-fructose 6-phosphate to fructose 1,6-bisphosphate by ATP, the first committing step of glycolysis. |
P0C7T5 | ATXN1L | S289 | ochoa | Ataxin-1-like (Brother of ataxin-1) (Brother of ATXN1) | Chromatin-binding factor that repress Notch signaling in the absence of Notch intracellular domain by acting as a CBF1 corepressor. Binds to the HEY promoter and might assist, along with NCOR2, RBPJ-mediated repression (PubMed:21475249). Can suppress ATXN1 cytotoxicity in spinocerebellar ataxia type 1 (SCA1). In concert with CIC and ATXN1, involved in brain development (By similarity). {ECO:0000250|UniProtKB:P0C7T6, ECO:0000269|PubMed:21475249}. |
P0CG12 | DERPC | S302 | ochoa | Decreased expression in renal and prostate cancer protein | Potential tumor suppressor. Inhibits prostate tumor cell growth, when overexpressed. {ECO:0000269|PubMed:12477976}. |
P10636 | MAPT | S46 | ochoa | Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) | Promotes microtubule assembly and stability, and might be involved in the establishment and maintenance of neuronal polarity (PubMed:21985311). The C-terminus binds axonal microtubules while the N-terminus binds neural plasma membrane components, suggesting that tau functions as a linker protein between both (PubMed:21985311, PubMed:32961270). Axonal polarity is predetermined by TAU/MAPT localization (in the neuronal cell) in the domain of the cell body defined by the centrosome. The short isoforms allow plasticity of the cytoskeleton whereas the longer isoforms may preferentially play a role in its stabilization. {ECO:0000269|PubMed:21985311, ECO:0000269|PubMed:32961270}. |
P11021 | HSPA5 | T62 | psp | Endoplasmic reticulum chaperone BiP (EC 3.6.4.10) (78 kDa glucose-regulated protein) (GRP-78) (Binding-immunoglobulin protein) (BiP) (Heat shock protein 70 family protein 5) (HSP70 family protein 5) (Heat shock protein family A member 5) (Immunoglobulin heavy chain-binding protein) | Endoplasmic reticulum chaperone that plays a key role in protein folding and quality control in the endoplasmic reticulum lumen (PubMed:2294010, PubMed:23769672, PubMed:23990668, PubMed:28332555). Involved in the correct folding of proteins and degradation of misfolded proteins via its interaction with DNAJC10/ERdj5, probably to facilitate the release of DNAJC10/ERdj5 from its substrate (By similarity). Acts as a key repressor of the EIF2AK3/PERK and ERN1/IRE1-mediated unfolded protein response (UPR) (PubMed:11907036, PubMed:1550958, PubMed:19538957, PubMed:36739529). In the unstressed endoplasmic reticulum, recruited by DNAJB9/ERdj4 to the luminal region of ERN1/IRE1, leading to disrupt the dimerization of ERN1/IRE1, thereby inactivating ERN1/IRE1 (By similarity). Also binds and inactivates EIF2AK3/PERK in unstressed cells (PubMed:11907036). Accumulation of misfolded protein in the endoplasmic reticulum causes release of HSPA5/BiP from ERN1/IRE1 and EIF2AK3/PERK, allowing their homodimerization and subsequent activation (PubMed:11907036). Plays an auxiliary role in post-translational transport of small presecretory proteins across endoplasmic reticulum (ER). May function as an allosteric modulator for SEC61 channel-forming translocon complex, likely cooperating with SEC62 to enable the productive insertion of these precursors into SEC61 channel. Appears to specifically regulate translocation of precursors having inhibitory residues in their mature region that weaken channel gating. May also play a role in apoptosis and cell proliferation (PubMed:26045166). {ECO:0000250|UniProtKB:G3I8R9, ECO:0000250|UniProtKB:P20029, ECO:0000269|PubMed:11907036, ECO:0000269|PubMed:1550958, ECO:0000269|PubMed:19538957, ECO:0000269|PubMed:2294010, ECO:0000269|PubMed:23769672, ECO:0000269|PubMed:23990668, ECO:0000269|PubMed:26045166, ECO:0000269|PubMed:28332555, ECO:0000269|PubMed:29719251, ECO:0000269|PubMed:36739529}.; FUNCTION: (Microbial infection) Plays an important role in viral binding to the host cell membrane and entry for several flaviruses such as Dengue virus, Zika virus and Japanese encephalitis virus (PubMed:15098107, PubMed:28053106, PubMed:33432092). Acts as a component of the cellular receptor for Dengue virus serotype 2/DENV-2 on human liver cells (PubMed:15098107). {ECO:0000269|PubMed:15098107, ECO:0000269|PubMed:28053106, ECO:0000269|PubMed:33432092}.; FUNCTION: (Microbial infection) Acts as a receptor for CotH proteins expressed by fungi of the order mucorales, the causative agent of mucormycosis, which plays an important role in epithelial cell invasion by the fungi (PubMed:20484814, PubMed:24355926, PubMed:32487760). Acts as a receptor for R.delemar CotH3 in nasal epithelial cells, which may be an early step in rhinoorbital/cerebral mucormycosis (RCM) disease progression (PubMed:32487760). {ECO:0000269|PubMed:20484814, ECO:0000269|PubMed:24355926, ECO:0000269|PubMed:32487760}. |
P11172 | UMPS | S214 | ochoa|psp | Uridine 5'-monophosphate synthase (UMP synthase) [Includes: Orotate phosphoribosyltransferase (OPRT) (OPRTase) (EC 2.4.2.10); Orotidine 5'-phosphate decarboxylase (ODC) (OMPD) (EC 4.1.1.23) (OMPdecase)] | Bifunctional enzyme catalyzing the last two steps of de novo pyrimidine biosynthesis, orotate phosphoribosyltransferase (OPRT), which converts orotate to orotidine-5'-monophosphate (OMP), and orotidine-5'-monophosphate decarboxylase (ODC), the terminal enzymatic reaction that decarboxylates OMP to uridine monophosphate (UMP). {ECO:0000269|PubMed:18184586, ECO:0000269|PubMed:9042911}. |
P11308 | ERG | S96 | psp | Transcriptional regulator ERG (Transforming protein ERG) | Transcriptional regulator. May participate in transcriptional regulation through the recruitment of SETDB1 histone methyltransferase and subsequent modification of local chromatin structure. |
P13631 | RARG | S36 | ochoa | Retinoic acid receptor gamma (RAR-gamma) (Nuclear receptor subfamily 1 group B member 3) | Receptor for retinoic acid. Retinoic acid receptors bind as heterodimers to their target response elements in response to their ligands, all-trans or 9-cis retinoic acid, and regulate gene expression in various biological processes. The RAR/RXR heterodimers bind to the retinoic acid response elements (RARE) composed of tandem 5'-AGGTCA-3' sites known as DR1-DR5. In the absence of ligand, acts mainly as an activator of gene expression due to weak binding to corepressors. Required for limb bud development. In concert with RARA or RARB, required for skeletal growth, matrix homeostasis and growth plate function (By similarity). {ECO:0000250}. |
P14868 | DARS1 | S249 | ochoa | Aspartate--tRNA ligase, cytoplasmic (EC 6.1.1.12) (Aspartyl-tRNA synthetase) (AspRS) (Cell proliferation-inducing gene 40 protein) | Catalyzes the specific attachment of an amino acid to its cognate tRNA in a 2 step reaction: the amino acid (AA) is first activated by ATP to form AA-AMP and then transferred to the acceptor end of the tRNA. {ECO:0000250|UniProtKB:P15178}. |
P15884 | TCF4 | S66 | ochoa | Transcription factor 4 (TCF-4) (Class B basic helix-loop-helix protein 19) (bHLHb19) (Immunoglobulin transcription factor 2) (ITF-2) (SL3-3 enhancer factor 2) (SEF-2) | Transcription factor that binds to the immunoglobulin enhancer Mu-E5/KE5-motif. Involved in the initiation of neuronal differentiation. Activates transcription by binding to the E box (5'-CANNTG-3'). Binds to the E-box present in the somatostatin receptor 2 initiator element (SSTR2-INR) to activate transcription (By similarity). Preferentially binds to either 5'-ACANNTGT-3' or 5'-CCANNTGG-3'. {ECO:0000250}. |
P18669 | PGAM1 | S31 | ochoa | Phosphoglycerate mutase 1 (EC 5.4.2.11) (EC 5.4.2.4) (BPG-dependent PGAM 1) (Phosphoglycerate mutase isozyme B) (PGAM-B) | Catalyzes the interconversion of 2-phosphoglycerate and 3-phosphoglyceratea crucial step in glycolysis, by using 2,3-bisphosphoglycerate (PubMed:23653202). Also catalyzes the interconversion of (2R)-2,3-bisphosphoglycerate and (2R)-3-phospho-glyceroyl phosphate (PubMed:23653202). {ECO:0000269|PubMed:23653202}. |
P21333 | FLNA | S1923 | ochoa | Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) | Promotes orthogonal branching of actin filaments and links actin filaments to membrane glycoproteins. Anchors various transmembrane proteins to the actin cytoskeleton and serves as a scaffold for a wide range of cytoplasmic signaling proteins. Interaction with FLNB may allow neuroblast migration from the ventricular zone into the cortical plate. Tethers cell surface-localized furin, modulates its rate of internalization and directs its intracellular trafficking (By similarity). Involved in ciliogenesis. Plays a role in cell-cell contacts and adherens junctions during the development of blood vessels, heart and brain organs. Plays a role in platelets morphology through interaction with SYK that regulates ITAM- and ITAM-like-containing receptor signaling, resulting in by platelet cytoskeleton organization maintenance (By similarity). During the axon guidance process, required for growth cone collapse induced by SEMA3A-mediated stimulation of neurons (PubMed:25358863). {ECO:0000250, ECO:0000250|UniProtKB:Q8BTM8, ECO:0000269|PubMed:22121117, ECO:0000269|PubMed:25358863}. |
P21333 | FLNA | S2615 | ochoa | Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) | Promotes orthogonal branching of actin filaments and links actin filaments to membrane glycoproteins. Anchors various transmembrane proteins to the actin cytoskeleton and serves as a scaffold for a wide range of cytoplasmic signaling proteins. Interaction with FLNB may allow neuroblast migration from the ventricular zone into the cortical plate. Tethers cell surface-localized furin, modulates its rate of internalization and directs its intracellular trafficking (By similarity). Involved in ciliogenesis. Plays a role in cell-cell contacts and adherens junctions during the development of blood vessels, heart and brain organs. Plays a role in platelets morphology through interaction with SYK that regulates ITAM- and ITAM-like-containing receptor signaling, resulting in by platelet cytoskeleton organization maintenance (By similarity). During the axon guidance process, required for growth cone collapse induced by SEMA3A-mediated stimulation of neurons (PubMed:25358863). {ECO:0000250, ECO:0000250|UniProtKB:Q8BTM8, ECO:0000269|PubMed:22121117, ECO:0000269|PubMed:25358863}. |
P27987 | ITPKB | S544 | ochoa | Inositol-trisphosphate 3-kinase B (EC 2.7.1.127) (Inositol 1,4,5-trisphosphate 3-kinase B) (IP3 3-kinase B) (IP3K B) (InsP 3-kinase B) | Catalyzes the phosphorylation of 1D-myo-inositol 1,4,5-trisphosphate (InsP3) into 1D-myo-inositol 1,3,4,5-tetrakisphosphate and participates to the regulation of calcium homeostasis. {ECO:0000269|PubMed:11846419, ECO:0000269|PubMed:12747803, ECO:0000269|PubMed:1654894}. |
P29317 | EPHA2 | S277 | psp | Ephrin type-A receptor 2 (EC 2.7.10.1) (Epithelial cell kinase) (Tyrosine-protein kinase receptor ECK) | Receptor tyrosine kinase which binds promiscuously membrane-bound ephrin-A family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Activated by the ligand ephrin-A1/EFNA1 regulates migration, integrin-mediated adhesion, proliferation and differentiation of cells. Regulates cell adhesion and differentiation through DSG1/desmoglein-1 and inhibition of the ERK1/ERK2 (MAPK3/MAPK1, respectively) signaling pathway. May also participate in UV radiation-induced apoptosis and have a ligand-independent stimulatory effect on chemotactic cell migration. During development, may function in distinctive aspects of pattern formation and subsequently in development of several fetal tissues. Involved for instance in angiogenesis, in early hindbrain development and epithelial proliferation and branching morphogenesis during mammary gland development. Engaged by the ligand ephrin-A5/EFNA5 may regulate lens fiber cells shape and interactions and be important for lens transparency development and maintenance. With ephrin-A2/EFNA2 may play a role in bone remodeling through regulation of osteoclastogenesis and osteoblastogenesis. {ECO:0000269|PubMed:10655584, ECO:0000269|PubMed:16236711, ECO:0000269|PubMed:18339848, ECO:0000269|PubMed:19573808, ECO:0000269|PubMed:20679435, ECO:0000269|PubMed:20861311, ECO:0000269|PubMed:23358419, ECO:0000269|PubMed:26158630, ECO:0000269|PubMed:27385333}.; FUNCTION: (Microbial infection) Acts as a receptor for hepatitis C virus (HCV) in hepatocytes and facilitates its cell entry. Mediates HCV entry by promoting the formation of the CD81-CLDN1 receptor complexes that are essential for HCV entry and by enhancing membrane fusion of cells expressing HCV envelope glycoproteins. {ECO:0000269|PubMed:21516087}.; FUNCTION: Acts as a receptor for human cytomegalovirus (HCMV) to mediate viral entry and fusion in glioblastoma cells. {ECO:0000269|PubMed:37146061}. |
P31269 | HOXA9 | S161 | ochoa | Homeobox protein Hox-A9 (Homeobox protein Hox-1G) | Sequence-specific transcription factor which is part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis. Required for induction of SELE/E-selectin and VCAM1 on the endothelial cells surface at sites of inflammation (PubMed:22269951). Positively regulates EIF4E-mediated mRNA nuclear export and also increases the translation efficiency of ODC mRNA in the cytoplasm by competing with factors which repress EIF4E activity such as PRH (By similarity). {ECO:0000250|UniProtKB:P09631, ECO:0000269|PubMed:22269951}. |
P33993 | MCM7 | S365 | psp | DNA replication licensing factor MCM7 (EC 3.6.4.12) (CDC47 homolog) (P1.1-MCM3) | Acts as a component of the MCM2-7 complex (MCM complex) which is the replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. Core component of CDC45-MCM-GINS (CMG) helicase, the molecular machine that unwinds template DNA during replication, and around which the replisome is built (PubMed:25661590, PubMed:32453425, PubMed:34694004, PubMed:34700328, PubMed:35585232, PubMed:9305914). The active ATPase sites in the MCM2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the ATP-binding site of the Walker A box of the adjacent subunit. The six ATPase active sites, however, are likely to contribute differentially to the complex helicase activity (PubMed:32453425). Required for S-phase checkpoint activation upon UV-induced damage. {ECO:0000269|PubMed:15210935, ECO:0000269|PubMed:15538388, ECO:0000269|PubMed:25661590, ECO:0000269|PubMed:32453425, ECO:0000269|PubMed:34694004, ECO:0000269|PubMed:34700328, ECO:0000269|PubMed:35585232, ECO:0000269|PubMed:9305914}. |
P35568 | IRS1 | S616 | ochoa|psp | Insulin receptor substrate 1 (IRS-1) | Signaling adapter protein that participates in the signal transduction from two prominent receptor tyrosine kinases, insulin receptor/INSR and insulin-like growth factor I receptor/IGF1R (PubMed:7541045, PubMed:33991522, PubMed:38625937). Plays therefore an important role in development, growth, glucose homeostasis as well as lipid metabolism (PubMed:19639489). Upon phosphorylation by the insulin receptor, functions as a signaling scaffold that propagates insulin action through binding to SH2 domain-containing proteins including the p85 regulatory subunit of PI3K, NCK1, NCK2, GRB2 or SHP2 (PubMed:11171109, PubMed:8265614). Recruitment of GRB2 leads to the activation of the guanine nucleotide exchange factor SOS1 which in turn triggers the Ras/Raf/MEK/MAPK signaling cascade (By similarity). Activation of the PI3K/AKT pathway is responsible for most of insulin metabolic effects in the cell, and the Ras/Raf/MEK/MAPK is involved in the regulation of gene expression and in cooperation with the PI3K pathway regulates cell growth and differentiation. Acts a positive regulator of the Wnt/beta-catenin signaling pathway through suppression of DVL2 autophagy-mediated degradation leading to cell proliferation (PubMed:24616100). {ECO:0000250|UniProtKB:P35570, ECO:0000269|PubMed:11171109, ECO:0000269|PubMed:16878150, ECO:0000269|PubMed:19639489, ECO:0000269|PubMed:38625937, ECO:0000269|PubMed:7541045, ECO:0000269|PubMed:8265614}. |
P42858 | HTT | S432 | ochoa|psp | Huntingtin (Huntington disease protein) (HD protein) [Cleaved into: Huntingtin, myristoylated N-terminal fragment] | [Huntingtin]: May play a role in microtubule-mediated transport or vesicle function.; FUNCTION: [Huntingtin, myristoylated N-terminal fragment]: Promotes the formation of autophagic vesicles. {ECO:0000269|PubMed:24459296}. |
P43268 | ETV4 | S140 | ochoa | ETS translocation variant 4 (Adenovirus E1A enhancer-binding protein) (E1A-F) (Polyomavirus enhancer activator 3 homolog) (Protein PEA3) | Transcriptional activator (PubMed:19307308, PubMed:31552090). May play a role in keratinocyte differentiation (PubMed:31552090). {ECO:0000269|PubMed:19307308, ECO:0000269|PubMed:31552090}.; FUNCTION: (Microbial infection) Binds to the enhancer of the adenovirus E1A gene and acts as a transcriptional activator; the core-binding sequence is 5'-[AC]GGA[AT]GT-3'. {ECO:0000269|PubMed:8441666}. |
P43405 | SYK | S307 | ochoa | Tyrosine-protein kinase SYK (EC 2.7.10.2) (Spleen tyrosine kinase) (p72-Syk) | Non-receptor tyrosine kinase which mediates signal transduction downstream of a variety of transmembrane receptors including classical immunoreceptors like the B-cell receptor (BCR). Regulates several biological processes including innate and adaptive immunity, cell adhesion, osteoclast maturation, platelet activation and vascular development (PubMed:12387735, PubMed:33782605). Assembles into signaling complexes with activated receptors at the plasma membrane via interaction between its SH2 domains and the receptor tyrosine-phosphorylated ITAM domains. The association with the receptor can also be indirect and mediated by adapter proteins containing ITAM or partial hemITAM domains. The phosphorylation of the ITAM domains is generally mediated by SRC subfamily kinases upon engagement of the receptor. More rarely signal transduction via SYK could be ITAM-independent. Direct downstream effectors phosphorylated by SYK include DEPTOR, VAV1, PLCG1, PI-3-kinase, LCP2 and BLNK (PubMed:12456653, PubMed:15388330, PubMed:34634301, PubMed:8657103). Initially identified as essential in B-cell receptor (BCR) signaling, it is necessary for the maturation of B-cells most probably at the pro-B to pre-B transition (PubMed:12456653). Activated upon BCR engagement, it phosphorylates and activates BLNK an adapter linking the activated BCR to downstream signaling adapters and effectors. It also phosphorylates and activates PLCG1 and the PKC signaling pathway. It also phosphorylates BTK and regulates its activity in B-cell antigen receptor (BCR)-coupled signaling. In addition to its function downstream of BCR also plays a role in T-cell receptor signaling. Also plays a crucial role in the innate immune response to fungal, bacterial and viral pathogens. It is for instance activated by the membrane lectin CLEC7A. Upon stimulation by fungal proteins, CLEC7A together with SYK activates immune cells inducing the production of ROS. Also activates the inflammasome and NF-kappa-B-mediated transcription of chemokines and cytokines in presence of pathogens. Regulates neutrophil degranulation and phagocytosis through activation of the MAPK signaling cascade (By similarity). Required for the stimulation of neutrophil phagocytosis by IL15 (PubMed:15123770). Also mediates the activation of dendritic cells by cell necrosis stimuli. Also involved in mast cells activation. Involved in interleukin-3/IL3-mediated signaling pathway in basophils (By similarity). Also functions downstream of receptors mediating cell adhesion (PubMed:12387735). Relays for instance, integrin-mediated neutrophils and macrophages activation and P-selectin receptor/SELPG-mediated recruitment of leukocytes to inflammatory loci. Also plays a role in non-immune processes. It is for instance involved in vascular development where it may regulate blood and lymphatic vascular separation. It is also required for osteoclast development and function. Functions in the activation of platelets by collagen, mediating PLCG2 phosphorylation and activation. May be coupled to the collagen receptor by the ITAM domain-containing FCER1G. Also activated by the membrane lectin CLEC1B that is required for activation of platelets by PDPN/podoplanin. Involved in platelet adhesion being activated by ITGB3 engaged by fibrinogen. Together with CEACAM20, enhances production of the cytokine CXCL8/IL-8 via the NFKB pathway and may thus have a role in the intestinal immune response (By similarity). {ECO:0000250|UniProtKB:P48025, ECO:0000269|PubMed:12387735, ECO:0000269|PubMed:12456653, ECO:0000269|PubMed:15123770, ECO:0000269|PubMed:15388330, ECO:0000269|PubMed:19909739, ECO:0000269|PubMed:33782605, ECO:0000269|PubMed:34634301, ECO:0000269|PubMed:8657103, ECO:0000269|PubMed:9535867}. |
P46821 | MAP1B | S1076 | ochoa | Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain; MAP1 light chain LC1] | Facilitates tyrosination of alpha-tubulin in neuronal microtubules (By similarity). Phosphorylated MAP1B is required for proper microtubule dynamics and plays a role in the cytoskeletal changes that accompany neuronal differentiation and neurite extension (PubMed:33268592). Possibly MAP1B binds to at least two tubulin subunits in the polymer, and this bridging of subunits might be involved in nucleating microtubule polymerization and in stabilizing microtubules. Acts as a positive cofactor in DAPK1-mediated autophagic vesicle formation and membrane blebbing. {ECO:0000250, ECO:0000269|PubMed:18195017, ECO:0000269|PubMed:33268592}. |
P49796 | RGS3 | S401 | ochoa | Regulator of G-protein signaling 3 (RGP3) (RGS3) | Down-regulates signaling from heterotrimeric G-proteins by increasing the GTPase activity of the alpha subunits, thereby driving them into their inactive GDP-bound form. Down-regulates G-protein-mediated release of inositol phosphates and activation of MAP kinases. {ECO:0000269|PubMed:10749886, ECO:0000269|PubMed:11294858, ECO:0000269|PubMed:8602223, ECO:0000269|PubMed:9858594}. |
P50461 | CSRP3 | S95 | ochoa | Cysteine and glycine-rich protein 3 (Cardiac LIM protein) (Cysteine-rich protein 3) (CRP3) (LIM domain protein, cardiac) (Muscle LIM protein) | Positive regulator of myogenesis. Acts as a cofactor for myogenic bHLH transcription factors such as MYOD1, and probably MYOG and MYF6. Enhances the DNA-binding activity of the MYOD1:TCF3 isoform E47 complex and may promote formation of a functional MYOD1:TCF3 isoform E47:MEF2A complex involved in myogenesis (By similarity). Plays a crucial and specific role in the organization of cytosolic structures in cardiomyocytes. Could play a role in mechanical stretch sensing. May be a scaffold protein that promotes the assembly of interacting proteins at Z-line structures. It is essential for calcineurin anchorage to the Z line. Required for stress-induced calcineurin-NFAT activation (By similarity). The role in regulation of cytoskeleton dynamics by association with CFL2 is reported conflictingly: Shown to enhance CFL2-mediated F-actin depolymerization dependent on the CSRP3:CFL2 molecular ratio, and also shown to reduce the ability of CLF1 and CFL2 to enhance actin depolymerization (PubMed:19752190, PubMed:24934443). Proposed to contribute to the maintenance of muscle cell integrity through an actin-based mechanism. Can directly bind to actin filaments, cross-link actin filaments into bundles without polarity selectivity and protect them from dilution- and cofilin-mediated depolymerization; the function seems to involve its self-association (PubMed:24934443). In vitro can inhibit PKC/PRKCA activity (PubMed:27353086). Proposed to be involved in cardiac stress signaling by down-regulating excessive PKC/PRKCA signaling (By similarity). {ECO:0000250|UniProtKB:P50462, ECO:0000250|UniProtKB:P50463, ECO:0000269|PubMed:19752190, ECO:0000269|PubMed:24934443, ECO:0000269|PubMed:27353086}.; FUNCTION: [Isoform 2]: May play a role in early sarcomere organization. Overexpression in myotubes negatively regulates myotube differentiation. By association with isoform 1 and thus changing the CSRP3 isoform 1:CFL2 stoichiometry is proposed to down-regulate CFL2-mediated F-actin depolymerization. {ECO:0000269|PubMed:24860983}. |
P50851 | LRBA | S979 | ochoa | Lipopolysaccharide-responsive and beige-like anchor protein (Beige-like protein) (CDC4-like protein) | Involved in coupling signal transduction and vesicle trafficking to enable polarized secretion and/or membrane deposition of immune effector molecules (By similarity). Involved in phagophore growth during mitophagy by regulating ATG9A trafficking to mitochondria (PubMed:33773106). {ECO:0000250|UniProtKB:Q9ESE1, ECO:0000269|PubMed:33773106}. |
P51398 | DAP3 | S44 | ochoa | Small ribosomal subunit protein mS29 (EC 3.6.5.-) (28S ribosomal protein S29, mitochondrial) (MRP-S29) (S29mt) (Death-associated protein 3) (DAP-3) (Ionizing radiation resistance conferring protein) | As a component of the mitochondrial small ribosomal subunit, it plays a role in the translation of mitochondrial mRNAs (PubMed:39701103). Involved in mediating interferon-gamma-induced cell death (PubMed:7499268). Displays GTPase activity in vitro (PubMed:39701103). {ECO:0000269|PubMed:39701103, ECO:0000269|PubMed:7499268}. |
P51610 | HCFC1 | S1222 | ochoa | Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] | Transcriptional coregulator (By similarity). Serves as a scaffold protein, bridging interactions between transcription factors, including THAP11 and ZNF143, and transcriptional coregulators (PubMed:26416877). Involved in control of the cell cycle (PubMed:10629049, PubMed:10779346, PubMed:15190068, PubMed:16624878, PubMed:23629655). Also antagonizes transactivation by ZBTB17 and GABP2; represses ZBTB17 activation of the p15(INK4b) promoter and inhibits its ability to recruit p300 (PubMed:10675337, PubMed:12244100). Coactivator for EGR2 and GABP2 (PubMed:12244100, PubMed:14532282). Tethers the chromatin modifying Set1/Ash2 histone H3 'Lys-4' methyltransferase (H3K4me) and Sin3 histone deacetylase (HDAC) complexes (involved in the activation and repression of transcription, respectively) together (PubMed:12670868). Component of a THAP1/THAP3-HCFC1-OGT complex that is required for the regulation of the transcriptional activity of RRM1 (PubMed:20200153). As part of the NSL complex it may be involved in acetylation of nucleosomal histone H4 on several lysine residues (PubMed:20018852). Recruits KMT2E/MLL5 to E2F1 responsive promoters promoting transcriptional activation and thereby facilitates G1 to S phase transition (PubMed:23629655). Modulates expression of homeobox protein PDX1, perhaps acting in concert with transcription factor E2F1, thereby regulating pancreatic beta-cell growth and glucose-stimulated insulin secretion (By similarity). May negatively modulate transcriptional activity of FOXO3 (By similarity). {ECO:0000250|UniProtKB:D3ZN95, ECO:0000269|PubMed:10629049, ECO:0000269|PubMed:10675337, ECO:0000269|PubMed:10779346, ECO:0000269|PubMed:12244100, ECO:0000269|PubMed:12670868, ECO:0000269|PubMed:14532282, ECO:0000269|PubMed:15190068, ECO:0000269|PubMed:16624878, ECO:0000269|PubMed:20018852, ECO:0000269|PubMed:20200153, ECO:0000269|PubMed:23629655, ECO:0000269|PubMed:26416877}.; FUNCTION: (Microbial infection) In case of human herpes simplex virus (HSV) infection, HCFC1 forms a multiprotein-DNA complex with the viral transactivator protein VP16 and POU2F1 thereby enabling the transcription of the viral immediate early genes. {ECO:0000269|PubMed:10629049, ECO:0000269|PubMed:17578910}. |
P52179 | MYOM1 | S1493 | ochoa | Myomesin-1 (190 kDa connectin-associated protein) (190 kDa titin-associated protein) (Myomesin family member 1) | Major component of the vertebrate myofibrillar M band. Binds myosin, titin, and light meromyosin. This binding is dose dependent. |
P52701 | MSH6 | S292 | ochoa | DNA mismatch repair protein Msh6 (hMSH6) (G/T mismatch-binding protein) (GTBP) (GTMBP) (MutS protein homolog 6) (MutS-alpha 160 kDa subunit) (p160) | Component of the post-replicative DNA mismatch repair system (MMR). Heterodimerizes with MSH2 to form MutS alpha, which binds to DNA mismatches thereby initiating DNA repair. When bound, MutS alpha bends the DNA helix and shields approximately 20 base pairs, and recognizes single base mismatches and dinucleotide insertion-deletion loops (IDL) in the DNA. After mismatch binding, forms a ternary complex with the MutL alpha heterodimer, which is thought to be responsible for directing the downstream MMR events, including strand discrimination, excision, and resynthesis. ATP binding and hydrolysis play a pivotal role in mismatch repair functions. The ATPase activity associated with MutS alpha regulates binding similar to a molecular switch: mismatched DNA provokes ADP-->ATP exchange, resulting in a discernible conformational transition that converts MutS alpha into a sliding clamp capable of hydrolysis-independent diffusion along the DNA backbone. This transition is crucial for mismatch repair. MutS alpha may also play a role in DNA homologous recombination repair. Recruited on chromatin in G1 and early S phase via its PWWP domain that specifically binds trimethylated 'Lys-36' of histone H3 (H3K36me3): early recruitment to chromatin to be replicated allowing a quick identification of mismatch repair to initiate the DNA mismatch repair reaction. {ECO:0000269|PubMed:10078208, ECO:0000269|PubMed:10660545, ECO:0000269|PubMed:15064730, ECO:0000269|PubMed:21120944, ECO:0000269|PubMed:23622243, ECO:0000269|PubMed:9564049, ECO:0000269|PubMed:9822679, ECO:0000269|PubMed:9822680}. |
P78312 | FAM193A | S985 | ochoa | Protein FAM193A (Protein IT14) | None |
P78344 | EIF4G2 | S395 | ochoa | Eukaryotic translation initiation factor 4 gamma 2 (eIF-4-gamma 2) (eIF-4G 2) (eIF4G 2) (Death-associated protein 5) (DAP-5) (p97) | Appears to play a role in the switch from cap-dependent to IRES-mediated translation during mitosis, apoptosis and viral infection. Cleaved by some caspases and viral proteases. {ECO:0000269|PubMed:11511540, ECO:0000269|PubMed:11943866, ECO:0000269|PubMed:9032289, ECO:0000269|PubMed:9049310}. |
P78559 | MAP1A | S1288 | ochoa | Microtubule-associated protein 1A (MAP-1A) (Proliferation-related protein p80) [Cleaved into: MAP1A heavy chain; MAP1 light chain LC2] | Structural protein involved in the filamentous cross-bridging between microtubules and other skeletal elements. |
P82675 | MRPS5 | S386 | ochoa | Small ribosomal subunit protein uS5m (28S ribosomal protein S5, mitochondrial) (MRP-S5) (S5mt) | None |
P84550 | SKOR1 | S748 | ochoa | SKI family transcriptional corepressor 1 (Functional Smad-suppressing element on chromosome 15) (Fussel-15) (LBX1 corepressor 1) (Ladybird homeobox corepressor 1) | Acts as a transcriptional corepressor of LBX1 (By similarity). Inhibits BMP signaling. {ECO:0000250}. |
Q00587 | CDC42EP1 | S303 | ochoa | Cdc42 effector protein 1 (Binder of Rho GTPases 5) (Serum protein MSE55) | Probably involved in the organization of the actin cytoskeleton. Induced membrane extensions in fibroblasts. {ECO:0000269|PubMed:10430899}. |
Q00839 | HNRNPU | S799 | ochoa | Heterogeneous nuclear ribonucleoprotein U (hnRNP U) (GRIP120) (Nuclear p120 ribonucleoprotein) (Scaffold-attachment factor A) (SAF-A) (p120) (pp120) | DNA- and RNA-binding protein involved in several cellular processes such as nuclear chromatin organization, telomere-length regulation, transcription, mRNA alternative splicing and stability, Xist-mediated transcriptional silencing and mitotic cell progression (PubMed:10490622, PubMed:18082603, PubMed:19029303, PubMed:22325991, PubMed:25986610, PubMed:28622508). Plays a role in the regulation of interphase large-scale gene-rich chromatin organization through chromatin-associated RNAs (caRNAs) in a transcription-dependent manner, and thereby maintains genomic stability (PubMed:1324173, PubMed:28622508, PubMed:8174554). Required for the localization of the long non-coding Xist RNA on the inactive chromosome X (Xi) and the subsequent initiation and maintenance of X-linked transcriptional gene silencing during X-inactivation (By similarity). Plays a role as a RNA polymerase II (Pol II) holoenzyme transcription regulator (PubMed:10490622, PubMed:15711563, PubMed:19617346, PubMed:23811339, PubMed:8174554, PubMed:9353307). Promotes transcription initiation by direct association with the core-TFIIH basal transcription factor complex for the assembly of a functional pre-initiation complex with Pol II in a actin-dependent manner (PubMed:10490622, PubMed:15711563). Blocks Pol II transcription elongation activity by inhibiting the C-terminal domain (CTD) phosphorylation of Pol II and dissociates from Pol II pre-initiation complex prior to productive transcription elongation (PubMed:10490622). Positively regulates CBX5-induced transcriptional gene silencing and retention of CBX5 in the nucleus (PubMed:19617346). Negatively regulates glucocorticoid-mediated transcriptional activation (PubMed:9353307). Key regulator of transcription initiation and elongation in embryonic stem cells upon leukemia inhibitory factor (LIF) signaling (By similarity). Involved in the long non-coding RNA H19-mediated Pol II transcriptional repression (PubMed:23811339). Participates in the circadian regulation of the core clock component BMAL1 transcription (By similarity). Plays a role in the regulation of telomere length (PubMed:18082603). Plays a role as a global pre-mRNA alternative splicing modulator by regulating U2 small nuclear ribonucleoprotein (snRNP) biogenesis (PubMed:22325991). Plays a role in mRNA stability (PubMed:17174306, PubMed:17289661, PubMed:19029303). Component of the CRD-mediated complex that promotes MYC mRNA stabilization (PubMed:19029303). Enhances the expression of specific genes, such as tumor necrosis factor TNFA, by regulating mRNA stability, possibly through binding to the 3'-untranslated region (UTR) (PubMed:17174306). Plays a role in mitotic cell cycle regulation (PubMed:21242313, PubMed:25986610). Involved in the formation of stable mitotic spindle microtubules (MTs) attachment to kinetochore, spindle organization and chromosome congression (PubMed:21242313). Phosphorylation at Ser-59 by PLK1 is required for chromosome alignement and segregation and progression through mitosis (PubMed:25986610). Also contributes to the targeting of AURKA to mitotic spindle MTs (PubMed:21242313). Binds to double- and single-stranded DNA and RNA, poly(A), poly(C) and poly(G) oligoribonucleotides (PubMed:1628625, PubMed:8068679, PubMed:8174554, PubMed:9204873, PubMed:9405365). Binds to chromatin-associated RNAs (caRNAs) (PubMed:28622508). Associates with chromatin to scaffold/matrix attachment region (S/MAR) elements in a chromatin-associated RNAs (caRNAs)-dependent manner (PubMed:10671544, PubMed:11003645, PubMed:11909954, PubMed:1324173, PubMed:28622508, PubMed:7509195, PubMed:9204873, PubMed:9405365). Binds to the Xist RNA (PubMed:26244333). Binds the long non-coding H19 RNA (PubMed:23811339). Binds to SMN1/2 pre-mRNAs at G/U-rich regions (PubMed:22325991). Binds to small nuclear RNAs (snRNAs) (PubMed:22325991). Binds to the 3'-UTR of TNFA mRNA (PubMed:17174306). Binds (via RNA-binding RGG-box region) to the long non-coding Xist RNA; this binding is direct and bridges the Xist RNA and the inactive chromosome X (Xi) (By similarity). Also negatively regulates embryonic stem cell differentiation upon LIF signaling (By similarity). Required for embryonic development (By similarity). Binds to brown fat long non-coding RNA 1 (Blnc1); facilitates the recruitment of Blnc1 by ZBTB7B required to drive brown and beige fat development and thermogenesis (By similarity). {ECO:0000250|UniProtKB:Q8VEK3, ECO:0000269|PubMed:10490622, ECO:0000269|PubMed:10671544, ECO:0000269|PubMed:11003645, ECO:0000269|PubMed:11909954, ECO:0000269|PubMed:1324173, ECO:0000269|PubMed:15711563, ECO:0000269|PubMed:1628625, ECO:0000269|PubMed:17174306, ECO:0000269|PubMed:17289661, ECO:0000269|PubMed:18082603, ECO:0000269|PubMed:19029303, ECO:0000269|PubMed:19617346, ECO:0000269|PubMed:21242313, ECO:0000269|PubMed:22325991, ECO:0000269|PubMed:23811339, ECO:0000269|PubMed:25986610, ECO:0000269|PubMed:26244333, ECO:0000269|PubMed:28622508, ECO:0000269|PubMed:7509195, ECO:0000269|PubMed:8068679, ECO:0000269|PubMed:8174554, ECO:0000269|PubMed:9204873, ECO:0000269|PubMed:9353307, ECO:0000269|PubMed:9405365}.; FUNCTION: (Microbial infection) Negatively regulates immunodeficiency virus type 1 (HIV-1) replication by preventing the accumulation of viral mRNA transcripts in the cytoplasm. {ECO:0000269|PubMed:16916646}. |
Q01101 | INSM1 | S101 | ochoa | Insulinoma-associated protein 1 (Zinc finger protein IA-1) | Sequence-specific DNA-binding transcriptional regulator that plays a key role in neurogenesis and neuroendocrine cell differentiation during embryonic and/or fetal development. Binds to the consensus sequence 5'-[TG][TC][TC][TT][GA]GGG[CG]A-3' in target promoters. Acts as a transcriptional repressor of NEUROD1 and INS expression via its interaction with cyclin CCND1 in a cell cycle-independent manner. Negatively regulates skeletal muscle-specific gene expression in endocrine cells of the pituitary by inhibiting the Notch signaling pathway. Represses target gene transcription by recruiting chromatin-modifying factors, such as HDAC1, HDAC2, HDAC3, KDM1A and RCOR1 histone deacetylases. Binds to its own promoter, suggesting autoregulation as a self-control feedback mechanism. Competes with histone H3 for the same binding site on the histone demethylase complex formed by KDM1A and RCOR1, and thereby inhibits demethylation of histone H3 at 'Lys-4' (PubMed:23721412). Promotes the generation and expansion of neuronal basal progenitor cells in the developing neocortex. Involved in the differentiation of endocrine cells of the developing anterior pituitary gland, of the pancreas and intestine, and of sympatho-adrenal cells in the peripheral nervous system. Promotes cell cycle signaling arrest and inhibition of cellular proliferation. {ECO:0000269|PubMed:11842116, ECO:0000269|PubMed:16511571, ECO:0000269|PubMed:16569215, ECO:0000269|PubMed:18417529, ECO:0000269|PubMed:19124461, ECO:0000269|PubMed:23721412}. |
Q08AN1 | ZNF616 | S177 | ochoa | Zinc finger protein 616 | May be involved in transcriptional regulation. |
Q09666 | AHNAK | S41 | ochoa | Neuroblast differentiation-associated protein AHNAK (Desmoyokin) | May be required for neuronal cell differentiation. |
Q10571 | MN1 | S1007 | ochoa | Transcriptional activator MN1 (Probable tumor suppressor protein MN1) | Transcriptional activator which specifically regulates expression of TBX22 in the posterior region of the developing palate. Required during later stages of palate development for growth and medial fusion of the palatal shelves. Promotes maturation and normal function of calvarial osteoblasts, including expression of the osteoclastogenic cytokine TNFSF11/RANKL. Necessary for normal development of the membranous bones of the skull (By similarity). May play a role in tumor suppression (Probable). {ECO:0000250|UniProtKB:D3YWE6, ECO:0000305|PubMed:7731706}. |
Q12778 | FOXO1 | S249 | psp | Forkhead box protein O1 (Forkhead box protein O1A) (Forkhead in rhabdomyosarcoma) | Transcription factor that is the main target of insulin signaling and regulates metabolic homeostasis in response to oxidative stress (PubMed:10358076, PubMed:12228231, PubMed:15220471, PubMed:15890677, PubMed:18356527, PubMed:19221179, PubMed:20543840, PubMed:21245099). Binds to the insulin response element (IRE) with consensus sequence 5'-TT[G/A]TTTTG-3' and the related Daf-16 family binding element (DBE) with consensus sequence 5'-TT[G/A]TTTAC-3' (PubMed:10358076). Activity suppressed by insulin (PubMed:10358076). Main regulator of redox balance and osteoblast numbers and controls bone mass (By similarity). Orchestrates the endocrine function of the skeleton in regulating glucose metabolism (By similarity). Also acts as a key regulator of chondrogenic commitment of skeletal progenitor cells in response to lipid availability: when lipids levels are low, translocates to the nucleus and promotes expression of SOX9, which induces chondrogenic commitment and suppresses fatty acid oxidation (By similarity). Acts synergistically with ATF4 to suppress osteocalcin/BGLAP activity, increasing glucose levels and triggering glucose intolerance and insulin insensitivity (By similarity). Also suppresses the transcriptional activity of RUNX2, an upstream activator of osteocalcin/BGLAP (By similarity). Acts as an inhibitor of glucose sensing in pancreatic beta cells by acting as a transcription repressor and suppressing expression of PDX1 (By similarity). In hepatocytes, promotes gluconeogenesis by acting together with PPARGC1A and CEBPA to activate the expression of genes such as IGFBP1, G6PC1 and PCK1 (By similarity). Also promotes gluconeogenesis by directly promoting expression of PPARGC1A and G6PC1 (PubMed:17024043). Important regulator of cell death acting downstream of CDK1, PKB/AKT1 and STK4/MST1 (PubMed:18356527, PubMed:19221179). Promotes neural cell death (PubMed:18356527). Mediates insulin action on adipose tissue (By similarity). Regulates the expression of adipogenic genes such as PPARG during preadipocyte differentiation and, adipocyte size and adipose tissue-specific gene expression in response to excessive calorie intake (By similarity). Regulates the transcriptional activity of GADD45A and repair of nitric oxide-damaged DNA in beta-cells (By similarity). Required for the autophagic cell death induction in response to starvation or oxidative stress in a transcription-independent manner (PubMed:20543840). Mediates the function of MLIP in cardiomyocytes hypertrophy and cardiac remodeling (By similarity). Positive regulator of apoptosis in cardiac smooth muscle cells as a result of its transcriptional activation of pro-apoptotic genes (PubMed:19483080). Regulates endothelial cell (EC) viability and apoptosis in a PPIA/CYPA-dependent manner via transcription of CCL2 and BCL2L11 which are involved in EC chemotaxis and apoptosis (PubMed:31063815). {ECO:0000250|UniProtKB:A4L7N3, ECO:0000250|UniProtKB:G3V7R4, ECO:0000250|UniProtKB:Q9R1E0, ECO:0000269|PubMed:10358076, ECO:0000269|PubMed:12228231, ECO:0000269|PubMed:15220471, ECO:0000269|PubMed:15890677, ECO:0000269|PubMed:17024043, ECO:0000269|PubMed:18356527, ECO:0000269|PubMed:19221179, ECO:0000269|PubMed:19483080, ECO:0000269|PubMed:20543840, ECO:0000269|PubMed:21245099, ECO:0000269|PubMed:31063815}. |
Q12778 | FOXO1 | S470 | ochoa | Forkhead box protein O1 (Forkhead box protein O1A) (Forkhead in rhabdomyosarcoma) | Transcription factor that is the main target of insulin signaling and regulates metabolic homeostasis in response to oxidative stress (PubMed:10358076, PubMed:12228231, PubMed:15220471, PubMed:15890677, PubMed:18356527, PubMed:19221179, PubMed:20543840, PubMed:21245099). Binds to the insulin response element (IRE) with consensus sequence 5'-TT[G/A]TTTTG-3' and the related Daf-16 family binding element (DBE) with consensus sequence 5'-TT[G/A]TTTAC-3' (PubMed:10358076). Activity suppressed by insulin (PubMed:10358076). Main regulator of redox balance and osteoblast numbers and controls bone mass (By similarity). Orchestrates the endocrine function of the skeleton in regulating glucose metabolism (By similarity). Also acts as a key regulator of chondrogenic commitment of skeletal progenitor cells in response to lipid availability: when lipids levels are low, translocates to the nucleus and promotes expression of SOX9, which induces chondrogenic commitment and suppresses fatty acid oxidation (By similarity). Acts synergistically with ATF4 to suppress osteocalcin/BGLAP activity, increasing glucose levels and triggering glucose intolerance and insulin insensitivity (By similarity). Also suppresses the transcriptional activity of RUNX2, an upstream activator of osteocalcin/BGLAP (By similarity). Acts as an inhibitor of glucose sensing in pancreatic beta cells by acting as a transcription repressor and suppressing expression of PDX1 (By similarity). In hepatocytes, promotes gluconeogenesis by acting together with PPARGC1A and CEBPA to activate the expression of genes such as IGFBP1, G6PC1 and PCK1 (By similarity). Also promotes gluconeogenesis by directly promoting expression of PPARGC1A and G6PC1 (PubMed:17024043). Important regulator of cell death acting downstream of CDK1, PKB/AKT1 and STK4/MST1 (PubMed:18356527, PubMed:19221179). Promotes neural cell death (PubMed:18356527). Mediates insulin action on adipose tissue (By similarity). Regulates the expression of adipogenic genes such as PPARG during preadipocyte differentiation and, adipocyte size and adipose tissue-specific gene expression in response to excessive calorie intake (By similarity). Regulates the transcriptional activity of GADD45A and repair of nitric oxide-damaged DNA in beta-cells (By similarity). Required for the autophagic cell death induction in response to starvation or oxidative stress in a transcription-independent manner (PubMed:20543840). Mediates the function of MLIP in cardiomyocytes hypertrophy and cardiac remodeling (By similarity). Positive regulator of apoptosis in cardiac smooth muscle cells as a result of its transcriptional activation of pro-apoptotic genes (PubMed:19483080). Regulates endothelial cell (EC) viability and apoptosis in a PPIA/CYPA-dependent manner via transcription of CCL2 and BCL2L11 which are involved in EC chemotaxis and apoptosis (PubMed:31063815). {ECO:0000250|UniProtKB:A4L7N3, ECO:0000250|UniProtKB:G3V7R4, ECO:0000250|UniProtKB:Q9R1E0, ECO:0000269|PubMed:10358076, ECO:0000269|PubMed:12228231, ECO:0000269|PubMed:15220471, ECO:0000269|PubMed:15890677, ECO:0000269|PubMed:17024043, ECO:0000269|PubMed:18356527, ECO:0000269|PubMed:19221179, ECO:0000269|PubMed:19483080, ECO:0000269|PubMed:20543840, ECO:0000269|PubMed:21245099, ECO:0000269|PubMed:31063815}. |
Q13620 | CUL4B | S28 | ochoa | Cullin-4B (CUL-4B) | Core component of multiple cullin-RING-based E3 ubiquitin-protein ligase complexes which mediate the ubiquitination and subsequent proteasomal degradation of target proteins (PubMed:14578910, PubMed:16322693, PubMed:16678110, PubMed:18593899, PubMed:22118460, PubMed:29779948, PubMed:30166453, PubMed:33854232, PubMed:33854239). The functional specificity of the E3 ubiquitin-protein ligase complex depends on the variable substrate recognition subunit (PubMed:14578910, PubMed:16678110, PubMed:18593899, PubMed:22118460, PubMed:29779948). CUL4B may act within the complex as a scaffold protein, contributing to catalysis through positioning of the substrate and the ubiquitin-conjugating enzyme (PubMed:14578910, PubMed:16678110, PubMed:18593899, PubMed:22118460). Plays a role as part of the E3 ubiquitin-protein ligase complex in polyubiquitination of CDT1, histone H2A, histone H3 and histone H4 in response to radiation-induced DNA damage (PubMed:14578910, PubMed:16678110, PubMed:18593899). Targeted to UV damaged chromatin by DDB2 and may be important for DNA repair and DNA replication (PubMed:16678110). A number of DCX complexes (containing either TRPC4AP or DCAF12 as substrate-recognition component) are part of the DesCEND (destruction via C-end degrons) pathway, which recognizes a C-degron located at the extreme C terminus of target proteins, leading to their ubiquitination and degradation (PubMed:29779948). The DCX(AMBRA1) complex is a master regulator of the transition from G1 to S cell phase by mediating ubiquitination of phosphorylated cyclin-D (CCND1, CCND2 and CCND3) (PubMed:33854232, PubMed:33854239). The DCX(AMBRA1) complex also acts as a regulator of Cul5-RING (CRL5) E3 ubiquitin-protein ligase complexes by mediating ubiquitination and degradation of Elongin-C (ELOC) component of CRL5 complexes (PubMed:30166453). Required for ubiquitination of cyclin E (CCNE1 or CCNE2), and consequently, normal G1 cell cycle progression (PubMed:16322693, PubMed:19801544). Regulates the mammalian target-of-rapamycin (mTOR) pathway involved in control of cell growth, size and metabolism (PubMed:18235224). Specific CUL4B regulation of the mTORC1-mediated pathway is dependent upon 26S proteasome function and requires interaction between CUL4B and MLST8 (PubMed:18235224). With CUL4A, contributes to ribosome biogenesis (PubMed:26711351). {ECO:0000269|PubMed:14578910, ECO:0000269|PubMed:16322693, ECO:0000269|PubMed:16678110, ECO:0000269|PubMed:18235224, ECO:0000269|PubMed:18593899, ECO:0000269|PubMed:19801544, ECO:0000269|PubMed:22118460, ECO:0000269|PubMed:26711351, ECO:0000269|PubMed:29779948, ECO:0000269|PubMed:30166453, ECO:0000269|PubMed:33854232, ECO:0000269|PubMed:33854239}. |
Q14004 | CDK13 | S1483 | ochoa | Cyclin-dependent kinase 13 (EC 2.7.11.22) (EC 2.7.11.23) (CDC2-related protein kinase 5) (Cell division cycle 2-like protein kinase 5) (Cell division protein kinase 13) (hCDK13) (Cholinesterase-related cell division controller) | Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, probably by phosphorylating SRSF1/SF2. Required during hematopoiesis. In case of infection by HIV-1 virus, interacts with HIV-1 Tat protein acetylated at 'Lys-50' and 'Lys-51', thereby increasing HIV-1 mRNA splicing and promoting the production of the doubly spliced HIV-1 protein Nef. {ECO:0000269|PubMed:16721827, ECO:0000269|PubMed:1731328, ECO:0000269|PubMed:18480452, ECO:0000269|PubMed:20952539}. |
Q14160 | SCRIB | S1140 | ochoa | Protein scribble homolog (Scribble) (hScrib) (Protein LAP4) | Scaffold protein involved in different aspects of polarized cell differentiation regulating epithelial and neuronal morphogenesis and T-cell polarization (PubMed:15182672, PubMed:16344308, PubMed:16965391, PubMed:18641685, PubMed:18716323, PubMed:19041750, PubMed:27380321). Via its interaction with CRTAM, required for the late phase polarization of a subset of CD4+ T-cells, which in turn regulates TCR-mediated proliferation and IFNG and IL22 production (By similarity). Plays a role in cell directional movement, cell orientation, cell sheet organization and Golgi complex polarization at the cell migration front (By similarity). Promotes epithelial cell layer barrier function via maintaining cell-cell adhesion (By similarity). Most probably functions in the establishment of apico-basal cell polarity (PubMed:16344308, PubMed:19041750). May function in cell proliferation regulating progression from G1 to S phase and as a positive regulator of apoptosis for instance during acinar morphogenesis of the mammary epithelium (PubMed:16965391, PubMed:19041750). May regulate cell invasion via MAPK-mediated cell migration and adhesion (PubMed:18641685, PubMed:18716323). May play a role in exocytosis and in the targeting of synaptic vesicles to synapses (PubMed:15182672). Functions as an activator of Rac GTPase activity (PubMed:15182672). {ECO:0000250|UniProtKB:A0A8P0N4K0, ECO:0000250|UniProtKB:Q80U72, ECO:0000269|PubMed:15182672, ECO:0000269|PubMed:16344308, ECO:0000269|PubMed:16965391, ECO:0000269|PubMed:18641685, ECO:0000269|PubMed:18716323, ECO:0000269|PubMed:19041750, ECO:0000269|PubMed:27380321}. |
Q14315 | FLNC | S1637 | ochoa | Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin) | Muscle-specific filamin, which plays a central role in sarcomere assembly and organization (PubMed:34405687). Critical for normal myogenesis, it probably functions as a large actin-cross-linking protein with structural functions at the Z lines in muscle cells. May be involved in reorganizing the actin cytoskeleton in response to signaling events (By similarity). {ECO:0000250|UniProtKB:Q8VHX6, ECO:0000269|PubMed:34405687}. |
Q14684 | RRP1B | S706 | ochoa|psp | Ribosomal RNA processing protein 1 homolog B (RRP1-like protein B) | Positively regulates DNA damage-induced apoptosis by acting as a transcriptional coactivator of proapoptotic target genes of the transcriptional activator E2F1 (PubMed:20040599). Likely to play a role in ribosome biogenesis by targeting serine/threonine protein phosphatase PP1 to the nucleolus (PubMed:20926688). Involved in regulation of mRNA splicing (By similarity). Inhibits SIPA1 GTPase activity (By similarity). Involved in regulating expression of extracellular matrix genes (By similarity). Associates with chromatin and may play a role in modulating chromatin structure (PubMed:19710015). {ECO:0000250|UniProtKB:Q91YK2, ECO:0000269|PubMed:19710015, ECO:0000269|PubMed:20040599, ECO:0000269|PubMed:20926688}.; FUNCTION: (Microbial infection) Following influenza A virus (IAV) infection, promotes viral mRNA transcription by facilitating the binding of IAV RNA-directed RNA polymerase to capped mRNA. {ECO:0000269|PubMed:26311876}. |
Q14966 | ZNF638 | S605 | ochoa | Zinc finger protein 638 (Cutaneous T-cell lymphoma-associated antigen se33-1) (CTCL-associated antigen se33-1) (Nuclear protein 220) (Zinc finger matrin-like protein) | Transcription factor that binds to cytidine clusters in double-stranded DNA (PubMed:30487602, PubMed:8647861). Plays a key role in the silencing of unintegrated retroviral DNA: some part of the retroviral DNA formed immediately after infection remains unintegrated in the host genome and is transcriptionally repressed (PubMed:30487602). Mediates transcriptional repression of unintegrated viral DNA by specifically binding to the cytidine clusters of retroviral DNA and mediating the recruitment of chromatin silencers, such as the HUSH complex, SETDB1 and the histone deacetylases HDAC1 and HDAC4 (PubMed:30487602). Acts as an early regulator of adipogenesis by acting as a transcription cofactor of CEBPs (CEBPA, CEBPD and/or CEBPG), controlling the expression of PPARG and probably of other proadipogenic genes, such as SREBF1 (By similarity). May also regulate alternative splicing of target genes during adipogenesis (By similarity). {ECO:0000250|UniProtKB:Q61464, ECO:0000269|PubMed:30487602, ECO:0000269|PubMed:8647861}. |
Q15349 | RPS6KA2 | S546 | ochoa | Ribosomal protein S6 kinase alpha-2 (S6K-alpha-2) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 2) (p90-RSK 2) (p90RSK2) (MAP kinase-activated protein kinase 1c) (MAPK-activated protein kinase 1c) (MAPKAP kinase 1c) (MAPKAPK-1c) (Ribosomal S6 kinase 3) (RSK-3) (pp90RSK3) | Serine/threonine-protein kinase that acts downstream of ERK (MAPK1/ERK2 and MAPK3/ERK1) signaling and mediates mitogenic and stress-induced activation of transcription factors, regulates translation, and mediates cellular proliferation, survival, and differentiation. May function as tumor suppressor in epithelial ovarian cancer cells. {ECO:0000269|PubMed:16878154, ECO:0000269|PubMed:7623830}. |
Q15477 | SKIC2 | S1017 | ochoa | Superkiller complex protein 2 (Ski2) (EC 3.6.4.13) (Helicase-like protein) (HLP) | Helicase component of the SKI complex, a multiprotein complex that assists the RNA-degrading exosome during the mRNA decay and quality-control pathways (PubMed:16024656, PubMed:32006463, PubMed:35120588). The SKI complex catalyzes mRNA extraction from 80S ribosomal complexes in the 3'-5' direction and channels mRNA to the cytosolic exosome for degradation (PubMed:32006463, PubMed:35120588). SKI-mediated extraction of mRNA from stalled ribosomes allow binding of the Pelota-HBS1L complex and subsequent ribosome disassembly by ABCE1 for ribosome recycling (PubMed:32006463). In the nucleus, the SKI complex associates with transcriptionally active genes in a manner dependent on PAF1 complex (PAF1C) (PubMed:16024656). {ECO:0000269|PubMed:16024656, ECO:0000269|PubMed:32006463, ECO:0000269|PubMed:35120588}. |
Q16584 | MAP3K11 | S507 | ochoa | Mitogen-activated protein kinase kinase kinase 11 (EC 2.7.11.25) (Mixed lineage kinase 3) (Src-homology 3 domain-containing proline-rich kinase) | Activates the JUN N-terminal pathway. Required for serum-stimulated cell proliferation and for mitogen and cytokine activation of MAPK14 (p38), MAPK3 (ERK) and MAPK8 (JNK1) through phosphorylation and activation of MAP2K4/MKK4 and MAP2K7/MKK7. Plays a role in mitogen-stimulated phosphorylation and activation of BRAF, but does not phosphorylate BRAF directly. Influences microtubule organization during the cell cycle. {ECO:0000269|PubMed:12529434, ECO:0000269|PubMed:15258589, ECO:0000269|PubMed:8195146, ECO:0000269|PubMed:9003778}. |
Q16799 | RTN1 | S71 | ochoa | Reticulon-1 (Neuroendocrine-specific protein) | Inhibits amyloid precursor protein processing, probably by blocking BACE1 activity. {ECO:0000269|PubMed:15286784}. |
Q17R98 | ZNF827 | S518 | ochoa | Zinc finger protein 827 | As part of a ribonucleoprotein complex composed at least of HNRNPK, HNRNPL and the circular RNA circZNF827 that nucleates the complex on chromatin, may negatively regulate the transcription of genes involved in neuronal differentiation (PubMed:33174841). Could also recruit the nucleosome remodeling and histone deacetylase/NuRD complex to telomeric regions of chromosomes to regulate chromatin remodeling as part of telomere maintenance (PubMed:25150861). {ECO:0000269|PubMed:25150861, ECO:0000269|PubMed:33174841}. |
Q2KJY2 | KIF26B | S1613 | ochoa | Kinesin-like protein KIF26B | Essential for embryonic kidney development. Plays an important role in the compact adhesion between mesenchymal cells adjacent to the ureteric buds, possibly by interacting with MYH10. This could lead to the establishment of the basolateral integrity of the mesenchyme and the polarized expression of ITGA8, which maintains the GDNF expression required for further ureteric bud attraction. Although it seems to lack ATPase activity it is constitutively associated with microtubules (By similarity). {ECO:0000250}. |
Q504Q3 | PAN2 | S791 | ochoa | PAN2-PAN3 deadenylation complex catalytic subunit PAN2 (EC 3.1.13.4) (Inactive ubiquitin carboxyl-terminal hydrolase 52) (PAB1P-dependent poly(A)-specific ribonuclease) (Poly(A)-nuclease deadenylation complex subunit 2) (PAN deadenylation complex subunit 2) | Catalytic subunit of the poly(A)-nuclease (PAN) deadenylation complex, one of two cytoplasmic mRNA deadenylases involved in general and miRNA-mediated mRNA turnover. PAN specifically shortens poly(A) tails of RNA and the activity is stimulated by poly(A)-binding protein (PABP). PAN deadenylation is followed by rapid degradation of the shortened mRNA tails by the CCR4-NOT complex. Deadenylated mRNAs are then degraded by two alternative mechanisms, namely exosome-mediated 3'-5' exonucleolytic degradation, or deadenylation-dependent mRNA decaping and subsequent 5'-3' exonucleolytic degradation by XRN1. Also acts as an important regulator of the HIF1A-mediated hypoxic response. Required for HIF1A mRNA stability independent of poly(A) tail length regulation. {ECO:0000255|HAMAP-Rule:MF_03182, ECO:0000269|PubMed:14583602, ECO:0000269|PubMed:16284618, ECO:0000269|PubMed:23398456}. |
Q5SYE7 | NHSL1 | S639 | ochoa | NHS-like protein 1 | None |
Q5TC12 | ATPAF1 | S40 | ochoa | ATP synthase mitochondrial F1 complex assembly factor 1 (ATP11 homolog) | Has a complex stabilizing activity in the assembly of the mitochondrial F1-F0 complex. {ECO:0000250|UniProtKB:Q811I0}. |
Q5VSL9 | STRIP1 | S65 | ochoa | Striatin-interacting protein 1 (Protein FAM40A) | Plays a role in the regulation of cell morphology and cytoskeletal organization. Required in the cortical actin filament dynamics and cell shape. Part of the striatin-interacting phosphatase and kinase (STRIPAK) complexes. STRIPAK complexes have critical roles in protein (de)phosphorylation and are regulators of multiple signaling pathways including Hippo, MAPK, nuclear receptor and cytoskeleton remodeling. Different types of STRIPAK complexes are involved in a variety of biological processes such as cell growth, differentiation, apoptosis, metabolism and immune regulation. {ECO:0000269|PubMed:18782753, ECO:0000269|PubMed:21834987, ECO:0000269|PubMed:30622739, ECO:0000269|PubMed:33633399}. |
Q5VST9 | OBSCN | S6881 | ochoa | Obscurin (EC 2.7.11.1) (Obscurin-RhoGEF) (Obscurin-myosin light chain kinase) (Obscurin-MLCK) | Structural component of striated muscles which plays a role in myofibrillogenesis. Probably involved in the assembly of myosin into sarcomeric A bands in striated muscle (PubMed:11448995, PubMed:16205939). Has serine/threonine protein kinase activity and phosphorylates N-cadherin CDH2 and sodium/potassium-transporting ATPase subunit ATP1B1 (By similarity). Binds (via the PH domain) strongly to phosphatidylinositol 3,4-bisphosphate (PtdIns(3,4)P2) and phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2), and to a lesser extent to phosphatidylinositol 3-phosphate (PtdIns(3)P), phosphatidylinositol 4-phosphate (PtdIns(4)P), phosphatidylinositol 5-phosphate (PtdIns(5)P) and phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3) (PubMed:28826662). {ECO:0000250|UniProtKB:A2AAJ9, ECO:0000269|PubMed:11448995, ECO:0000269|PubMed:16205939, ECO:0000269|PubMed:28826662}. |
Q5VT25 | CDC42BPA | S1693 | ochoa | Serine/threonine-protein kinase MRCK alpha (EC 2.7.11.1) (CDC42-binding protein kinase alpha) (DMPK-like alpha) (Myotonic dystrophy kinase-related CDC42-binding kinase alpha) (MRCK alpha) (Myotonic dystrophy protein kinase-like alpha) | Serine/threonine-protein kinase which is an important downstream effector of CDC42 and plays a role in the regulation of cytoskeleton reorganization and cell migration (PubMed:15723050, PubMed:9092543, PubMed:9418861). Regulates actin cytoskeletal reorganization via phosphorylation of PPP1R12C and MYL9/MLC2 (PubMed:21457715). In concert with MYO18A and LURAP1, is involved in modulating lamellar actomyosin retrograde flow that is crucial to cell protrusion and migration (PubMed:18854160). Phosphorylates: PPP1R12A, LIMK1 and LIMK2 (PubMed:11340065, PubMed:11399775). May play a role in TFRC-mediated iron uptake (PubMed:20188707). In concert with FAM89B/LRAP25 mediates the targeting of LIMK1 to the lamellipodium resulting in its activation and subsequent phosphorylation of CFL1 which is important for lamellipodial F-actin regulation (By similarity). Triggers the formation of an extrusion apical actin ring required for epithelial extrusion of apoptotic cells (PubMed:29162624). {ECO:0000250|UniProtKB:Q3UU96, ECO:0000269|PubMed:11340065, ECO:0000269|PubMed:11399775, ECO:0000269|PubMed:15723050, ECO:0000269|PubMed:18854160, ECO:0000269|PubMed:20188707, ECO:0000269|PubMed:21457715, ECO:0000269|PubMed:29162624, ECO:0000269|PubMed:9092543, ECO:0000269|PubMed:9418861}. |
Q5VT97 | SYDE2 | S223 | ochoa | Rho GTPase-activating protein SYDE2 (Synapse defective protein 1 homolog 2) (Protein syd-1 homolog 2) | GTPase activator for the Rho-type GTPases by converting them to an inactive GDP-bound state. {ECO:0000250}. |
Q63HK5 | TSHZ3 | S682 | ochoa | Teashirt homolog 3 (Zinc finger protein 537) | Transcriptional regulator involved in developmental processes. Functions in association with APBB1, SET and HDAC factors as a transcriptional repressor, that inhibits the expression of CASP4. TSHZ3-mediated transcription repression involves the recruitment of histone deacetylases HDAC1 and HDAC2. Associates with chromatin in a region surrounding the CASP4 transcriptional start site(s) (PubMed:19343227). Regulates the development of neurons involved in both respiratory rhythm and airflow control. Promotes maintenance of nucleus ambiguus (nA) motoneurons, which govern upper airway function, and establishes a respiratory rhythm generator (RRG) activity compatible with survival at birth. Involved in the differentiation of the proximal uretic smooth muscle cells during developmental processes. Involved in the up-regulation of myocardin, that directs the expression of smooth muscle cells in the proximal ureter (By similarity). Involved in the modulation of glutamatergic synaptic transmission and long-term synaptic potentiation (By similarity). {ECO:0000250|UniProtKB:Q8CGV9, ECO:0000269|PubMed:19343227}. |
Q66K89 | E4F1 | S318 | ochoa | Transcription factor E4F1 (EC 2.3.2.27) (E4F transcription factor 1) (Putative E3 ubiquitin-protein ligase E4F1) (RING-type E3 ubiquitin transferase E4F1) (Transcription factor E4F) (p120E4F) (p50E4F) | May function as a transcriptional repressor. May also function as a ubiquitin ligase mediating ubiquitination of chromatin-associated TP53. Functions in cell survival and proliferation through control of the cell cycle. Functions in the p53 and pRB tumor suppressor pathways and regulates the cyclin CCNA2 transcription.; FUNCTION: Identified as a cellular target of the adenoviral oncoprotein E1A, it is required for both transcriptional activation and repression of viral genes. |
Q68CZ2 | TNS3 | S901 | ochoa | Tensin-3 (EC 3.1.3.-) (Tensin-like SH2 domain-containing protein 1) (Tumor endothelial marker 6) | May act as a protein phosphatase and/or a lipid phosphatase (Probable). Involved in the dissociation of the integrin-tensin-actin complex (PubMed:17643115). EGF activates TNS4 and down-regulates TNS3 which results in capping the tail of ITGB1 (PubMed:17643115). Increases DOCK5 guanine nucleotide exchange activity towards Rac and plays a role in osteoclast podosome organization (By similarity). Enhances RHOA activation in the presence of DLC1 (PubMed:26427649). Required for growth factor-induced epithelial cell migration; growth factor stimulation induces TNS3 phosphorylation which changes its binding preference from DLC1 to the p85 regulatory subunit of the PI3K kinase complex, displacing PI3K inhibitor PTEN and resulting in translocation of the TNS3-p85 complex to the leading edge of migrating cells to promote RAC1 activation (PubMed:26166433). Meanwhile, PTEN switches binding preference from p85 to DLC1 and the PTEN-DLC1 complex translocates to the posterior of migrating cells to activate RHOA (PubMed:26166433). Acts as an adapter protein by bridging the association of scaffolding protein PEAK1 with integrins ITGB1, ITGB3 and ITGB5 which contributes to the promotion of cell migration (PubMed:35687021). Controls tonsil-derived mesenchymal stem cell proliferation and differentiation by regulating the activity of integrin ITGB1 (PubMed:31905841). {ECO:0000250|UniProtKB:Q5SSZ5, ECO:0000269|PubMed:17643115, ECO:0000269|PubMed:26166433, ECO:0000269|PubMed:26427649, ECO:0000269|PubMed:31905841, ECO:0000269|PubMed:35687021, ECO:0000305}. |
Q6IE81 | JADE1 | S603 | ochoa | Protein Jade-1 (Jade family PHD finger protein 1) (PHD finger protein 17) | Scaffold subunit of some HBO1 complexes, which have a histone H4 acetyltransferase activity (PubMed:16387653, PubMed:19187766, PubMed:20129055, PubMed:24065767). Plays a key role in HBO1 complex by directing KAT7/HBO1 specificity towards histone H4 acetylation (H4K5ac, H4K8ac and H4K12ac), regulating DNA replication initiation, regulating DNA replication initiation (PubMed:20129055, PubMed:24065767). May also promote acetylation of nucleosomal histone H4 by KAT5 (PubMed:15502158). Promotes apoptosis (PubMed:16046545). May act as a renal tumor suppressor (PubMed:16046545). Negatively regulates canonical Wnt signaling; at least in part, cooperates with NPHP4 in this function (PubMed:22654112). {ECO:0000269|PubMed:15502158, ECO:0000269|PubMed:16046545, ECO:0000269|PubMed:16387653, ECO:0000269|PubMed:19187766, ECO:0000269|PubMed:20129055, ECO:0000269|PubMed:22654112, ECO:0000269|PubMed:24065767}. |
Q6KC79 | NIPBL | S103 | ochoa | Nipped-B-like protein (Delangin) (SCC2 homolog) | Plays an important role in the loading of the cohesin complex on to DNA. Forms a heterodimeric complex (also known as cohesin loading complex) with MAU2/SCC4 which mediates the loading of the cohesin complex onto chromatin (PubMed:22628566, PubMed:28914604). Plays a role in cohesin loading at sites of DNA damage. Its recruitment to double-strand breaks (DSBs) sites occurs in a CBX3-, RNF8- and RNF168-dependent manner whereas its recruitment to UV irradiation-induced DNA damage sites occurs in a ATM-, ATR-, RNF8- and RNF168-dependent manner (PubMed:28167679). Along with ZNF609, promotes cortical neuron migration during brain development by regulating the transcription of crucial genes in this process. Preferentially binds promoters containing paused RNA polymerase II. Up-regulates the expression of SEMA3A, NRP1, PLXND1 and GABBR2 genes, among others (By similarity). {ECO:0000250|UniProtKB:Q6KCD5, ECO:0000269|PubMed:22628566, ECO:0000269|PubMed:28167679, ECO:0000269|PubMed:28914604}. |
Q6NZY4 | ZCCHC8 | S658 | ochoa | Zinc finger CCHC domain-containing protein 8 (TRAMP-like complex RNA-binding factor ZCCHC8) | Scaffolding subunit of the trimeric nuclear exosome targeting (NEXT) complex that is involved in the surveillance and turnover of aberrant transcripts and non-coding RNAs (PubMed:27871484). NEXT functions as an RNA exosome cofactor that directs a subset of non-coding short-lived RNAs for exosomal degradation. May be involved in pre-mRNA splicing (Probable). It is required for 3'-end maturation of telomerase RNA component (TERC), TERC 3'-end targeting to the nuclear RNA exosome, and for telomerase function (PubMed:31488579). {ECO:0000269|PubMed:27871484, ECO:0000269|PubMed:31488579, ECO:0000305|PubMed:16263084}. |
Q6P1R3 | MSANTD2 | S48 | ochoa | Myb/SANT-like DNA-binding domain-containing protein 2 | None |
Q6P996 | PDXDC1 | S757 | ochoa | Pyridoxal-dependent decarboxylase domain-containing protein 1 (EC 4.1.1.-) | None |
Q6PJ61 | FBXO46 | S240 | ochoa | F-box only protein 46 (F-box only protein 34-like) | Substrate-recognition component of the SCF(FBXO46) protein ligase complex, which mediates the ubiquitination and degradation of target proteins (PubMed:30171069). In absence of stress, the SCF(FBXO46) complex catalyzes ubiquitination and degradation of MTOR-phosphorylated FBXO31 (PubMed:30171069). {ECO:0000269|PubMed:30171069}. |
Q6SZW1 | SARM1 | S54 | ochoa | NAD(+) hydrolase SARM1 (NADase SARM1) (hSARM1) (EC 3.2.2.6) (NADP(+) hydrolase SARM1) (EC 3.2.2.-) (Sterile alpha and Armadillo repeat protein) (Sterile alpha and TIR motif-containing protein 1) (Sterile alpha motif domain-containing protein 2) (MyD88-5) (SAM domain-containing protein 2) (Tir-1 homolog) (HsTIR) | NAD(+) hydrolase, which plays a key role in axonal degeneration following injury by regulating NAD(+) metabolism (PubMed:25908823, PubMed:27671644, PubMed:28334607). Acts as a negative regulator of MYD88- and TRIF-dependent toll-like receptor signaling pathway by promoting Wallerian degeneration, an injury-induced form of programmed subcellular death which involves degeneration of an axon distal to the injury site (PubMed:15123841, PubMed:16964262, PubMed:20306472, PubMed:25908823). Wallerian degeneration is triggered by NAD(+) depletion: in response to injury, SARM1 is activated and catalyzes cleavage of NAD(+) into ADP-D-ribose (ADPR), cyclic ADPR (cADPR) and nicotinamide; NAD(+) cleavage promoting cytoskeletal degradation and axon destruction (PubMed:25908823, PubMed:28334607, PubMed:30333228, PubMed:31128467, PubMed:31439792, PubMed:31439793, PubMed:32049506, PubMed:32828421, PubMed:33053563). Also able to hydrolyze NADP(+), but not other NAD(+)-related molecules (PubMed:29395922). Can activate neuronal cell death in response to stress (PubMed:20306472). Regulates dendritic arborization through the MAPK4-JNK pathway (By similarity). Involved in innate immune response: inhibits both TICAM1/TRIF- and MYD88-dependent activation of JUN/AP-1, TRIF-dependent activation of NF-kappa-B and IRF3, and the phosphorylation of MAPK14/p38 (PubMed:16964262). {ECO:0000250|UniProtKB:Q6PDS3, ECO:0000269|PubMed:15123841, ECO:0000269|PubMed:16964262, ECO:0000269|PubMed:20306472, ECO:0000269|PubMed:25908823, ECO:0000269|PubMed:27671644, ECO:0000269|PubMed:28334607, ECO:0000269|PubMed:29395922, ECO:0000269|PubMed:30333228, ECO:0000269|PubMed:31128467, ECO:0000269|PubMed:31439792, ECO:0000269|PubMed:31439793, ECO:0000269|PubMed:32049506, ECO:0000269|PubMed:32828421, ECO:0000269|PubMed:33053563}. |
Q6WKZ4 | RAB11FIP1 | S1214 | ochoa | Rab11 family-interacting protein 1 (Rab11-FIP1) (Rab-coupling protein) | A Rab11 effector protein involved in the endosomal recycling process. Also involved in controlling membrane trafficking along the phagocytic pathway and in phagocytosis. Interaction with RAB14 may function in the process of neurite formation (PubMed:26032412). {ECO:0000269|PubMed:11786538, ECO:0000269|PubMed:15181150, ECO:0000269|PubMed:15355514, ECO:0000269|PubMed:16920206, ECO:0000269|PubMed:26032412}. |
Q6ZMB5 | TMEM184A | S368 | ochoa | Transmembrane protein 184A | Acts as a heparin receptor in vascular cells (By similarity). May be involved in vesicle transport in exocrine cells and Sertoli cells (By similarity). {ECO:0000250|UniProtKB:Q3UFJ6, ECO:0000250|UniProtKB:Q4QQS1}. |
Q6ZNH5 | ZNF497 | S98 | ochoa | Zinc finger protein 497 | May be involved in transcriptional regulation. |
Q6ZUT6 | CCDC9B | S55 | ochoa | Coiled-coil domain-containing protein 9B | None |
Q6ZUT6 | CCDC9B | S193 | ochoa | Coiled-coil domain-containing protein 9B | None |
Q6ZVH7 | ESPNL | S635 | ochoa | Espin-like protein | Binds to but does not cross-link actin. Required for the formation and maintenance of inner ear hair cell stereocilia and staircase formation. Essential for normal hearing. {ECO:0000250|UniProtKB:Q3UYR4}. |
Q702N8 | XIRP1 | S481 | ochoa | Xin actin-binding repeat-containing protein 1 (Cardiomyopathy-associated protein 1) | Protects actin filaments from depolymerization (PubMed:15454575). Required for correct cardiac intercalated disk ultrastructure via maintenance of cell-cell adhesion stability, and as a result maintains cardiac organ morphology, conductance and heart beat rhythm (By similarity). Required for development of normal skeletal muscle morphology and muscle fiber type composition (By similarity). Plays a role in regulating muscle satellite cell activation and survival, as a result promotes muscle fiber recovery from injury and fatigue (By similarity). {ECO:0000250|UniProtKB:O70373, ECO:0000269|PubMed:15454575}. |
Q70EL1 | USP54 | S1036 | ochoa | Ubiquitin carboxyl-terminal hydrolase 54 (EC 3.4.19.12) (Ubiquitin-specific peptidase 54) | Deubiquitinase that specifically mediates 'Lys-63'-linked deubiquitination of substrates with a polyubiquitin chain composed of at least 3 ubiquitins (PubMed:39587316). Specifically recognizes ubiquitin chain in position S2 and catalyzes cleavage of polyubiquitin within 'Lys-63'-linked chains (PubMed:39587316). Not able to deubiquitinate substrates with shorter ubiquitin chains (PubMed:39587316). Mediates deubiquitination of PLK4, maintaining PLK4 stability by reducing its ubiquitination-mediated degradation (PubMed:36590171). {ECO:0000269|PubMed:36590171, ECO:0000269|PubMed:39587316}. |
Q71F56 | MED13L | S1081 | ochoa | Mediator of RNA polymerase II transcription subunit 13-like (Mediator complex subunit 13-like) (Thyroid hormone receptor-associated protein 2) (Thyroid hormone receptor-associated protein complex 240 kDa component-like) | Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. This subunit may specifically regulate transcription of targets of the Wnt signaling pathway and SHH signaling pathway. |
Q76I76 | SSH2 | S1283 | ochoa | Protein phosphatase Slingshot homolog 2 (EC 3.1.3.16) (EC 3.1.3.48) (SSH-like protein 2) (SSH-2L) (hSSH-2L) | Protein phosphatase which regulates actin filament dynamics. Dephosphorylates and activates the actin binding/depolymerizing factor cofilin, which subsequently binds to actin filaments and stimulates their disassembly. Inhibitory phosphorylation of cofilin is mediated by LIMK1, which may also be dephosphorylated and inactivated by this protein (PubMed:11832213). Required for spermatogenesis (By similarity). Involved in acrosome biogenesis, probably by regulating cofilin-mediated actin cytoskeleton remodeling during proacrosomal vesicle fusion and/or Golgi to perinuclear vesicle trafficking (By similarity). {ECO:0000250|UniProtKB:Q5SW75, ECO:0000269|PubMed:11832213}. |
Q7KZI7 | MARK2 | S619 | ochoa|psp | Serine/threonine-protein kinase MARK2 (EC 2.7.11.1) (EC 2.7.11.26) (ELKL motif kinase 1) (EMK-1) (MAP/microtubule affinity-regulating kinase 2) (PAR1 homolog) (PAR1 homolog b) (Par-1b) (Par1b) | Serine/threonine-protein kinase (PubMed:23666762). Involved in cell polarity and microtubule dynamics regulation. Phosphorylates CRTC2/TORC2, DCX, HDAC7, KIF13B, MAP2, MAP4 and RAB11FIP2. Phosphorylates the microtubule-associated protein MAPT/TAU (PubMed:23666762). Plays a key role in cell polarity by phosphorylating the microtubule-associated proteins MAP2, MAP4 and MAPT/TAU at KXGS motifs, causing detachment from microtubules, and their disassembly. Regulates epithelial cell polarity by phosphorylating RAB11FIP2. Involved in the regulation of neuronal migration through its dual activities in regulating cellular polarity and microtubule dynamics, possibly by phosphorylating and regulating DCX. Regulates axogenesis by phosphorylating KIF13B, promoting interaction between KIF13B and 14-3-3 and inhibiting microtubule-dependent accumulation of KIF13B. Also required for neurite outgrowth and establishment of neuronal polarity. Regulates localization and activity of some histone deacetylases by mediating phosphorylation of HDAC7, promoting subsequent interaction between HDAC7 and 14-3-3 and export from the nucleus. Also acts as a positive regulator of the Wnt signaling pathway, probably by mediating phosphorylation of dishevelled proteins (DVL1, DVL2 and/or DVL3). Modulates the developmental decision to build a columnar versus a hepatic epithelial cell apparently by promoting a switch from a direct to a transcytotic mode of apical protein delivery. Essential for the asymmetric development of membrane domains of polarized epithelial cells. {ECO:0000269|PubMed:11433294, ECO:0000269|PubMed:12429843, ECO:0000269|PubMed:14976552, ECO:0000269|PubMed:15158914, ECO:0000269|PubMed:15324659, ECO:0000269|PubMed:15365179, ECO:0000269|PubMed:16775013, ECO:0000269|PubMed:16980613, ECO:0000269|PubMed:18626018, ECO:0000269|PubMed:20194617, ECO:0000269|PubMed:23666762}. |
Q7Z4K8 | TRIM46 | S627 | ochoa | Tripartite motif-containing protein 46 (Gene Y protein) (GeneY) (Tripartite, fibronectin type-III and C-terminal SPRY motif protein) | Microtubule-associated protein that is involved in the formation of parallel microtubule bundles linked by cross-bridges in the proximal axon. Required for the uniform orientation and maintenance of the parallel microtubule fascicles, which are important for efficient cargo delivery and trafficking in axons. Thereby also required for proper axon specification, the establishment of neuronal polarity and proper neuronal migration. {ECO:0000250|UniProtKB:Q7TNM2}. |
Q7Z6B7 | SRGAP1 | S886 | ochoa | SLIT-ROBO Rho GTPase-activating protein 1 (srGAP1) (Rho GTPase-activating protein 13) | GTPase-activating protein for RhoA and Cdc42 small GTPases. Together with CDC42 seems to be involved in the pathway mediating the repulsive signaling of Robo and Slit proteins in neuronal migration. SLIT2, probably through interaction with ROBO1, increases the interaction of SRGAP1 with ROBO1 and inactivates CDC42. {ECO:0000269|PubMed:11672528}. |
Q86U70 | LDB1 | S323 | ochoa | LIM domain-binding protein 1 (LDB-1) (Carboxyl-terminal LIM domain-binding protein 2) (CLIM-2) (LIM domain-binding factor CLIM2) (hLdb1) (Nuclear LIM interactor) | Binds to the LIM domain of a wide variety of LIM domain-containing transcription factors. May regulate the transcriptional activity of LIM-containing proteins by determining specific partner interactions. Plays a role in the development of interneurons and motor neurons in cooperation with LHX3 and ISL1. Acts synergistically with LHX1/LIM1 in axis formation and activation of gene expression. Acts with LMO2 in the regulation of red blood cell development, maintaining erythroid precursors in an immature state. {ECO:0000250|UniProtKB:P70662}. |
Q86US8 | SMG6 | S203 | ochoa | Telomerase-binding protein EST1A (EC 3.1.-.-) (Ever shorter telomeres 1A) (hEST1A) (Nonsense mediated mRNA decay factor SMG6) (Smg-6 homolog) (hSmg5/7a) | Component of the telomerase ribonucleoprotein (RNP) complex that is essential for the replication of chromosome termini (PubMed:19179534). May have a general role in telomere regulation (PubMed:12676087, PubMed:12699629). Promotes in vitro the ability of TERT to elongate telomeres (PubMed:12676087, PubMed:12699629). Overexpression induces telomere uncapping, chromosomal end-to-end fusions (telomeric DNA persists at the fusion points) and did not perturb TRF2 telomeric localization (PubMed:12676087, PubMed:12699629). Binds to the single-stranded 5'-(GTGTGG)(4)GTGT-3' telomeric DNA, but not to a telomerase RNA template component (TER) (PubMed:12676087, PubMed:12699629). {ECO:0000269|PubMed:12676087, ECO:0000269|PubMed:12699629, ECO:0000269|PubMed:19179534}.; FUNCTION: Plays a role in nonsense-mediated mRNA decay (PubMed:17053788, PubMed:18974281, PubMed:19060897, PubMed:20930030). Is thought to provide a link to the mRNA degradation machinery as it has endonuclease activity required to initiate NMD, and to serve as an adapter for UPF1 to protein phosphatase 2A (PP2A), thereby triggering UPF1 dephosphorylation (PubMed:17053788, PubMed:18974281, PubMed:19060897, PubMed:20930030). Degrades single-stranded RNA (ssRNA), but not ssDNA or dsRNA (PubMed:17053788, PubMed:18974281, PubMed:19060897, PubMed:20930030). {ECO:0000269|PubMed:17053788, ECO:0000269|PubMed:18974281, ECO:0000269|PubMed:19060897, ECO:0000269|PubMed:20930030}. |
Q8IVJ1 | SLC41A1 | S89 | ochoa | Solute carrier family 41 member 1 | Na(+)/Mg(2+) ion exchanger that acts as a predominant Mg(2+) efflux system at the plasma membrane (PubMed:18367447, PubMed:22031603, PubMed:23661805, PubMed:23976986). Transporter activity is driven by the inwardly directed electrochemical gradient for Na(+) ions, thus directly depends on the extracellular Na(+) ion concentration set by Na(+)/K(+) pump (PubMed:22031603, PubMed:23661805). Generates circadian cellular Mg(2+) fluxes that feed back to regulate clock-controlled gene expression and metabolism and facilitate higher energetic demands during the day (PubMed:27074515). Has a role in regulating the activity of ATP-dependent enzymes, including those operating in Krebs cycle and the electron transport chain (By similarity). {ECO:0000250|UniProtKB:Q8BJA2, ECO:0000269|PubMed:18367447, ECO:0000269|PubMed:22031603, ECO:0000269|PubMed:23661805, ECO:0000269|PubMed:23976986, ECO:0000269|PubMed:27074515}. |
Q8IVL1 | NAV2 | S1559 | ochoa | Neuron navigator 2 (EC 3.6.4.12) (Helicase APC down-regulated 1) (Pore membrane and/or filament-interacting-like protein 2) (Retinoic acid inducible in neuroblastoma 1) (Steerin-2) (Unc-53 homolog 2) (unc53H2) | Possesses 3' to 5' helicase activity and exonuclease activity. Involved in neuronal development, specifically in the development of different sensory organs. {ECO:0000269|PubMed:12214280, ECO:0000269|PubMed:15158073}. |
Q8IWQ3 | BRSK2 | S393 | ochoa | Serine/threonine-protein kinase BRSK2 (EC 2.7.11.1) (Brain-selective kinase 2) (EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 2) (BR serine/threonine-protein kinase 2) (Serine/threonine-protein kinase 29) (Serine/threonine-protein kinase SAD-A) | Serine/threonine-protein kinase that plays a key role in polarization of neurons and axonogenesis, cell cycle progress and insulin secretion. Phosphorylates CDK16, CDC25C, MAPT/TAU, PAK1 and WEE1. Following phosphorylation and activation by STK11/LKB1, acts as a key regulator of polarization of cortical neurons, probably by mediating phosphorylation of microtubule-associated proteins such as MAPT/TAU at 'Thr-529' and 'Ser-579'. Also regulates neuron polarization by mediating phosphorylation of WEE1 at 'Ser-642' in postmitotic neurons, leading to down-regulate WEE1 activity in polarized neurons. Plays a role in the regulation of the mitotic cell cycle progress and the onset of mitosis. Plays a role in the regulation of insulin secretion in response to elevated glucose levels, probably via phosphorylation of CDK16 and PAK1. While BRSK2 phosphorylated at Thr-174 can inhibit insulin secretion (PubMed:22798068), BRSK2 phosphorylated at Thr-260 can promote insulin secretion (PubMed:22669945). Regulates reorganization of the actin cytoskeleton. May play a role in the apoptotic response triggered by endoplasmic reticulum (ER) stress. {ECO:0000269|PubMed:14976552, ECO:0000269|PubMed:20026642, ECO:0000269|PubMed:21985311, ECO:0000269|PubMed:22669945, ECO:0000269|PubMed:22798068, ECO:0000269|PubMed:23029325}. |
Q8IZC7 | ZNF101 | S152 | ochoa | Zinc finger protein 101 (Zinc finger protein HZF12) | May be involved in transcriptional regulation. |
Q8N1G0 | ZNF687 | S1146 | ochoa | Zinc finger protein 687 | May be involved in transcriptional regulation. |
Q8N1G1 | REXO1 | S422 | ochoa | RNA exonuclease 1 homolog (EC 3.1.-.-) (Elongin-A-binding protein 1) (EloA-BP1) (Transcription elongation factor B polypeptide 3-binding protein 1) | Seems to have no detectable effect on transcription elongation in vitro. {ECO:0000269|PubMed:12943681}. |
Q8N2Y8 | RUSC2 | S574 | ochoa | AP-4 complex accessory subunit RUSC2 (Interacting protein of Rab1) (Iporin) (RUN and SH3 domain-containing protein 2) | Associates with the adapter-like complex 4 (AP-4) and may therefore play a role in vesicular trafficking of proteins at the trans-Golgi network. {ECO:0000269|PubMed:30262884}. |
Q8N350 | CBARP | S304 | ochoa | Voltage-dependent calcium channel beta subunit-associated regulatory protein | Negatively regulates voltage-gated calcium channels by preventing the interaction between their alpha and beta subunits. Thereby, negatively regulates calcium channels activity at the plasma membrane and indirectly inhibits calcium-regulated exocytosis. {ECO:0000250|UniProtKB:Q66L44}. |
Q8N3K9 | CMYA5 | S168 | ochoa | Cardiomyopathy-associated protein 5 (Dystrobrevin-binding protein 2) (Genethonin-3) (Myospryn) (SPRY domain-containing protein 2) (Tripartite motif-containing protein 76) | May serve as an anchoring protein that mediates the subcellular compartmentation of protein kinase A (PKA) via binding to PRKAR2A (By similarity). May function as a repressor of calcineurin-mediated transcriptional activity. May attenuate calcineurin ability to induce slow-fiber gene program in muscle and may negatively modulate skeletal muscle regeneration (By similarity). Plays a role in the assembly of ryanodine receptor (RYR2) clusters in striated muscle (By similarity). {ECO:0000250, ECO:0000250|UniProtKB:Q70KF4}. |
Q8N594 | MPND | S123 | ochoa | MPN domain-containing protein (EC 3.4.-.-) | Probable protease (By similarity). Acts as a sensor of N(6)-methyladenosine methylation on DNA (m6A): recognizes and binds m6A DNA, leading to its degradation (PubMed:30982744). Binds only double strand DNA (dsDNA) in a sequence-independent manner (By similarity). {ECO:0000250|UniProtKB:Q3TV65, ECO:0000250|UniProtKB:Q5VVJ2, ECO:0000269|PubMed:30982744}. |
Q8N5C8 | TAB3 | S80 | ochoa | TGF-beta-activated kinase 1 and MAP3K7-binding protein 3 (Mitogen-activated protein kinase kinase kinase 7-interacting protein 3) (NF-kappa-B-activating protein 1) (TAK1-binding protein 3) (TAB-3) (TGF-beta-activated kinase 1-binding protein 3) | Adapter required to activate the JNK and NF-kappa-B signaling pathways through the specific recognition of 'Lys-63'-linked polyubiquitin chains by its RanBP2-type zinc finger (NZF) (PubMed:14633987, PubMed:14766965, PubMed:15327770, PubMed:22158122). Acts as an adapter linking MAP3K7/TAK1 and TRAF6 to 'Lys-63'-linked polyubiquitin chains (PubMed:14633987, PubMed:14766965, PubMed:15327770, PubMed:22158122, PubMed:36593296). The RanBP2-type zinc finger (NZF) specifically recognizes Lys-63'-linked polyubiquitin chains unanchored or anchored to the substrate proteins such as RIPK1/RIP1 and RIPK2: this acts as a scaffold to organize a large signaling complex to promote autophosphorylation of MAP3K7/TAK1, and subsequent activation of I-kappa-B-kinase (IKK) core complex by MAP3K7/TAK1 (PubMed:15327770, PubMed:18079694, PubMed:22158122). {ECO:0000269|PubMed:14633987, ECO:0000269|PubMed:14766965, ECO:0000269|PubMed:15327770, ECO:0000269|PubMed:18079694, ECO:0000269|PubMed:22158122, ECO:0000269|PubMed:36593296}.; FUNCTION: [Isoform 2]: May be an oncogenic factor. {ECO:0000269|PubMed:14766965}. |
Q8NCE0 | TSEN2 | S215 | ochoa | tRNA-splicing endonuclease subunit Sen2 (EC 4.6.1.16) (tRNA-intron endonuclease Sen2) (HsSen2) | Constitutes one of the two catalytic subunit of the tRNA-splicing endonuclease complex, a complex responsible for identification and cleavage of the splice sites in pre-tRNA. It cleaves pre-tRNA at the 5'- and 3'-splice sites to release the intron. The products are an intron and two tRNA half-molecules bearing 2',3'-cyclic phosphate and 5'-OH termini. There are no conserved sequences at the splice sites, but the intron is invariably located at the same site in the gene, placing the splice sites an invariant distance from the constant structural features of the tRNA body. Isoform 1 probably carries the active site for 5'-splice site cleavage. The tRNA splicing endonuclease is also involved in mRNA processing via its association with pre-mRNA 3'-end processing factors, establishing a link between pre-tRNA splicing and pre-mRNA 3'-end formation, suggesting that the endonuclease subunits function in multiple RNA-processing events. Isoform 2 is responsible for processing a yet unknown RNA substrate. The complex containing isoform 2 is not able to cleave pre-tRNAs properly, although it retains endonucleolytic activity. {ECO:0000269|PubMed:15109492}. |
Q8TB72 | PUM2 | S136 | ochoa | Pumilio homolog 2 (Pumilio-2) | Sequence-specific RNA-binding protein that acts as a post-transcriptional repressor by binding the 3'-UTR of mRNA targets. Binds to an RNA consensus sequence, the Pumilio Response Element (PRE), 5'-UGUANAUA-3', that is related to the Nanos Response Element (NRE) (, PubMed:21397187). Mediates post-transcriptional repression of transcripts via different mechanisms: acts via direct recruitment of the CCR4-POP2-NOT deadenylase leading to translational inhibition and mRNA degradation (PubMed:22955276). Also mediates deadenylation-independent repression by promoting accessibility of miRNAs (PubMed:18776931, PubMed:22345517). Acts as a post-transcriptional repressor of E2F3 mRNAs by binding to its 3'-UTR and facilitating miRNA regulation (PubMed:22345517). Plays a role in cytoplasmic sensing of viral infection (PubMed:25340845). Represses a program of genes necessary to maintain genomic stability such as key mitotic, DNA repair and DNA replication factors. Its ability to repress those target mRNAs is regulated by the lncRNA NORAD (non-coding RNA activated by DNA damage) which, due to its high abundance and multitude of PUMILIO binding sites, is able to sequester a significant fraction of PUM1 and PUM2 in the cytoplasm (PubMed:26724866). May regulate DCUN1D3 mRNA levels (PubMed:25349211). May support proliferation and self-renewal of stem cells. Binds specifically to miRNA MIR199A precursor, with PUM1, regulates miRNA MIR199A expression at a postranscriptional level (PubMed:28431233). {ECO:0000269|PubMed:18776931, ECO:0000269|PubMed:21397187, ECO:0000269|PubMed:22345517, ECO:0000269|PubMed:22955276, ECO:0000269|PubMed:25340845, ECO:0000269|PubMed:25349211, ECO:0000269|PubMed:26724866, ECO:0000269|PubMed:28431233}. |
Q8TEQ6 | GEMIN5 | S48 | ochoa | Gem-associated protein 5 (Gemin5) | The SMN complex catalyzes the assembly of small nuclear ribonucleoproteins (snRNPs), the building blocks of the spliceosome, and thereby plays an important role in the splicing of cellular pre-mRNAs (PubMed:16857593, PubMed:18984161, PubMed:20513430, PubMed:33963192). Most spliceosomal snRNPs contain a common set of Sm proteins SNRPB, SNRPD1, SNRPD2, SNRPD3, SNRPE, SNRPF and SNRPG that assemble in a heptameric protein ring on the Sm site of the small nuclear RNA to form the core snRNP (Sm core). In the cytosol, the Sm proteins SNRPD1, SNRPD2, SNRPE, SNRPF and SNRPG are trapped in an inactive 6S pICln-Sm complex by the chaperone CLNS1A that controls the assembly of the core snRNP (PubMed:18984161). To assemble core snRNPs, the SMN complex accepts the trapped 5Sm proteins from CLNS1A forming an intermediate (PubMed:18984161). Binding of snRNA inside 5Sm ultimately triggers eviction of the SMN complex, thereby allowing binding of SNRPD3 and SNRPB to complete assembly of the core snRNP. Within the SMN complex, GEMIN5 recognizes and delivers the small nuclear RNAs (snRNAs) to the SMN complex (PubMed:11714716, PubMed:16314521, PubMed:16857593, PubMed:19377484, PubMed:19750007, PubMed:20513430, PubMed:27834343, PubMed:27881600, PubMed:27881601). Binds to the 7-methylguanosine cap of RNA molecules (PubMed:19750007, PubMed:27834343, PubMed:27881600, PubMed:27881601, Ref.27). Binds to the 3'-UTR of SMN1 mRNA and regulates its translation; does not affect mRNA stability (PubMed:25911097). May play a role in the regulation of protein synthesis via its interaction with ribosomes (PubMed:27507887). {ECO:0000269|PubMed:11714716, ECO:0000269|PubMed:16314521, ECO:0000269|PubMed:16857593, ECO:0000269|PubMed:18984161, ECO:0000269|PubMed:19377484, ECO:0000269|PubMed:19750007, ECO:0000269|PubMed:20513430, ECO:0000269|PubMed:25911097, ECO:0000269|PubMed:27507887, ECO:0000269|PubMed:27834343, ECO:0000269|PubMed:27881600, ECO:0000269|PubMed:27881601, ECO:0000269|PubMed:33963192, ECO:0000269|Ref.27}. |
Q8TF30 | WHAMM | S181 | ochoa | WASP homolog-associated protein with actin, membranes and microtubules (WAS protein homology region 2 domain-containing protein 1) (WH2 domain-containing protein 1) | Acts as a nucleation-promoting factor (NPF) that stimulates Arp2/3-mediated actin polymerization both at the Golgi apparatus and along tubular membranes. Its activity in membrane tubulation requires F-actin and interaction with microtubules. Proposed to use coordinated actin-nucleating and microtubule-binding activities of distinct WHAMM molecules to drive membrane tubule elongation; when MT-bound can recruit and remodel membrane vesicles but is prevented to activate the Arp2/3 complex. Involved as a regulator of Golgi positioning and morphology. Participates in vesicle transport between the reticulum endoplasmic and the Golgi complex. Required for RhoD-dependent actin reorganization such as in cell adhesion and cell migration. {ECO:0000269|PubMed:18614018, ECO:0000269|PubMed:23027905, ECO:0000269|PubMed:23087206}. |
Q8WVV9 | HNRNPLL | S75 | ochoa | Heterogeneous nuclear ribonucleoprotein L-like (hnRNPLL) (Stromal RNA-regulating factor) | RNA-binding protein that functions as a regulator of alternative splicing for multiple target mRNAs, including PTPRC/CD45 and STAT5A. Required for alternative splicing of PTPRC. {ECO:0000269|PubMed:18669861}. |
Q92576 | PHF3 | S1642 | ochoa | PHD finger protein 3 | None |
Q92585 | MAML1 | S120 | ochoa | Mastermind-like protein 1 (Mam-1) | Acts as a transcriptional coactivator for NOTCH proteins. Has been shown to amplify NOTCH-induced transcription of HES1. Enhances phosphorylation and proteolytic turnover of the NOTCH intracellular domain in the nucleus through interaction with CDK8. Binds to CREBBP/CBP which promotes nucleosome acetylation at NOTCH enhancers and activates transcription. Induces phosphorylation and localization of CREBBP to nuclear foci. Plays a role in hematopoietic development by regulating NOTCH-mediated lymphoid cell fate decisions. {ECO:0000269|PubMed:11101851, ECO:0000269|PubMed:11390662, ECO:0000269|PubMed:12050117, ECO:0000269|PubMed:15546612, ECO:0000269|PubMed:17317671}. |
Q92610 | ZNF592 | S1089 | ochoa | Zinc finger protein 592 | May be involved in transcriptional regulation. {ECO:0000269|PubMed:20531441}. |
Q92871 | PMM1 | S242 | ochoa | Phosphomannomutase 1 (PMM 1) (EC 5.4.2.8) (PMMH-22) | Involved in the synthesis of the GDP-mannose and dolichol-phosphate-mannose required for a number of critical mannosyl transfer reactions. In addition, may be responsible for the degradation of glucose-1,6-bisphosphate in ischemic brain. {ECO:0000269|PubMed:16540464}. |
Q96E09 | PABIR1 | S48 | ochoa | PPP2R1A-PPP2R2A-interacting phosphatase regulator 1 (PABIR family member 1) | Acts as an inhibitor of serine/threonine-protein phosphatase 2A (PP2A) activity (PubMed:27588481, PubMed:33108758, PubMed:38123684). Inhibits PP2A activity by blocking the substrate binding site on PPP2R2A and the active site of PPP2CA (PubMed:38123684). Potentiates ubiquitin-mediated proteasomal degradation of serine/threonine-protein phosphatase 2A catalytic subunit alpha (PPP2CA) (PubMed:27588481). Inhibits PP2A-mediated dephosphorylation of WEE1, promoting ubiquitin-mediated proteolysis of WEE1, thereby releasing G2/M checkpoint (PubMed:33108758). {ECO:0000269|PubMed:27588481, ECO:0000269|PubMed:33108758, ECO:0000269|PubMed:38123684}. |
Q96HI0 | SENP5 | S465 | ochoa | Sentrin-specific protease 5 (EC 3.4.22.-) (Sentrin/SUMO-specific protease SENP5) | Protease that catalyzes two essential functions in the SUMO pathway: processing of full-length SUMO3 to its mature form and deconjugation of SUMO2 and SUMO3 from targeted proteins. Has weak proteolytic activity against full-length SUMO1 or SUMO1 conjugates. Required for cell division. {ECO:0000269|PubMed:16608850, ECO:0000269|PubMed:16738315}. |
Q96HU1 | SGSM3 | S65 | ochoa | Small G protein signaling modulator 3 (Merlin-associated protein) (RUN and TBC1 domain-containing protein 3) (Rab-GTPase-activating protein-like protein) (RabGAPLP) | May play a cooperative role in NF2-mediated growth suppression of cells. {ECO:0000269|PubMed:15541357}. |
Q96K76 | USP47 | S910 | ochoa | Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47) | Ubiquitin-specific protease that specifically deubiquitinates monoubiquitinated DNA polymerase beta (POLB), stabilizing POLB thereby playing a role in base-excision repair (BER). Acts as a regulator of cell growth and genome integrity. May also indirectly regulate CDC25A expression at a transcriptional level. {ECO:0000269|PubMed:19966869, ECO:0000269|PubMed:21362556}. |
Q96KS0 | EGLN2 | S130 | ochoa|psp | Prolyl hydroxylase EGLN2 (EC 1.14.11.-) (Egl nine homolog 2) (EC 1.14.11.29) (Estrogen-induced tag 6) (EIT-6) (HPH-3) (Hypoxia-inducible factor prolyl hydroxylase 1) (HIF-PH1) (HIF-prolyl hydroxylase 1) (HPH-1) (Prolyl hydroxylase domain-containing protein 1) (PHD1) | Prolyl hydroxylase that mediates hydroxylation of proline residues in target proteins, such as ATF4, IKBKB, CEP192 and HIF1A (PubMed:11595184, PubMed:12039559, PubMed:15925519, PubMed:16509823, PubMed:17114296, PubMed:23932902). Target proteins are preferentially recognized via a LXXLAP motif (PubMed:11595184, PubMed:12039559, PubMed:15925519). Cellular oxygen sensor that catalyzes, under normoxic conditions, the post-translational formation of 4-hydroxyproline in hypoxia-inducible factor (HIF) alpha proteins (PubMed:11595184, PubMed:12039559, PubMed:12181324, PubMed:15925519, PubMed:19339211). Hydroxylates a specific proline found in each of the oxygen-dependent degradation (ODD) domains (N-terminal, NODD, and C-terminal, CODD) of HIF1A (PubMed:11595184, PubMed:12039559, PubMed:12181324, PubMed:15925519). Also hydroxylates HIF2A (PubMed:11595184, PubMed:12039559, PubMed:15925519). Has a preference for the CODD site for both HIF1A and HIF2A (PubMed:11595184, PubMed:12039559, PubMed:15925519). Hydroxylated HIFs are then targeted for proteasomal degradation via the von Hippel-Lindau ubiquitination complex (PubMed:11595184, PubMed:12039559, PubMed:15925519). Under hypoxic conditions, the hydroxylation reaction is attenuated allowing HIFs to escape degradation resulting in their translocation to the nucleus, heterodimerization with HIF1B, and increased expression of hypoxy-inducible genes (PubMed:11595184, PubMed:12039559, PubMed:15925519). EGLN2 is involved in regulating hypoxia tolerance and apoptosis in cardiac and skeletal muscle (PubMed:11595184, PubMed:12039559, PubMed:15925519). Also regulates susceptibility to normoxic oxidative neuronal death (PubMed:11595184, PubMed:12039559, PubMed:15925519). Links oxygen sensing to cell cycle and primary cilia formation by hydroxylating the critical centrosome component CEP192 which promotes its ubiquitination and subsequent proteasomal degradation (PubMed:23932902). Hydroxylates IKBKB, mediating NF-kappa-B activation in hypoxic conditions (PubMed:17114296). Also mediates hydroxylation of ATF4, leading to decreased protein stability of ATF4 (By similarity). {ECO:0000250|UniProtKB:Q91YE2, ECO:0000269|PubMed:11595184, ECO:0000269|PubMed:12039559, ECO:0000269|PubMed:12181324, ECO:0000269|PubMed:15925519, ECO:0000269|PubMed:16509823, ECO:0000269|PubMed:17114296, ECO:0000269|PubMed:19339211, ECO:0000269|PubMed:23932902}. |
Q96L73 | NSD1 | S979 | ochoa | Histone-lysine N-methyltransferase, H3 lysine-36 specific (EC 2.1.1.357) (Androgen receptor coactivator 267 kDa protein) (Androgen receptor-associated protein of 267 kDa) (H3-K36-HMTase) (Lysine N-methyltransferase 3B) (Nuclear receptor-binding SET domain-containing protein 1) (NR-binding SET domain-containing protein) | Histone methyltransferase that dimethylates Lys-36 of histone H3 (H3K36me2). Transcriptional intermediary factor capable of both negatively or positively influencing transcription, depending on the cellular context. {ECO:0000269|PubMed:21196496}. |
Q96PV7 | FAM193B | S730 | ochoa | Protein FAM193B | None |
Q96R06 | SPAG5 | S341 | ochoa | Sperm-associated antigen 5 (Astrin) (Deepest) (Mitotic spindle-associated protein p126) (MAP126) | Essential component of the mitotic spindle required for normal chromosome segregation and progression into anaphase (PubMed:11724960, PubMed:12356910, PubMed:27462074). Required for chromosome alignment, normal timing of sister chromatid segregation, and maintenance of spindle pole architecture (PubMed:17664331, PubMed:27462074). In complex with SKAP, promotes stable microtubule-kinetochore attachments. May contribute to the regulation of separase activity. May regulate AURKA localization to mitotic spindle, but not to centrosomes and CCNB1 localization to both mitotic spindle and centrosomes (PubMed:18361916, PubMed:21402792). Involved in centriole duplication. Required for CDK5RAP2, CEP152, WDR62 and CEP63 centrosomal localization and promotes the centrosomal localization of CDK2 (PubMed:26297806). In non-mitotic cells, upon stress induction, inhibits mammalian target of rapamycin complex 1 (mTORC1) association and recruits the mTORC1 component RPTOR to stress granules (SGs), thereby preventing mTORC1 hyperactivation-induced apoptosis (PubMed:23953116). May enhance GSK3B-mediated phosphorylation of other substrates, such as MAPT/TAU (PubMed:18055457). {ECO:0000269|PubMed:12356910, ECO:0000269|PubMed:17664331, ECO:0000269|PubMed:18055457, ECO:0000269|PubMed:18361916, ECO:0000269|PubMed:21402792, ECO:0000269|PubMed:23953116, ECO:0000269|PubMed:26297806, ECO:0000269|PubMed:27462074, ECO:0000305|PubMed:11724960}. |
Q96RU3 | FNBP1 | S517 | ochoa | Formin-binding protein 1 (Formin-binding protein 17) (hFBP17) | May act as a link between RND2 signaling and regulation of the actin cytoskeleton (By similarity). Required to coordinate membrane tubulation with reorganization of the actin cytoskeleton during the late stage of clathrin-mediated endocytosis. Binds to lipids such as phosphatidylinositol 4,5-bisphosphate and phosphatidylserine and promotes membrane invagination and the formation of tubules. Also enhances actin polymerization via the recruitment of WASL/N-WASP, which in turn activates the Arp2/3 complex. Actin polymerization may promote the fission of membrane tubules to form endocytic vesicles. May be required for the lysosomal retention of FASLG/FASL. {ECO:0000250, ECO:0000269|PubMed:15252009, ECO:0000269|PubMed:16318909, ECO:0000269|PubMed:16326391, ECO:0000269|PubMed:16418535, ECO:0000269|PubMed:17512409}. |
Q99612 | KLF6 | S192 | ochoa | Krueppel-like factor 6 (B-cell-derived protein 1) (Core promoter element-binding protein) (GC-rich sites-binding factor GBF) (Proto-oncogene BCD1) (Suppressor of tumorigenicity 12 protein) (Transcription factor Zf9) | Transcriptional activator (By similarity). Binds a GC box motif. Could play a role in B-cell growth and development. {ECO:0000250}. |
Q9BQ75 | CMSS1 | S228 | ochoa | Protein CMSS1 (Cms1 ribosomal small subunit homolog) | None |
Q9BTX1 | NDC1 | S471 | ochoa | Nucleoporin NDC1 (hNDC1) (Transmembrane protein 48) | Component of the nuclear pore complex (NPC), which plays a key role in de novo assembly and insertion of NPC in the nuclear envelope. Required for NPC and nuclear envelope assembly, possibly by forming a link between the nuclear envelope membrane and soluble nucleoporins, thereby anchoring the NPC in the membrane. {ECO:0000269|PubMed:16600873, ECO:0000269|PubMed:16702233}. |
Q9BTX1 | NDC1 | S500 | ochoa | Nucleoporin NDC1 (hNDC1) (Transmembrane protein 48) | Component of the nuclear pore complex (NPC), which plays a key role in de novo assembly and insertion of NPC in the nuclear envelope. Required for NPC and nuclear envelope assembly, possibly by forming a link between the nuclear envelope membrane and soluble nucleoporins, thereby anchoring the NPC in the membrane. {ECO:0000269|PubMed:16600873, ECO:0000269|PubMed:16702233}. |
Q9BVI0 | PHF20 | S880 | ochoa | PHD finger protein 20 (Glioma-expressed antigen 2) (Hepatocellular carcinoma-associated antigen 58) (Novel zinc finger protein) (Transcription factor TZP) | Methyllysine-binding protein, component of the MOF histone acetyltransferase protein complex. Not required for maintaining the global histone H4 'Lys-16' acetylation (H4K16ac) levels or locus specific histone acetylation, but instead works downstream in transcriptional regulation of MOF target genes (By similarity). As part of the NSL complex it may be involved in acetylation of nucleosomal histone H4 on several lysine residues. Contributes to methyllysine-dependent p53/TP53 stabilization and up-regulation after DNA damage. {ECO:0000250, ECO:0000269|PubMed:20018852, ECO:0000269|PubMed:22864287}. |
Q9BWE0 | REPIN1 | S27 | ochoa | DNA-binding protein REPIN1 (60 kDa origin-specific DNA-binding protein) (60 kDa replication initiation region protein) (ATT-binding protein) (DHFR oribeta-binding protein RIP60) (Zinc finger protein 464) | Sequence-specific double-stranded DNA-binding protein (PubMed:10606657, PubMed:11328883, PubMed:2174103, PubMed:2247056, PubMed:8355269). Binds ATT-rich and T-rich DNA sequences and facilitates DNA bending (PubMed:10606657, PubMed:11328883, PubMed:2174103, PubMed:2247056, PubMed:8355269). May regulate the expression of genes involved in cellular fatty acid import, including SCARB1/CD36, and genes involved in lipid droplet formation (By similarity). May regulate the expression of LCN2, and thereby influence iron metabolism and apoptosis-related pathways (By similarity). May regulate the expression of genes involved in glucose transport (By similarity). {ECO:0000250|UniProtKB:Q5U4E2, ECO:0000269|PubMed:10606657, ECO:0000269|PubMed:11328883, ECO:0000269|PubMed:2174103, ECO:0000269|PubMed:2247056, ECO:0000269|PubMed:8355269}. |
Q9BX95 | SGPP1 | S101 | ochoa | Sphingosine-1-phosphate phosphatase 1 (SPPase1) (Spp1) (hSPP1) (hSPPase1) (EC 3.1.3.-) (Sphingosine-1-phosphatase 1) (Sphingosine-1-phosphate phosphohydrolase 1) (SPP-1) | Specifically dephosphorylates sphingosine 1-phosphate (S1P), dihydro-S1P, and phyto-S1P. Does not act on ceramide 1-phosphate, lysophosphatidic acid or phosphatidic acid (PubMed:16782891). Sphingosine-1-phosphate phosphatase activity is needed for efficient recycling of sphingosine into the sphingolipid synthesis pathway (PubMed:11756451, PubMed:12815058, PubMed:16782891). Regulates the intracellular levels of the bioactive sphingolipid metabolite S1P that regulates diverse biological processes acting both as an extracellular receptor ligand or as an intracellular second messenger (PubMed:11756451, PubMed:12815058, PubMed:16782891). Involved in efficient ceramide synthesis from exogenous sphingoid bases. Converts S1P to sphingosine, which is readily metabolized to ceramide via ceramide synthase. In concert with sphingosine kinase 2 (SphK2), recycles sphingosine into ceramide through a phosphorylation/dephosphorylation cycle (By similarity). Regulates endoplasmic-to-Golgi trafficking of ceramides, resulting in the regulation of ceramide levels in the endoplasmic reticulum, preferentially long-chain ceramide species, and influences the anterograde membrane transport of both ceramide and proteins from the endoplasmic reticulum to the Golgi apparatus (PubMed:16782891). The modulation of intracellular ceramide levels in turn regulates apoptosis (By similarity). Via S1P levels, modulates resting tone, intracellular Ca(2+) and myogenic vasoconstriction in resistance arteries (PubMed:18583713). Also involved in unfolded protein response (UPR) and ER stress-induced autophagy via regulation of intracellular S1P levels (PubMed:18583713, PubMed:20798685). Involved in the regulation of epidermal homeostasis and keratinocyte differentiation (By similarity). {ECO:0000250|UniProtKB:Q9JI99, ECO:0000269|PubMed:11756451, ECO:0000269|PubMed:12815058, ECO:0000269|PubMed:16782891, ECO:0000269|PubMed:18583713, ECO:0000269|PubMed:20798685}. |
Q9C0B5 | ZDHHC5 | S247 | ochoa | Palmitoyltransferase ZDHHC5 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 5) (DHHC-5) (Zinc finger protein 375) | Palmitoyltransferase that catalyzes the addition of palmitate onto various protein substrates such as CTNND2, CD36, GSDMD, NLRP3, NOD1, NOD2, STAT3 and S1PR1 thus plays a role in various biological processes including cell adhesion, inflammation, fatty acid uptake, bacterial sensing or cardiac functions (PubMed:21820437, PubMed:29185452, PubMed:31402609, PubMed:31649195, PubMed:34293401, PubMed:38092000, PubMed:38530158, PubMed:38599239). Plays an important role in the regulation of synapse efficacy by mediating palmitoylation of delta-catenin/CTNND2, thereby increasing synaptic delivery and surface stabilization of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors (AMPARs) (PubMed:26334723). Under basal conditions, remains at the synaptic membrane through FYN-mediated phosphorylation that prevents association with endocytic proteins (PubMed:26334723). Neuronal activity enhances the internalization and trafficking of DHHC5 from spines to dendritic shafts where it palmitoylates delta-catenin/CTNND2 (PubMed:26334723). Regulates cell adhesion at the plasma membrane by palmitoylating GOLGA7B and DSG2 (PubMed:31402609). Plays a role in innate immune response by mediating the palmitoylation of NOD1 and NOD2 and their proper recruitment to the bacterial entry site and phagosomes (PubMed:31649195, PubMed:34293401). Also participates in fatty acid uptake by palmitoylating CD36 and thereby targeting it to the plasma membrane (PubMed:32958780). Upon binding of fatty acids to CD36, gets phosphorylated by LYN leading to inactivation and subsequent CD36 caveolar endocytosis (PubMed:32958780). Controls oligodendrocyte development by catalyzing STAT3 palmitoylation (By similarity). Acts as a regulator of inflammatory response by mediating palmitoylation of NLRP3 and GSDMD (PubMed:38092000, PubMed:38530158, PubMed:38599239). Palmitoylates NLRP3 to promote inflammasome assembly and activation (PubMed:38092000). Activates pyroptosis by catalyzing palmitoylation of gasdermin-D (GSDMD), thereby promoting membrane translocation and pore formation of GSDMD (PubMed:38530158, PubMed:38599239). {ECO:0000250|UniProtKB:Q8VDZ4, ECO:0000269|PubMed:21820437, ECO:0000269|PubMed:26334723, ECO:0000269|PubMed:29185452, ECO:0000269|PubMed:31402609, ECO:0000269|PubMed:31649195, ECO:0000269|PubMed:32958780, ECO:0000269|PubMed:34293401, ECO:0000269|PubMed:38092000, ECO:0000269|PubMed:38530158, ECO:0000269|PubMed:38599239}. |
Q9C0H5 | ARHGAP39 | S432 | ochoa | Rho GTPase-activating protein 39 | None |
Q9C0K0 | BCL11B | S788 | ochoa | B-cell lymphoma/leukemia 11B (BCL-11B) (B-cell CLL/lymphoma 11B) (COUP-TF-interacting protein 2) (Radiation-induced tumor suppressor gene 1 protein) (hRit1) | Key regulator of both differentiation and survival of T-lymphocytes during thymocyte development in mammals. Essential in controlling the responsiveness of hematopoietic stem cells to chemotactic signals by modulating the expression of the receptors CCR7 and CCR9, which direct the movement of progenitor cells from the bone marrow to the thymus (PubMed:27959755). Is a regulator of IL2 promoter and enhances IL2 expression in activated CD4(+) T-lymphocytes (PubMed:16809611). Tumor-suppressor that represses transcription through direct, TFCOUP2-independent binding to a GC-rich response element (By similarity). May also function in the P53-signaling pathway (By similarity). {ECO:0000250|UniProtKB:Q99PV8, ECO:0000269|PubMed:16809611, ECO:0000269|PubMed:27959755}. |
Q9GZU1 | MCOLN1 | S547 | ochoa | Mucolipin-1 (ML1) (MG-2) (Mucolipidin) (Transient receptor potential channel mucolipin 1) (TRPML1) | Nonselective cation channel probably playing a role in the regulation of membrane trafficking events and of metal homeostasis (PubMed:11013137, PubMed:12459486, PubMed:14749347, PubMed:15336987, PubMed:18794901, PubMed:25720963, PubMed:27623384, PubMed:29019983). Acts as a Ca(2+)-permeable cation channel with inwardly rectifying activity (PubMed:25720963, PubMed:29019983). Proposed to play a major role in Ca(2+) release from late endosome and lysosome vesicles to the cytoplasm, which is important for many lysosome-dependent cellular events, including the fusion and trafficking of these organelles, exocytosis and autophagy (PubMed:11013137, PubMed:12459486, PubMed:14749347, PubMed:15336987, PubMed:25720963, PubMed:27623384, PubMed:29019983). Required for efficient uptake of large particles in macrophages in which Ca(2+) release from the lysosomes triggers lysosomal exocytosis. May also play a role in phagosome-lysosome fusion (By similarity). Involved in lactosylceramide trafficking indicative for a role in the regulation of late endocytic membrane fusion/fission events (PubMed:16978393). By mediating lysosomal Ca(2+) release is involved in regulation of mTORC1 signaling and in mTOR/TFEB-dependent lysosomal adaptation to environmental cues such as nutrient levels (PubMed:25720963, PubMed:25733853, PubMed:27787197). Seems to act as lysosomal active oxygen species (ROS) sensor involved in ROS-induced TFEB activation and autophagy (PubMed:27357649). Also functions as a Fe(2+) permeable channel in late endosomes and lysosomes (PubMed:18794901). Also permeable to Mg(2+), Na(+). K(+) and Cs(+) (By similarity). Proposed to play a role in zinc homeostasis probably implicating its association with TMEM163 (PubMed:25130899) In adaptive immunity, TRPML2 and TRPML1 may play redundant roles in the function of the specialized lysosomes of B cells (By similarity). {ECO:0000250|UniProtKB:Q99J21, ECO:0000269|PubMed:12459486, ECO:0000269|PubMed:14749347, ECO:0000269|PubMed:15336987, ECO:0000269|PubMed:16978393, ECO:0000269|PubMed:18794901, ECO:0000269|PubMed:25130899, ECO:0000269|PubMed:25720963, ECO:0000269|PubMed:25733853, ECO:0000269|PubMed:27357649, ECO:0000269|PubMed:27623384, ECO:0000269|PubMed:27787197, ECO:0000269|PubMed:29019983, ECO:0000305|PubMed:11013137}.; FUNCTION: May contribute to cellular lipase activity within the late endosomal pathway or at the cell surface which may be involved in processes of membrane reshaping and vesiculation, especially the growth of tubular structures. However, it is not known, whether it conveys the enzymatic activity directly, or merely facilitates the activity of an associated phospholipase. {ECO:0000305|PubMed:21256127}. |
Q9H008 | LHPP | S241 | ochoa | Phospholysine phosphohistidine inorganic pyrophosphate phosphatase (hLHPP) (EC 3.1.3.-) (EC 3.6.1.1) | Phosphatase that hydrolyzes imidodiphosphate, 3-phosphohistidine and 6-phospholysine. Has broad substrate specificity and can also hydrolyze inorganic diphosphate, but with lower efficiency (By similarity). {ECO:0000250}. |
Q9H0W5 | CCDC8 | S261 | ochoa|psp | Coiled-coil domain-containing protein 8 | Core component of the 3M complex, a complex required to regulate microtubule dynamics and genome integrity. It is unclear how the 3M complex regulates microtubules, it could act by controlling the level of a microtubule stabilizer (PubMed:24793695, PubMed:24793696). Required for localization of CUL7 to the centrosome (PubMed:24793695). {ECO:0000269|PubMed:24793695, ECO:0000269|PubMed:24793696}. |
Q9H165 | BCL11A | S734 | ochoa | BCL11 transcription factor A (B-cell CLL/lymphoma 11A) (B-cell lymphoma/leukemia 11A) (BCL-11A) (COUP-TF-interacting protein 1) (Ecotropic viral integration site 9 protein homolog) (EVI-9) (Zinc finger protein 856) | Transcription factor (PubMed:16704730, PubMed:29606353). Associated with the BAF SWI/SNF chromatin remodeling complex (PubMed:23644491, PubMed:39607926). Binds to the 5'-TGACCA-3' sequence motif in regulatory regions of target genes, including a distal promoter of the HBG1 hemoglobin subunit gamma-1 gene (PubMed:29606353, PubMed:39423807). Involved in regulation of the developmental switch from gamma- to beta-globin, probably via direct repression of HBG1; hence indirectly repressing fetal hemoglobin (HbF) level (PubMed:26375765, PubMed:29606353, PubMed:39423807, PubMed:39607926). Involved in brain development (PubMed:27453576). May play a role in hematopoiesis (By similarity). Essential factor in lymphopoiesis required for B-cell formation in fetal liver (By similarity). May function as a modulator of the transcriptional repression activity of NR2F2 (By similarity). {ECO:0000250|UniProtKB:Q9QYE3, ECO:0000269|PubMed:16704730, ECO:0000269|PubMed:23644491, ECO:0000269|PubMed:29606353, ECO:0000269|PubMed:39423807, ECO:0000269|PubMed:39607926, ECO:0000303|PubMed:26375765, ECO:0000303|PubMed:27453576}. |
Q9H2M9 | RAB3GAP2 | S450 | ochoa | Rab3 GTPase-activating protein non-catalytic subunit (RGAP-iso) (Rab3 GTPase-activating protein 150 kDa subunit) (Rab3-GAP p150) (Rab3-GAP150) (Rab3-GAP regulatory subunit) | Regulatory subunit of the Rab3 GTPase-activating (Rab3GAP) complex composed of RAB3GAP1 and RAB3GAP2, which has GTPase-activating protein (GAP) activity towards various Rab3 subfamily members (RAB3A, RAB3B, RAB3C and RAB3D), RAB5A and RAB43, and guanine nucleotide exchange factor (GEF) activity towards RAB18 (PubMed:24891604, PubMed:9733780). As part of the Rab3GAP complex, acts as a GAP for Rab3 proteins by converting active RAB3-GTP to the inactive form RAB3-GDP (By similarity). Rab3 proteins are involved in regulated exocytosis of neurotransmitters and hormones (By similarity). The Rab3GAP complex acts as a GEF for RAB18 by promoting the conversion of inactive RAB18-GDP to the active form RAB18-GTP (PubMed:24891604). Recruits and stabilizes RAB18 at the cis-Golgi membrane in human fibroblasts where RAB18 is most likely activated (PubMed:26063829). Also involved in RAB18 recruitment at the endoplasmic reticulum (ER) membrane where it maintains proper ER structure (PubMed:24891604). Required for normal eye and brain development (By similarity). May participate in neurodevelopmental processes such as proliferation, migration and differentiation before synapse formation, and non-synaptic vesicular release of neurotransmitters (By similarity). {ECO:0000250|UniProtKB:Q15042, ECO:0000269|PubMed:24891604, ECO:0000269|PubMed:26063829, ECO:0000269|PubMed:9733780}. |
Q9H8Y5 | ANKZF1 | S56 | ochoa | tRNA endonuclease ANKZF1 (EC 3.1.-.-) (Ankyrin repeat and zinc finger domain-containing protein 1) (Zinc finger protein 744) | Endonuclease that cleaves polypeptidyl-tRNAs downstream of the ribosome-associated quality control (RQC) pathway to release incompletely synthesized polypeptides for degradation (PubMed:29632312, PubMed:30244831, PubMed:31011209). The RQC pathway disassembles aberrantly stalled translation complexes to recycle or degrade the constituent parts (PubMed:29632312, PubMed:30244831, PubMed:31011209). ANKZF1 acts downstream disassembly of stalled ribosomes and specifically cleaves off the terminal 3'-CCA nucleotides universal to all tRNAs from polypeptidyl-tRNAs, releasing (1) ubiquitinated polypeptides from 60S ribosomal subunit for degradation and (2) cleaved tRNAs (PubMed:31011209). ANKZF1-cleaved tRNAs are then repaired and recycled by ELAC1 and TRNT1 (PubMed:31011209, PubMed:32075755). Also plays a role in the cellular response to hydrogen peroxide and in the maintenance of mitochondrial integrity under conditions of cellular stress (PubMed:28302725). {ECO:0000269|PubMed:28302725, ECO:0000269|PubMed:29632312, ECO:0000269|PubMed:30244831, ECO:0000269|PubMed:31011209, ECO:0000269|PubMed:32075755}. |
Q9HAK2 | EBF2 | S161 | ochoa | Transcription factor COE2 (Early B-cell factor 2) (EBF-2) | Transcription factor that, in osteoblasts, activates the decoy receptor for RANKL, TNFRSF11B, which in turn regulates osteoclast differentiation. Acts in synergy with the Wnt-responsive LEF1/CTNNB1 pathway. Recognizes variations of the palindromic sequence 5'-ATTCCCNNGGGAATT-3' (By similarity). {ECO:0000250}. |
Q9HB58 | SP110 | S380 | ochoa | Sp110 nuclear body protein (Interferon-induced protein 41/75) (Speckled 110 kDa) (Transcriptional coactivator Sp110) | Transcription factor. May be a nuclear hormone receptor coactivator. Enhances transcription of genes with retinoic acid response elements (RARE). |
Q9HBE1 | PATZ1 | S282 | ochoa | POZ-, AT hook-, and zinc finger-containing protein 1 (BTB/POZ domain zinc finger transcription factor) (Protein kinase A RI subunit alpha-associated protein) (Zinc finger and BTB domain-containing protein 19) (Zinc finger protein 278) (Zinc finger sarcoma gene protein) | Transcriptional regulator that plays a role in many biological processes such as embryogenesis, senescence, T-cell development or neurogenesis (PubMed:10713105, PubMed:25755280, PubMed:31875552). Interacts with the TP53 protein to control genes that are important in proliferation and in the DNA-damage response. Mechanistically, the interaction inhibits the DNA binding and transcriptional activity of TP53/p53 (PubMed:25755280). Part of the transcriptional network modulating regulatory T-cell development and controls the generation of the regulatory T-cell pool under homeostatic conditions (PubMed:31875552). {ECO:0000269|PubMed:10713105, ECO:0000269|PubMed:25755280, ECO:0000269|PubMed:31875552}.; FUNCTION: (Microbial infection) Plays a positive role in viral cDNA synthesis. {ECO:0000269|PubMed:31060775}. |
Q9NP66 | HMG20A | S105 | ochoa | High mobility group protein 20A (HMG box-containing protein 20A) (HMG domain-containing protein 1) (HMG domain-containing protein HMGX1) | Plays a role in neuronal differentiation as chromatin-associated protein. Acts as inhibitor of HMG20B. Overcomes the repressive effects of the neuronal silencer REST and induces the activation of neuronal-specific genes. Involved in the recruitment of the histone methyltransferase KMT2A/MLL1 and consequent increased methylation of histone H3 lysine 4 (By similarity). {ECO:0000250}. |
Q9NQL9 | DMRT3 | S180 | ochoa | Doublesex- and mab-3-related transcription factor 3 | Probable transcription factor that plays a role in configuring the spinal circuits controlling stride in vertebrates. Involved in neuronal specification within specific subdivision of spinal cord neurons and in the development of a coordinated locomotor network controlling limb movements. May regulate transcription during sexual development (By similarity). {ECO:0000250}. |
Q9NR19 | ACSS2 | S30 | ochoa | Acetyl-coenzyme A synthetase, cytoplasmic (EC 6.2.1.1) (Acetate--CoA ligase) (Acetyl-CoA synthetase) (ACS) (AceCS) (Acetyl-CoA synthetase 1) (AceCS1) (Acyl-CoA synthetase short-chain family member 2) (Acyl-activating enzyme) (Propionate--CoA ligase) (EC 6.2.1.17) | Catalyzes the synthesis of acetyl-CoA from short-chain fatty acids (PubMed:10843999, PubMed:28003429, PubMed:28552616). Acetate is the preferred substrate (PubMed:10843999, PubMed:28003429). Can also utilize propionate with a much lower affinity (By similarity). Nuclear ACSS2 promotes glucose deprivation-induced lysosomal biogenesis and autophagy, tumor cell survival and brain tumorigenesis (PubMed:28552616). Glucose deprivation results in AMPK-mediated phosphorylation of ACSS2 leading to its translocation to the nucleus where it binds to TFEB and locally produces acetyl-CoA for histone acetylation in the promoter regions of TFEB target genes thereby activating their transcription (PubMed:28552616). The regulation of genes associated with autophagy and lysosomal activity through ACSS2 is important for brain tumorigenesis and tumor survival (PubMed:28552616). Acts as a chromatin-bound transcriptional coactivator that up-regulates histone acetylation and expression of neuronal genes (By similarity). Can be recruited to the loci of memory-related neuronal genes to maintain a local acetyl-CoA pool, providing the substrate for histone acetylation and promoting the expression of specific genes, which is essential for maintaining long-term spatial memory (By similarity). {ECO:0000250|UniProtKB:Q9QXG4, ECO:0000269|PubMed:10843999, ECO:0000269|PubMed:28003429, ECO:0000269|PubMed:28552616}. |
Q9NRG9 | AAAS | S33 | ochoa | Aladin (Adracalin) | Plays a role in the normal development of the peripheral and central nervous system (PubMed:11062474, PubMed:11159947, PubMed:16022285). Required for the correct localization of aurora kinase AURKA and the microtubule minus end-binding protein NUMA1 as well as a subset of AURKA targets which ensures proper spindle formation and timely chromosome alignment (PubMed:26246606). {ECO:0000269|PubMed:11062474, ECO:0000269|PubMed:11159947, ECO:0000269|PubMed:16022285, ECO:0000269|PubMed:26246606}. |
Q9NS62 | THSD1 | S619 | ochoa | Thrombospondin type-1 domain-containing protein 1 (Transmembrane molecule with thrombospondin module) | Is a positive regulator of nascent focal adhesion assembly, involved in the modulation of endothelial cell attachment to the extracellular matrix. {ECO:0000269|PubMed:27895300, ECO:0000269|PubMed:29069646}. |
Q9NWH9 | SLTM | S553 | ochoa | SAFB-like transcription modulator (Modulator of estrogen-induced transcription) | When overexpressed, acts as a general inhibitor of transcription that eventually leads to apoptosis. {ECO:0000250}. |
Q9NZ56 | FMN2 | S516 | ochoa | Formin-2 | Actin-binding protein that is involved in actin cytoskeleton assembly and reorganization (PubMed:21730168, PubMed:22330775). Acts as an actin nucleation factor and promotes assembly of actin filaments together with SPIRE1 and SPIRE2 (PubMed:21730168, PubMed:22330775). Involved in intracellular vesicle transport along actin fibers, providing a novel link between actin cytoskeleton dynamics and intracellular transport (By similarity). Required for asymmetric spindle positioning, asymmetric oocyte division and polar body extrusion during female germ cell meiosis (By similarity). Plays a role in responses to DNA damage, cellular stress and hypoxia by protecting CDKN1A against degradation, and thereby plays a role in stress-induced cell cycle arrest (PubMed:23375502). Also acts in the nucleus: together with SPIRE1 and SPIRE2, promotes assembly of nuclear actin filaments in response to DNA damage in order to facilitate movement of chromatin and repair factors after DNA damage (PubMed:26287480). Protects cells against apoptosis by protecting CDKN1A against degradation (PubMed:23375502). {ECO:0000250|UniProtKB:Q9JL04, ECO:0000269|PubMed:21730168, ECO:0000269|PubMed:22330775, ECO:0000269|PubMed:23375502, ECO:0000269|PubMed:26287480}. |
Q9NZM1 | MYOF | S963 | ochoa | Myoferlin (Fer-1-like protein 3) | Calcium/phospholipid-binding protein that plays a role in the plasmalemma repair mechanism of endothelial cells that permits rapid resealing of membranes disrupted by mechanical stress. Involved in endocytic recycling. Implicated in VEGF signal transduction by regulating the levels of the receptor KDR (By similarity). {ECO:0000250}. |
Q9P0L2 | MARK1 | S403 | ochoa | Serine/threonine-protein kinase MARK1 (EC 2.7.11.1) (EC 2.7.11.26) (MAP/microtubule affinity-regulating kinase 1) (PAR1 homolog c) (Par-1c) (Par1c) | Serine/threonine-protein kinase (PubMed:23666762). Involved in cell polarity and microtubule dynamics regulation. Phosphorylates DCX, MAP2 and MAP4. Phosphorylates the microtubule-associated protein MAPT/TAU (PubMed:23666762). Involved in cell polarity by phosphorylating the microtubule-associated proteins MAP2, MAP4 and MAPT/TAU at KXGS motifs, causing detachment from microtubules, and their disassembly. Involved in the regulation of neuronal migration through its dual activities in regulating cellular polarity and microtubule dynamics, possibly by phosphorylating and regulating DCX. Also acts as a positive regulator of the Wnt signaling pathway, probably by mediating phosphorylation of dishevelled proteins (DVL1, DVL2 and/or DVL3). {ECO:0000269|PubMed:11433294, ECO:0000269|PubMed:17573348, ECO:0000269|PubMed:23666762}. |
Q9P1Y5 | CAMSAP3 | S1031 | ochoa | Calmodulin-regulated spectrin-associated protein 3 (Protein Nezha) | Key microtubule-organizing protein that specifically binds the minus-end of non-centrosomal microtubules and regulates their dynamics and organization (PubMed:19041755, PubMed:23169647). Specifically recognizes growing microtubule minus-ends and autonomously decorates and stabilizes microtubule lattice formed by microtubule minus-end polymerization (PubMed:24486153). Acts on free microtubule minus-ends that are not capped by microtubule-nucleating proteins or other factors and protects microtubule minus-ends from depolymerization (PubMed:24486153). In addition, it also reduces the velocity of microtubule polymerization (PubMed:24486153). Required for the biogenesis and the maintenance of zonula adherens by anchoring the minus-end of microtubules to zonula adherens and by recruiting the kinesin KIFC3 to those junctional sites (PubMed:19041755). Required for orienting the apical-to-basal polarity of microtubules in epithelial cells: acts by tethering non-centrosomal microtubules to the apical cortex, leading to their longitudinal orientation (PubMed:26715742, PubMed:27802168). Plays a key role in early embryos, which lack centrosomes: accumulates at the microtubule bridges that connect pairs of cells and enables the formation of a non-centrosomal microtubule-organizing center that directs intracellular transport in the early embryo (By similarity). Couples non-centrosomal microtubules with actin: interaction with MACF1 at the minus ends of non-centrosomal microtubules, tethers the microtubules to actin filaments, regulating focal adhesion size and cell migration (PubMed:27693509). Plays a key role in the generation of non-centrosomal microtubules by accumulating in the pericentrosomal region and cooperating with KATNA1 to release non-centrosomal microtubules from the centrosome (PubMed:28386021). Through the microtubule cytoskeleton, also regulates the organization of cellular organelles including the Golgi and the early endosomes (PubMed:28089391). Through interaction with AKAP9, involved in translocation of Golgi vesicles in epithelial cells, where microtubules are mainly non-centrosomal (PubMed:28089391). Plays an important role in motile cilia function by facilitatating proper orientation of basal bodies and formation of central microtubule pairs in motile cilia (By similarity). {ECO:0000250|UniProtKB:Q80VC9, ECO:0000269|PubMed:19041755, ECO:0000269|PubMed:23169647, ECO:0000269|PubMed:24486153, ECO:0000269|PubMed:26715742, ECO:0000269|PubMed:27693509, ECO:0000269|PubMed:27802168, ECO:0000269|PubMed:28089391, ECO:0000269|PubMed:28386021}. |
Q9P1Y6 | PHRF1 | S814 | ochoa | PHD and RING finger domain-containing protein 1 | None |
Q9P202 | WHRN | S245 | ochoa | Whirlin (Autosomal recessive deafness type 31 protein) | Involved in hearing and vision as member of the USH2 complex. Necessary for elongation and maintenance of inner and outer hair cell stereocilia in the organ of Corti in the inner ear. Involved in the maintenance of the hair bundle ankle region, which connects stereocilia in cochlear hair cells of the inner ear. In retina photoreceptors, required for the maintenance of periciliary membrane complex that seems to play a role in regulating intracellular protein transport. {ECO:0000250|UniProtKB:Q80VW5}. |
Q9P227 | ARHGAP23 | S517 | ochoa | Rho GTPase-activating protein 23 (Rho-type GTPase-activating protein 23) | GTPase activator for the Rho-type GTPases by converting them to an inactive GDP-bound state. {ECO:0000250}. |
Q9P286 | PAK5 | S277 | ochoa | Serine/threonine-protein kinase PAK 5 (EC 2.7.11.1) (p21-activated kinase 5) (PAK-5) (p21-activated kinase 7) (PAK-7) | Serine/threonine protein kinase that plays a role in a variety of different signaling pathways including cytoskeleton regulation, cell migration, proliferation or cell survival. Activation by various effectors including growth factor receptors or active CDC42 and RAC1 results in a conformational change and a subsequent autophosphorylation on several serine and/or threonine residues. Phosphorylates the proto-oncogene RAF1 and stimulates its kinase activity. Promotes cell survival by phosphorylating the BCL2 antagonist of cell death BAD. Phosphorylates CTNND1, probably to regulate cytoskeletal organization and cell morphology. Keeps microtubules stable through MARK2 inhibition and destabilizes the F-actin network leading to the disappearance of stress fibers and focal adhesions. {ECO:0000269|PubMed:12897128, ECO:0000269|PubMed:16014608, ECO:0000269|PubMed:16581795, ECO:0000269|PubMed:18465753, ECO:0000269|PubMed:20564219}. |
Q9P2E9 | RRBP1 | S533 | ochoa | Ribosome-binding protein 1 (180 kDa ribosome receptor homolog) (RRp) (ES/130-related protein) (Ribosome receptor protein) | Acts as a ribosome receptor and mediates interaction between the ribosome and the endoplasmic reticulum membrane. {ECO:0000250}. |
Q9P2F8 | SIPA1L2 | S379 | ochoa | Signal-induced proliferation-associated 1-like protein 2 (SIPA1-like protein 2) | None |
Q9UBB5 | MBD2 | S44 | ochoa | Methyl-CpG-binding domain protein 2 (Demethylase) (DMTase) (Methyl-CpG-binding protein MBD2) | Binds CpG islands in promoters where the DNA is methylated at position 5 of cytosine within CpG dinucleotides (PubMed:9774669). Binds hemimethylated DNA as well (PubMed:10947852, PubMed:24307175). Recruits histone deacetylases and DNA methyltransferases to chromatin (PubMed:10471499, PubMed:10947852). Acts as a component of the histone deacetylase NuRD complex which participates in the remodeling of chromatin (PubMed:16428440, PubMed:28977666). Acts as a transcriptional repressor and plays a role in gene silencing (PubMed:10471499, PubMed:10947852, PubMed:16415179). Functions as a scaffold protein, targeting GATAD2A and GATAD2B to chromatin to promote repression (PubMed:16415179). May enhance the activation of some unmethylated cAMP-responsive promoters (PubMed:12665568). {ECO:0000269|PubMed:10471499, ECO:0000269|PubMed:10947852, ECO:0000269|PubMed:12665568, ECO:0000269|PubMed:16415179, ECO:0000269|PubMed:16428440, ECO:0000269|PubMed:24307175, ECO:0000269|PubMed:28977666, ECO:0000269|PubMed:9774669}. |
Q9UG56 | PISD | S341 | ochoa | Phosphatidylserine decarboxylase proenzyme, mitochondrial (EC 4.1.1.65) [Cleaved into: Phosphatidylserine decarboxylase beta chain; Phosphatidylserine decarboxylase alpha chain] | Catalyzes the formation of phosphatidylethanolamine (PtdEtn) from phosphatidylserine (PtdSer) (PubMed:30488656, PubMed:30858161). Plays a central role in phospholipid metabolism and in the interorganelle trafficking of phosphatidylserine. May be involved in lipid droplet biogenesis at the endoplasmic reticulum membrane (By similarity). {ECO:0000250|UniProtKB:A0A8H4BVL9, ECO:0000255|HAMAP-Rule:MF_03208, ECO:0000269|PubMed:30488656, ECO:0000269|PubMed:30858161}. |
Q9UGL1 | KDM5B | S1328 | ochoa|psp | Lysine-specific demethylase 5B (EC 1.14.11.67) (Cancer/testis antigen 31) (CT31) (Histone demethylase JARID1B) (Jumonji/ARID domain-containing protein 1B) (PLU-1) (Retinoblastoma-binding protein 2 homolog 1) (RBP2-H1) ([histone H3]-trimethyl-L-lysine(4) demethylase 5B) | Histone demethylase that demethylates 'Lys-4' of histone H3, thereby playing a central role in histone code (PubMed:24952722, PubMed:27214403, PubMed:28262558). Does not demethylate histone H3 'Lys-9' or H3 'Lys-27'. Demethylates trimethylated, dimethylated and monomethylated H3 'Lys-4'. Acts as a transcriptional corepressor for FOXG1B and PAX9. Favors the proliferation of breast cancer cells by repressing tumor suppressor genes such as BRCA1 and HOXA5 (PubMed:24952722). In contrast, may act as a tumor suppressor for melanoma. Represses the CLOCK-BMAL1 heterodimer-mediated transcriptional activation of the core clock component PER2 (By similarity). {ECO:0000250|UniProtKB:Q80Y84, ECO:0000269|PubMed:12657635, ECO:0000269|PubMed:16645588, ECO:0000269|PubMed:17320161, ECO:0000269|PubMed:17363312, ECO:0000269|PubMed:24952722, ECO:0000269|PubMed:26645689, ECO:0000269|PubMed:26741168, ECO:0000269|PubMed:27214403, ECO:0000269|PubMed:28262558}. |
Q9UGU0 | TCF20 | S31 | ochoa | Transcription factor 20 (TCF-20) (Nuclear factor SPBP) (Protein AR1) (Stromelysin-1 PDGF-responsive element-binding protein) (SPRE-binding protein) | Transcriptional activator that binds to the regulatory region of MMP3 and thereby controls stromelysin expression. It stimulates the activity of various transcriptional activators such as JUN, SP1, PAX6 and ETS1, suggesting a function as a coactivator. {ECO:0000269|PubMed:10995766}. |
Q9UHB7 | AFF4 | S549 | ochoa | AF4/FMR2 family member 4 (ALL1-fused gene from chromosome 5q31 protein) (Protein AF-5q31) (Major CDK9 elongation factor-associated protein) | Key component of the super elongation complex (SEC), a complex required to increase the catalytic rate of RNA polymerase II transcription by suppressing transient pausing by the polymerase at multiple sites along the DNA. In the SEC complex, AFF4 acts as a central scaffold that recruits other factors through direct interactions with ELL proteins (ELL, ELL2 or ELL3) and the P-TEFb complex. In case of infection by HIV-1 virus, the SEC complex is recruited by the viral Tat protein to stimulate viral gene expression. {ECO:0000269|PubMed:20159561, ECO:0000269|PubMed:20471948, ECO:0000269|PubMed:23251033}. |
Q9UIW0 | VAX2 | S42 | ochoa | Ventral anterior homeobox 2 | Transcription factor that may function in dorsoventral specification of the forebrain. Regulates the expression of Wnt signaling antagonists including the expression of a truncated TCF7L2 isoform that cannot bind CTNNB1 and acts therefore as a potent dominant-negative Wnt antagonist. Plays a crucial role in eye development and, in particular, in the specification of the ventral optic vesicle (By similarity). May be a regulator of axial polarization in the retina. {ECO:0000250}. |
Q9UKX7 | NUP50 | S221 | ochoa|psp | Nuclear pore complex protein Nup50 (50 kDa nucleoporin) (Nuclear pore-associated protein 60 kDa-like) (Nucleoporin Nup50) | Component of the nuclear pore complex that has a direct role in nuclear protein import (PubMed:20016008). Actively displaces NLSs from importin-alpha, and facilitates disassembly of the importin-alpha:beta-cargo complex and importin recycling (PubMed:20016008). Interacts with regulatory proteins of cell cycle progression including CDKN1B (By similarity). This interaction is required for correct intracellular transport and degradation of CDKN1B (By similarity). {ECO:0000250|UniProtKB:Q9JIH2, ECO:0000269|PubMed:20016008}. |
Q9ULD4 | BRPF3 | S943 | ochoa | Bromodomain and PHD finger-containing protein 3 | Scaffold subunit of various histone acetyltransferase (HAT) complexes, such as the MOZ/MORF and HBO1 complexes, which have a histone H3 acetyltransferase activity (PubMed:16387653, PubMed:26620551, PubMed:26677226). Plays a role in DNA replication initiation by directing KAT7/HBO1 specificity towards histone H3 'Lys-14' acetylation (H3K14ac), thereby facilitating the activation of replication origins (PubMed:26620551). Component of the MOZ/MORF complex which has a histone H3 acetyltransferase activity (PubMed:16387653). {ECO:0000269|PubMed:16387653, ECO:0000269|PubMed:26620551, ECO:0000269|PubMed:26677226}. |
Q9ULM0 | PLEKHH1 | S324 | ochoa | Pleckstrin homology domain-containing family H member 1 (PH domain-containing family H member 1) | None |
Q9UNH5 | CDC14A | S411 | psp | Dual specificity protein phosphatase CDC14A (EC 3.1.3.16) (EC 3.1.3.48) (CDC14 cell division cycle 14 homolog A) | Dual-specificity phosphatase. Required for centrosome separation and productive cytokinesis during cell division. Dephosphorylates SIRT2 around early anaphase. May dephosphorylate the APC subunit FZR1/CDH1, thereby promoting APC-FZR1 dependent degradation of mitotic cyclins and subsequent exit from mitosis. Required for normal hearing (PubMed:29293958). {ECO:0000269|PubMed:11901424, ECO:0000269|PubMed:12134069, ECO:0000269|PubMed:17488717, ECO:0000269|PubMed:29293958, ECO:0000269|PubMed:9367992}. |
Q9UPP1 | PHF8 | S804 | ochoa | Histone lysine demethylase PHF8 (EC 1.14.11.27) (EC 1.14.11.65) (PHD finger protein 8) ([histone H3]-dimethyl-L-lysine(36) demethylase PHF8) ([histone H3]-dimethyl-L-lysine(9) demethylase PHF8) | Histone lysine demethylase with selectivity for the di- and monomethyl states that plays a key role cell cycle progression, rDNA transcription and brain development. Demethylates mono- and dimethylated histone H3 'Lys-9' residue (H3K9Me1 and H3K9Me2), dimethylated H3 'Lys-27' (H3K27Me2) and monomethylated histone H4 'Lys-20' residue (H4K20Me1). Acts as a transcription activator as H3K9Me1, H3K9Me2, H3K27Me2 and H4K20Me1 are epigenetic repressive marks. Involved in cell cycle progression by being required to control G1-S transition. Acts as a coactivator of rDNA transcription, by activating polymerase I (pol I) mediated transcription of rRNA genes. Required for brain development, probably by regulating expression of neuron-specific genes. Only has activity toward H4K20Me1 when nucleosome is used as a substrate and when not histone octamer is used as substrate. May also have weak activity toward dimethylated H3 'Lys-36' (H3K36Me2), however, the relevance of this result remains unsure in vivo. Specifically binds trimethylated 'Lys-4' of histone H3 (H3K4me3), affecting histone demethylase specificity: has weak activity toward H3K9Me2 in absence of H3K4me3, while it has high activity toward H3K9me2 when binding H3K4me3. Positively modulates transcription of histone demethylase KDM5C, acting synergistically with transcription factor ARX; synergy may be related to enrichment of histone H3K4me3 in regulatory elements. {ECO:0000269|PubMed:19843542, ECO:0000269|PubMed:20023638, ECO:0000269|PubMed:20101266, ECO:0000269|PubMed:20208542, ECO:0000269|PubMed:20346720, ECO:0000269|PubMed:20421419, ECO:0000269|PubMed:20531378, ECO:0000269|PubMed:20548336, ECO:0000269|PubMed:20622853, ECO:0000269|PubMed:20622854, ECO:0000269|PubMed:31691806}. |
Q9UPQ9 | TNRC6B | S803 | ochoa | Trinucleotide repeat-containing gene 6B protein | Plays a role in RNA-mediated gene silencing by both micro-RNAs (miRNAs) and short interfering RNAs (siRNAs) (PubMed:16289642, PubMed:19167051, PubMed:19304925, PubMed:32354837). Required for miRNA-dependent translational repression and siRNA-dependent endonucleolytic cleavage of complementary mRNAs by argonaute family proteins (PubMed:16289642, PubMed:19167051, PubMed:19304925, PubMed:32354837). As scaffolding protein associates with argonaute proteins bound to partially complementary mRNAs and simultaneously can recruit CCR4-NOT and PAN deadenylase complexes (PubMed:21981923). {ECO:0000269|PubMed:16289642, ECO:0000269|PubMed:19167051, ECO:0000269|PubMed:19304925, ECO:0000269|PubMed:21981923, ECO:0000269|PubMed:32354837}. |
Q9UPR0 | PLCL2 | S71 | ochoa | Inactive phospholipase C-like protein 2 (PLC-L(2)) (PLC-L2) (Phospholipase C-L2) (Phospholipase C-epsilon-2) (PLC-epsilon-2) | May play an role in the regulation of Ins(1,4,5)P3 around the endoplasmic reticulum. {ECO:0000250}. |
Q9Y2L8 | ZKSCAN5 | S335 | ochoa | Zinc finger protein with KRAB and SCAN domains 5 (Zinc finger protein 95 homolog) (Zfp-95) | May be involved in transcriptional regulation. |
Q9Y2U5 | MAP3K2 | S349 | ochoa | Mitogen-activated protein kinase kinase kinase 2 (EC 2.7.11.25) (MAPK/ERK kinase kinase 2) (MEK kinase 2) (MEKK 2) | Component of a protein kinase signal transduction cascade. Regulates the JNK and ERK5 pathways by phosphorylating and activating MAP2K5 and MAP2K7 (By similarity). Plays a role in caveolae kiss-and-run dynamics. {ECO:0000250, ECO:0000269|PubMed:10713157, ECO:0000269|PubMed:16001074}. |
Q9Y320 | TMX2 | S211 | ochoa | Thioredoxin-related transmembrane protein 2 (Cell proliferation-inducing gene 26 protein) (Thioredoxin domain-containing protein 14) | Endoplasmic reticulum and mitochondria-associated protein that probably functions as a regulator of cellular redox state and thereby regulates protein post-translational modification, protein folding and mitochondrial activity. Indirectly regulates neuronal proliferation, migration, and organization in the developing brain. {ECO:0000269|PubMed:31735293}. |
Q9Y467 | SALL2 | S684 | ochoa | Sal-like protein 2 (Zinc finger protein 795) (Zinc finger protein SALL2) (Zinc finger protein Spalt-2) (Sal-2) (hSal2) | Probable transcription factor that plays a role in eye development before, during, and after optic fissure closure. {ECO:0000269|PubMed:24412933}. |
Q9Y4F9 | RIPOR2 | S730 | ochoa | Rho family-interacting cell polarization regulator 2 | Acts as an inhibitor of the small GTPase RHOA and plays several roles in the regulation of myoblast and hair cell differentiation, lymphocyte T proliferation and neutrophil polarization (PubMed:17150207, PubMed:23241886, PubMed:24687993, PubMed:24958875, PubMed:25588844, PubMed:27556504). Inhibits chemokine-induced T lymphocyte responses, such as cell adhesion, polarization and migration (PubMed:23241886). Involved also in the regulation of neutrophil polarization, chemotaxis and adhesion (By similarity). Required for normal development of inner and outer hair cell stereocilia within the cochlea of the inner ear (By similarity). Plays a role for maintaining the structural organization of the basal domain of stereocilia (By similarity). Involved in mechanosensory hair cell function (By similarity). Required for normal hearing (PubMed:24958875). {ECO:0000250|UniProtKB:Q80U16, ECO:0000269|PubMed:17150207, ECO:0000269|PubMed:23241886, ECO:0000269|PubMed:24687993, ECO:0000269|PubMed:24958875, ECO:0000269|PubMed:27556504}.; FUNCTION: [Isoform 2]: Acts as an inhibitor of the small GTPase RHOA (PubMed:25588844). Plays a role in fetal mononuclear myoblast differentiation by promoting filopodia and myotube formation (PubMed:17150207). Maintains naive T lymphocytes in a quiescent state (PubMed:27556504). {ECO:0000269|PubMed:17150207, ECO:0000269|PubMed:25588844, ECO:0000269|PubMed:27556504}. |
Q9Y4H2 | IRS2 | S1162 | ochoa | Insulin receptor substrate 2 (IRS-2) | Signaling adapter protein that participates in the signal transduction from two prominent receptor tyrosine kinases, insulin receptor/INSR and insulin-like growth factor I receptor/IGF1R (PubMed:25879670). Plays therefore an important role in development, growth, glucose homeostasis as well as lipid metabolism (PubMed:24616100). Upon phosphorylation by the insulin receptor, functions as a signaling scaffold that propagates insulin action through binding to SH2 domain-containing proteins including the p85 regulatory subunit of PI3K, NCK1, NCK2, GRB2 or SHP2 (PubMed:15316008, PubMed:19109239). Recruitment of GRB2 leads to the activation of the guanine nucleotide exchange factor SOS1 which in turn triggers the Ras/Raf/MEK/MAPK signaling cascade (By similarity). Activation of the PI3K/AKT pathway is responsible for most of insulin metabolic effects in the cell, and the Ras/Raf/MEK/MAPK is involved in the regulation of gene expression and in cooperation with the PI3K pathway regulates cell growth and differentiation. Acts a positive regulator of the Wnt/beta-catenin signaling pathway through suppression of DVL2 autophagy-mediated degradation leading to cell proliferation (PubMed:24616100). Plays a role in cell cycle progression by promoting a robust spindle assembly checkpoint (SAC) during M-phase (PubMed:32554797). In macrophages, IL4-induced tyrosine phosphorylation of IRS2 leads to the recruitment and activation of phosphoinositide 3-kinase (PI3K) (PubMed:19109239). {ECO:0000250|UniProtKB:P35570, ECO:0000269|PubMed:15316008, ECO:0000269|PubMed:19109239, ECO:0000269|PubMed:24616100, ECO:0000269|PubMed:25879670, ECO:0000269|PubMed:32554797}. |
Q9Y570 | PPME1 | S42 | ochoa | Protein phosphatase methylesterase 1 (PME-1) (EC 3.1.1.89) | Demethylates proteins that have been reversibly carboxymethylated. Demethylates PPP2CB (in vitro) and PPP2CA. Binding to PPP2CA displaces the manganese ion and inactivates the enzyme. {ECO:0000269|PubMed:10318862}. |
Q9Y6F1 | PARP3 | S461 | psp | Protein mono-ADP-ribosyltransferase PARP3 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 3) (ARTD3) (DNA ADP-ribosyltransferase PARP3) (EC 2.4.2.-) (IRT1) (NAD(+) ADP-ribosyltransferase 3) (ADPRT-3) (Poly [ADP-ribose] polymerase 3) (PARP-3) (hPARP-3) (Poly[ADP-ribose] synthase 3) (pADPRT-3) | Mono-ADP-ribosyltransferase that mediates mono-ADP-ribosylation of target proteins and plays a key role in the response to DNA damage (PubMed:16924674, PubMed:19354255, PubMed:20064938, PubMed:21211721, PubMed:21270334, PubMed:23742272, PubMed:24598253, PubMed:25043379, PubMed:28447610). Mediates mono-ADP-ribosylation of glutamate, aspartate or lysine residues on target proteins (PubMed:20064938, PubMed:25043379). In contrast to PARP1 and PARP2, it is not able to mediate poly-ADP-ribosylation (PubMed:25043379). Involved in DNA repair by mediating mono-ADP-ribosylation of a limited number of acceptor proteins involved in chromatin architecture and in DNA metabolism, such as histone H2B, XRCC5 and XRCC6 (PubMed:16924674, PubMed:24598253). ADP-ribosylation follows DNA damage and appears as an obligatory step in a detection/signaling pathway leading to the reparation of DNA strand breaks (PubMed:16924674, PubMed:21211721, PubMed:21270334). Involved in single-strand break repair by catalyzing mono-ADP-ribosylation of histone H2B on 'Glu-2' (H2BE2ADPr) of nucleosomes containing nicked DNA (PubMed:27530147). Cooperates with the XRCC5-XRCC6 (Ku80-Ku70) heterodimer to limit end-resection thereby promoting accurate NHEJ (PubMed:24598253). Suppresses G-quadruplex (G4) structures in response to DNA damage (PubMed:28447610). Associates with a number of DNA repair factors and is involved in the response to exogenous and endogenous DNA strand breaks (PubMed:16924674, PubMed:21211721, PubMed:21270334). Together with APLF, promotes the retention of the LIG4-XRCC4 complex on chromatin and accelerate DNA ligation during non-homologous end-joining (NHEJ) (PubMed:21211721). May link the DNA damage surveillance network to the mitotic fidelity checkpoint (PubMed:16924674). Acts as a negative regulator of immunoglobulin class switch recombination, probably by controlling the level of AICDA /AID on the chromatin (By similarity). In addition to proteins, also able to ADP-ribosylate DNA: mediates DNA mono-ADP-ribosylation of DNA strand break termini via covalent addition of a single ADP-ribose moiety to a 5'- or 3'-terminal phosphate residues in DNA containing multiple strand breaks (PubMed:29361132, PubMed:29520010). {ECO:0000250|UniProtKB:Q3ULW8, ECO:0000269|PubMed:16924674, ECO:0000269|PubMed:19354255, ECO:0000269|PubMed:20064938, ECO:0000269|PubMed:21211721, ECO:0000269|PubMed:21270334, ECO:0000269|PubMed:23742272, ECO:0000269|PubMed:24598253, ECO:0000269|PubMed:25043379, ECO:0000269|PubMed:27530147, ECO:0000269|PubMed:28447610, ECO:0000269|PubMed:29361132, ECO:0000269|PubMed:29520010}. |
O14976 | GAK | S399 | Sugiyama | Cyclin-G-associated kinase (EC 2.7.11.1) (DnaJ homolog subfamily C member 26) | Associates with cyclin G and CDK5. Seems to act as an auxilin homolog that is involved in the uncoating of clathrin-coated vesicles by Hsc70 in non-neuronal cells. Expression oscillates slightly during the cell cycle, peaking at G1 (PubMed:10625686). May play a role in clathrin-mediated endocytosis and intracellular trafficking, and in the dynamics of clathrin assembly/disassembly (PubMed:18489706). {ECO:0000269|PubMed:10625686, ECO:0000269|PubMed:18489706}. |
P11142 | HSPA8 | T38 | Sugiyama | Heat shock cognate 71 kDa protein (EC 3.6.4.10) (Heat shock 70 kDa protein 8) (Heat shock protein family A member 8) (Lipopolysaccharide-associated protein 1) (LAP-1) (LPS-associated protein 1) | Molecular chaperone implicated in a wide variety of cellular processes, including protection of the proteome from stress, folding and transport of newly synthesized polypeptides, chaperone-mediated autophagy, activation of proteolysis of misfolded proteins, formation and dissociation of protein complexes, and antigen presentation. Plays a pivotal role in the protein quality control system, ensuring the correct folding of proteins, the re-folding of misfolded proteins and controlling the targeting of proteins for subsequent degradation (PubMed:21148293, PubMed:21150129, PubMed:23018488, PubMed:24732912, PubMed:27916661, PubMed:2799391, PubMed:36586411). This is achieved through cycles of ATP binding, ATP hydrolysis and ADP release, mediated by co-chaperones (PubMed:12526792, PubMed:21148293, PubMed:21150129, PubMed:23018488, PubMed:24732912, PubMed:27916661). The co-chaperones have been shown to not only regulate different steps of the ATPase cycle of HSP70, but they also have an individual specificity such that one co-chaperone may promote folding of a substrate while another may promote degradation (PubMed:12526792, PubMed:21148293, PubMed:21150129, PubMed:23018488, PubMed:24732912, PubMed:27916661). The affinity of HSP70 for polypeptides is regulated by its nucleotide bound state. In the ATP-bound form, it has a low affinity for substrate proteins. However, upon hydrolysis of the ATP to ADP, it undergoes a conformational change that increases its affinity for substrate proteins. HSP70 goes through repeated cycles of ATP hydrolysis and nucleotide exchange, which permits cycles of substrate binding and release. The HSP70-associated co-chaperones are of three types: J-domain co-chaperones HSP40s (stimulate ATPase hydrolysis by HSP70), the nucleotide exchange factors (NEF) such as BAG1/2/3 (facilitate conversion of HSP70 from the ADP-bound to the ATP-bound state thereby promoting substrate release), and the TPR domain chaperones such as HOPX and STUB1 (PubMed:24121476, PubMed:24318877, PubMed:26865365, PubMed:27474739). Plays a critical role in mitochondrial import, delivers preproteins to the mitochondrial import receptor TOMM70 (PubMed:12526792). Acts as a repressor of transcriptional activation. Inhibits the transcriptional coactivator activity of CITED1 on Smad-mediated transcription. Component of the PRP19-CDC5L complex that forms an integral part of the spliceosome and is required for activating pre-mRNA splicing. May have a scaffolding role in the spliceosome assembly as it contacts all other components of the core complex. Binds bacterial lipopolysaccharide (LPS) and mediates LPS-induced inflammatory response, including TNF secretion by monocytes (PubMed:10722728, PubMed:11276205). Substrate recognition component in chaperone-mediated autophagy (CMA), a selective protein degradation process that mediates degradation of proteins with a -KFERQ motif: HSPA8/HSC70 specifically recognizes and binds cytosolic proteins bearing a -KFERQ motif and promotes their recruitment to the surface of the lysosome where they bind to lysosomal protein LAMP2 (PubMed:11559757, PubMed:2799391, PubMed:36586411). KFERQ motif-containing proteins are eventually transported into the lysosomal lumen where they are degraded (PubMed:11559757, PubMed:2799391, PubMed:36586411). In conjunction with LAMP2, facilitates MHC class II presentation of cytoplasmic antigens by guiding antigens to the lysosomal membrane for interaction with LAMP2 which then elicits MHC class II presentation of peptides to the cell membrane (PubMed:15894275). Participates in the ER-associated degradation (ERAD) quality control pathway in conjunction with J domain-containing co-chaperones and the E3 ligase STUB1 (PubMed:23990462). It is recruited to clathrin-coated vesicles through its interaction with DNAJC6 leading to activation of HSPA8/HSC70 ATPase activity and therefore uncoating of clathrin-coated vesicles (By similarity). {ECO:0000250|UniProtKB:P19120, ECO:0000269|PubMed:10722728, ECO:0000269|PubMed:11276205, ECO:0000269|PubMed:11559757, ECO:0000269|PubMed:12526792, ECO:0000269|PubMed:15894275, ECO:0000269|PubMed:21148293, ECO:0000269|PubMed:21150129, ECO:0000269|PubMed:23018488, ECO:0000269|PubMed:23990462, ECO:0000269|PubMed:24318877, ECO:0000269|PubMed:24732912, ECO:0000269|PubMed:27474739, ECO:0000269|PubMed:27916661, ECO:0000269|PubMed:2799391, ECO:0000269|PubMed:36586411, ECO:0000303|PubMed:24121476, ECO:0000303|PubMed:26865365}. |
P34931 | HSPA1L | T40 | Sugiyama | Heat shock 70 kDa protein 1-like (Heat shock 70 kDa protein 1L) (Heat shock 70 kDa protein 1-Hom) (HSP70-Hom) (Heat shock protein family A member 1L) | Molecular chaperone implicated in a wide variety of cellular processes, including protection of the proteome from stress, folding and transport of newly synthesized polypeptides, activation of proteolysis of misfolded proteins and the formation and dissociation of protein complexes. Plays a pivotal role in the protein quality control system, ensuring the correct folding of proteins, the re-folding of misfolded proteins and controlling the targeting of proteins for subsequent degradation. This is achieved through cycles of ATP binding, ATP hydrolysis and ADP release, mediated by co-chaperones. The affinity for polypeptides is regulated by its nucleotide bound state. In the ATP-bound form, it has a low affinity for substrate proteins. However, upon hydrolysis of the ATP to ADP, it undergoes a conformational change that increases its affinity for substrate proteins. It goes through repeated cycles of ATP hydrolysis and nucleotide exchange, which permits cycles of substrate binding and release (PubMed:26865365). Positive regulator of PRKN translocation to damaged mitochondria (PubMed:24270810). {ECO:0000269|PubMed:24270810, ECO:0000303|PubMed:26865365}. |
P54652 | HSPA2 | T39 | Sugiyama | Heat shock-related 70 kDa protein 2 (Heat shock 70 kDa protein 2) (Heat shock protein family A member 2) | Molecular chaperone implicated in a wide variety of cellular processes, including protection of the proteome from stress, folding and transport of newly synthesized polypeptides, activation of proteolysis of misfolded proteins and the formation and dissociation of protein complexes. Plays a pivotal role in the protein quality control system, ensuring the correct folding of proteins, the re-folding of misfolded proteins and controlling the targeting of proteins for subsequent degradation. This is achieved through cycles of ATP binding, ATP hydrolysis and ADP release, mediated by co-chaperones. The affinity for polypeptides is regulated by its nucleotide bound state. In the ATP-bound form, it has a low affinity for substrate proteins. However, upon hydrolysis of the ATP to ADP, it undergoes a conformational change that increases its affinity for substrate proteins. It goes through repeated cycles of ATP hydrolysis and nucleotide exchange, which permits cycles of substrate binding and release (PubMed:26865365). Plays a role in spermatogenesis. In association with SHCBP1L may participate in the maintenance of spindle integrity during meiosis in male germ cells (By similarity). {ECO:0000250|UniProtKB:P17156, ECO:0000303|PubMed:26865365}. |
Q8NBJ7 | SUMF2 | S44 | Sugiyama | Inactive C-alpha-formylglycine-generating enzyme 2 (Paralog of formylglycine-generating enzyme) (pFGE) (Sulfatase-modifying factor 2) | Lacks formylglycine generating activity and is unable to convert newly synthesized inactive sulfatases to their active form. Inhibits the activation of sulfatases by SUMF1. {ECO:0000269|PubMed:12757706, ECO:0000269|PubMed:15708861, ECO:0000269|PubMed:15962010}. |
Q9BZK7 | TBL1XR1 | S451 | Sugiyama | F-box-like/WD repeat-containing protein TBL1XR1 (Nuclear receptor corepressor/HDAC3 complex subunit TBLR1) (TBL1-related protein 1) (Transducin beta-like 1X-related protein 1) | F-box-like protein involved in the recruitment of the ubiquitin/19S proteasome complex to nuclear receptor-regulated transcription units. Plays an essential role in transcription activation mediated by nuclear receptors. Probably acts as integral component of the N-Cor corepressor complex that mediates the recruitment of the 19S proteasome complex, leading to the subsequent proteasomal degradation of N-Cor complex, thereby allowing cofactor exchange, and transcription activation. {ECO:0000269|PubMed:14980219}. |
P17066 | HSPA6 | T40 | Sugiyama | Heat shock 70 kDa protein 6 (Heat shock 70 kDa protein B') (Heat shock protein family A member 6) | Molecular chaperone implicated in a wide variety of cellular processes, including protection of the proteome from stress, folding and transport of newly synthesized polypeptides, activation of proteolysis of misfolded proteins and the formation and dissociation of protein complexes. Plays a pivotal role in the protein quality control system, ensuring the correct folding of proteins, the re-folding of misfolded proteins and controlling the targeting of proteins for subsequent degradation. This is achieved through cycles of ATP binding, ATP hydrolysis and ADP release, mediated by co-chaperones. The affinity for polypeptides is regulated by its nucleotide bound state. In the ATP-bound form, it has a low affinity for substrate proteins. However, upon hydrolysis of the ATP to ADP, it undergoes a conformational change that increases its affinity for substrate proteins. It goes through repeated cycles of ATP hydrolysis and nucleotide exchange, which permits cycles of substrate binding and release (PubMed:26865365). {ECO:0000303|PubMed:26865365}. |
P48741 | HSPA7 | T40 | Sugiyama | Putative heat shock 70 kDa protein 7 (Heat shock 70 kDa protein B) (Heat shock protein family A member 7) | None |
P62714 | PPP2CB | S212 | Sugiyama | Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform (PP2A-beta) (EC 3.1.3.16) | Catalytic subunit of protein phosphatase 2A (PP2A), a serine/threonine phosphatase involved in the regulation of a wide variety of enzymes, signal transduction pathways, and cellular events (Probable). PP2A can modulate the activity of phosphorylase B kinase, casein kinase 2, mitogen-stimulated S6 kinase, and MAP-2 kinase. Part of the striatin-interacting phosphatase and kinase (STRIPAK) complexes. STRIPAK complexes have critical roles in protein (de)phosphorylation and are regulators of multiple signaling pathways including Hippo, MAPK, nuclear receptor and cytoskeleton remodeling. Different types of STRIPAK complexes are involved in a variety of biological processes such as cell growth, differentiation, apoptosis, metabolism and immune regulation (PubMed:18782753). {ECO:0000269|PubMed:18782753, ECO:0000269|PubMed:2555176, ECO:0000305}. |
P67775 | PPP2CA | S212 | Sugiyama | Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform (PP2A-alpha) (EC 3.1.3.16) (Replication protein C) (RP-C) | Catalytic subunit of protein phosphatase 2A (PP2A), a serine/threonine phosphatase involved in the regulation of a wide variety of enzymes, signal transduction pathways, and cellular events (PubMed:10801873, PubMed:12473674, PubMed:17245430, PubMed:22613722, PubMed:33243860, PubMed:34004147, PubMed:9920888). PP2A is the major phosphatase for microtubule-associated proteins (MAPs) (PubMed:22613722). PP2A can modulate the activity of phosphorylase B kinase casein kinase 2, mitogen-stimulated S6 kinase, and MAP-2 kinase (PubMed:22613722). Cooperates with SGO2 to protect centromeric cohesin from separase-mediated cleavage in oocytes specifically during meiosis I (By similarity). Can dephosphorylate various proteins, such as SV40 large T antigen, AXIN1, p53/TP53, PIM3, WEE1 (PubMed:10801873, PubMed:12473674, PubMed:17245430, PubMed:9920888). Activates RAF1 by dephosphorylating it at 'Ser-259' (PubMed:10801873). Mediates dephosphorylation of WEE1, preventing its ubiquitin-mediated proteolysis, increasing WEE1 protein levels, and promoting the G2/M checkpoint (PubMed:33108758). Mediates dephosphorylation of MYC; promoting its ubiquitin-mediated proteolysis: interaction with AMBRA1 enhances interaction between PPP2CA and MYC (PubMed:25438055). Mediates dephosphorylation of FOXO3; promoting its stabilization: interaction with AMBRA1 enhances interaction between PPP2CA and FOXO3 (PubMed:30513302). Catalyzes dephosphorylation of the pyrin domain of NLRP3, promoting assembly of the NLRP3 inflammasome (By similarity). Together with RACK1 adapter, mediates dephosphorylation of AKT1 at 'Ser-473', preventing AKT1 activation and AKT-mTOR signaling pathway (By similarity). Dephosphorylation of AKT1 is essential for regulatory T-cells (Treg) homeostasis and stability (By similarity). Catalyzes dephosphorylation of PIM3, promotinh PIM3 ubiquitination and proteasomal degradation (PubMed:12473674). Part of the striatin-interacting phosphatase and kinase (STRIPAK) complexes (PubMed:33633399). STRIPAK complexes have critical roles in protein (de)phosphorylation and are regulators of multiple signaling pathways including Hippo, MAPK, nuclear receptor and cytoskeleton remodeling (PubMed:33633399). Different types of STRIPAK complexes are involved in a variety of biological processes such as cell growth, differentiation, apoptosis, metabolism and immune regulation (PubMed:33633399). Key mediator of a quality checkpoint during transcription elongation as part of the Integrator-PP2A (INTAC) complex (PubMed:33243860, PubMed:34004147, PubMed:37080207). The INTAC complex drives premature transcription termination of transcripts that are unfavorably configured for transcriptional elongation: within the INTAC complex, PPP2CA catalyzes dephosphorylation of the C-terminal domain (CTD) of Pol II subunit POLR2A/RPB1 and SUPT5H/SPT5, thereby preventing transcriptional elongation (PubMed:33243860, PubMed:34004147, PubMed:37080207). {ECO:0000250|UniProtKB:P63330, ECO:0000269|PubMed:10801873, ECO:0000269|PubMed:12473674, ECO:0000269|PubMed:17245430, ECO:0000269|PubMed:22613722, ECO:0000269|PubMed:25438055, ECO:0000269|PubMed:30513302, ECO:0000269|PubMed:33108758, ECO:0000269|PubMed:33243860, ECO:0000269|PubMed:33633399, ECO:0000269|PubMed:34004147, ECO:0000269|PubMed:37080207, ECO:0000269|PubMed:9920888}. |
O00469 | PLOD2 | S441 | Sugiyama | Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 (EC 1.14.11.4) (Lysyl hydroxylase 2) (LH2) | Forms hydroxylysine residues in -Xaa-Lys-Gly- sequences in collagens. These hydroxylysines serve as sites of attachment for carbohydrate units and are essential for the stability of the intermolecular collagen cross-links. {ECO:0000250|UniProtKB:P24802}. |
Q02750 | MAP2K1 | S244 | SIGNOR | Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (MKK1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1) | Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Binding of extracellular ligands such as growth factors, cytokines and hormones to their cell-surface receptors activates RAS and this initiates RAF1 activation. RAF1 then further activates the dual-specificity protein kinases MAP2K1/MEK1 and MAP2K2/MEK2. Both MAP2K1/MEK1 and MAP2K2/MEK2 function specifically in the MAPK/ERK cascade, and catalyze the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2, leading to their activation and further transduction of the signal within the MAPK/ERK cascade. Activates BRAF in a KSR1 or KSR2-dependent manner; by binding to KSR1 or KSR2 releases the inhibitory intramolecular interaction between KSR1 or KSR2 protein kinase and N-terminal domains which promotes KSR1 or KSR2-BRAF dimerization and BRAF activation (PubMed:29433126). Depending on the cellular context, this pathway mediates diverse biological functions such as cell growth, adhesion, survival and differentiation, predominantly through the regulation of transcription, metabolism and cytoskeletal rearrangements. One target of the MAPK/ERK cascade is peroxisome proliferator-activated receptor gamma (PPARG), a nuclear receptor that promotes differentiation and apoptosis. MAP2K1/MEK1 has been shown to export PPARG from the nucleus. The MAPK/ERK cascade is also involved in the regulation of endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC), as well as in the fragmentation of the Golgi apparatus during mitosis. {ECO:0000269|PubMed:14737111, ECO:0000269|PubMed:17101779, ECO:0000269|PubMed:29433126}. |
P51451 | BLK | S190 | Sugiyama | Tyrosine-protein kinase Blk (EC 2.7.10.2) (B lymphocyte kinase) (p55-Blk) | Non-receptor tyrosine kinase involved in B-lymphocyte development, differentiation and signaling (By similarity). B-cell receptor (BCR) signaling requires a tight regulation of several protein tyrosine kinases and phosphatases, and associated coreceptors (By similarity). Binding of antigen to the B-cell antigen receptor (BCR) triggers signaling that ultimately leads to B-cell activation (By similarity). Signaling through BLK plays an important role in transmitting signals through surface immunoglobulins and supports the pro-B to pre-B transition, as well as the signaling for growth arrest and apoptosis downstream of B-cell receptor (By similarity). Specifically binds and phosphorylates CD79A at 'Tyr-188'and 'Tyr-199', as well as CD79B at 'Tyr-196' and 'Tyr-207' (By similarity). Also phosphorylates the immunoglobulin G receptors FCGR2A, FCGR2B and FCGR2C (PubMed:8756631). With FYN and LYN, plays an essential role in pre-B-cell receptor (pre-BCR)-mediated NF-kappa-B activation (By similarity). Also contributes to BTK activation by indirectly stimulating BTK intramolecular autophosphorylation (By similarity). In pancreatic islets, acts as a modulator of beta-cells function through the up-regulation of PDX1 and NKX6-1 and consequent stimulation of insulin secretion in response to glucose (PubMed:19667185). Phosphorylates CGAS, promoting retention of CGAS in the cytosol (PubMed:30356214). {ECO:0000250|UniProtKB:P16277, ECO:0000269|PubMed:19667185, ECO:0000269|PubMed:30356214, ECO:0000269|PubMed:8756631}. |
P23284 | PPIB | S139 | Sugiyama | Peptidyl-prolyl cis-trans isomerase B (PPIase B) (EC 5.2.1.8) (CYP-S1) (Cyclophilin B) (Rotamase B) (S-cyclophilin) (SCYLP) | PPIase that catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides and may therefore assist protein folding. {ECO:0000269|PubMed:20676357}. |
P78368 | CSNK1G2 | S27 | Sugiyama | Casein kinase I isoform gamma-2 (CKI-gamma 2) (EC 2.7.11.1) | Serine/threonine-protein kinase. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. It can phosphorylate a large number of proteins. Participates in Wnt signaling (By similarity). Phosphorylates COL4A3BP/CERT, MTA1 and SMAD3. SMAD3 phosphorylation promotes its ligand-dependent ubiquitination and subsequent proteasome degradation, thus inhibiting SMAD3-mediated TGF-beta responses. Hyperphosphorylation of the serine-repeat motif of COL4A3BP/CERT leads to its inactivation by dissociation from the Golgi complex, thus down-regulating ER-to-Golgi transport of ceramide and sphingomyelin synthesis. Triggers PER1 proteasomal degradation probably through phosphorylation (PubMed:15077195, PubMed:15917222, PubMed:18794808, PubMed:19005213). Involved in brain development and vesicular trafficking and neurotransmitter releasing from small synaptic vesicles. Regulates fast synaptic transmission mediated by glutamate (By similarity). Involved in regulation of reactive oxygen species (ROS) levels (PubMed:37099597). {ECO:0000250|UniProtKB:P48729, ECO:0000250|UniProtKB:Q8BVP5, ECO:0000269|PubMed:15077195, ECO:0000269|PubMed:15917222, ECO:0000269|PubMed:18794808, ECO:0000269|PubMed:19005213, ECO:0000269|PubMed:37099597}. |
Q01813 | PFKP | S679 | SIGNOR | ATP-dependent 6-phosphofructokinase, platelet type (ATP-PFK) (PFK-P) (EC 2.7.1.11) (6-phosphofructokinase type C) (Phosphofructo-1-kinase isozyme C) (PFK-C) (Phosphohexokinase) | Catalyzes the phosphorylation of D-fructose 6-phosphate to fructose 1,6-bisphosphate by ATP, the first committing step of glycolysis. |
Q8WVV9 | HNRNPLL | S86 | Sugiyama | Heterogeneous nuclear ribonucleoprotein L-like (hnRNPLL) (Stromal RNA-regulating factor) | RNA-binding protein that functions as a regulator of alternative splicing for multiple target mRNAs, including PTPRC/CD45 and STAT5A. Required for alternative splicing of PTPRC. {ECO:0000269|PubMed:18669861}. |
P50895 | BCAM | S298 | Sugiyama | Basal cell adhesion molecule (Auberger B antigen) (B-CAM cell surface glycoprotein) (F8/G253 antigen) (Lutheran antigen) (Lutheran blood group glycoprotein) (CD antigen CD239) | Transmembrane glycoprotein that functions as both a receptor and an adhesion molecule playing a crucial role in cell adhesion, motility, migration and invasion (PubMed:9616226, PubMed:31413112). Extracellular domain enables binding to extracellular matrix proteins, such as laminin, integrin and other ligands while its intracellular domain interacts with cytoskeletal proteins like hemoglobin, facilitating cell signal transduction (PubMed:17158232). Serves as a receptor for laminin alpha-5/LAMA5 to promote cell adhesion (PubMed:15975931). Mechanistically, JAK2 induces BCAM phosphorylation and activates its adhesion to laminin by stimulating a Rap1/AKT signaling pathway in the absence of EPOR (PubMed:23160466). {ECO:0000269|PubMed:15975931, ECO:0000269|PubMed:17158232, ECO:0000269|PubMed:23160466, ECO:0000269|PubMed:31413112, ECO:0000269|PubMed:9616226}. |
P62714 | PPP2CB | S75 | Sugiyama | Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform (PP2A-beta) (EC 3.1.3.16) | Catalytic subunit of protein phosphatase 2A (PP2A), a serine/threonine phosphatase involved in the regulation of a wide variety of enzymes, signal transduction pathways, and cellular events (Probable). PP2A can modulate the activity of phosphorylase B kinase, casein kinase 2, mitogen-stimulated S6 kinase, and MAP-2 kinase. Part of the striatin-interacting phosphatase and kinase (STRIPAK) complexes. STRIPAK complexes have critical roles in protein (de)phosphorylation and are regulators of multiple signaling pathways including Hippo, MAPK, nuclear receptor and cytoskeleton remodeling. Different types of STRIPAK complexes are involved in a variety of biological processes such as cell growth, differentiation, apoptosis, metabolism and immune regulation (PubMed:18782753). {ECO:0000269|PubMed:18782753, ECO:0000269|PubMed:2555176, ECO:0000305}. |
P67775 | PPP2CA | S75 | Sugiyama | Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform (PP2A-alpha) (EC 3.1.3.16) (Replication protein C) (RP-C) | Catalytic subunit of protein phosphatase 2A (PP2A), a serine/threonine phosphatase involved in the regulation of a wide variety of enzymes, signal transduction pathways, and cellular events (PubMed:10801873, PubMed:12473674, PubMed:17245430, PubMed:22613722, PubMed:33243860, PubMed:34004147, PubMed:9920888). PP2A is the major phosphatase for microtubule-associated proteins (MAPs) (PubMed:22613722). PP2A can modulate the activity of phosphorylase B kinase casein kinase 2, mitogen-stimulated S6 kinase, and MAP-2 kinase (PubMed:22613722). Cooperates with SGO2 to protect centromeric cohesin from separase-mediated cleavage in oocytes specifically during meiosis I (By similarity). Can dephosphorylate various proteins, such as SV40 large T antigen, AXIN1, p53/TP53, PIM3, WEE1 (PubMed:10801873, PubMed:12473674, PubMed:17245430, PubMed:9920888). Activates RAF1 by dephosphorylating it at 'Ser-259' (PubMed:10801873). Mediates dephosphorylation of WEE1, preventing its ubiquitin-mediated proteolysis, increasing WEE1 protein levels, and promoting the G2/M checkpoint (PubMed:33108758). Mediates dephosphorylation of MYC; promoting its ubiquitin-mediated proteolysis: interaction with AMBRA1 enhances interaction between PPP2CA and MYC (PubMed:25438055). Mediates dephosphorylation of FOXO3; promoting its stabilization: interaction with AMBRA1 enhances interaction between PPP2CA and FOXO3 (PubMed:30513302). Catalyzes dephosphorylation of the pyrin domain of NLRP3, promoting assembly of the NLRP3 inflammasome (By similarity). Together with RACK1 adapter, mediates dephosphorylation of AKT1 at 'Ser-473', preventing AKT1 activation and AKT-mTOR signaling pathway (By similarity). Dephosphorylation of AKT1 is essential for regulatory T-cells (Treg) homeostasis and stability (By similarity). Catalyzes dephosphorylation of PIM3, promotinh PIM3 ubiquitination and proteasomal degradation (PubMed:12473674). Part of the striatin-interacting phosphatase and kinase (STRIPAK) complexes (PubMed:33633399). STRIPAK complexes have critical roles in protein (de)phosphorylation and are regulators of multiple signaling pathways including Hippo, MAPK, nuclear receptor and cytoskeleton remodeling (PubMed:33633399). Different types of STRIPAK complexes are involved in a variety of biological processes such as cell growth, differentiation, apoptosis, metabolism and immune regulation (PubMed:33633399). Key mediator of a quality checkpoint during transcription elongation as part of the Integrator-PP2A (INTAC) complex (PubMed:33243860, PubMed:34004147, PubMed:37080207). The INTAC complex drives premature transcription termination of transcripts that are unfavorably configured for transcriptional elongation: within the INTAC complex, PPP2CA catalyzes dephosphorylation of the C-terminal domain (CTD) of Pol II subunit POLR2A/RPB1 and SUPT5H/SPT5, thereby preventing transcriptional elongation (PubMed:33243860, PubMed:34004147, PubMed:37080207). {ECO:0000250|UniProtKB:P63330, ECO:0000269|PubMed:10801873, ECO:0000269|PubMed:12473674, ECO:0000269|PubMed:17245430, ECO:0000269|PubMed:22613722, ECO:0000269|PubMed:25438055, ECO:0000269|PubMed:30513302, ECO:0000269|PubMed:33108758, ECO:0000269|PubMed:33243860, ECO:0000269|PubMed:33633399, ECO:0000269|PubMed:34004147, ECO:0000269|PubMed:37080207, ECO:0000269|PubMed:9920888}. |
Q96PY6 | NEK1 | S436 | Sugiyama | Serine/threonine-protein kinase Nek1 (EC 2.7.11.1) (Never in mitosis A-related kinase 1) (NimA-related protein kinase 1) (Renal carcinoma antigen NY-REN-55) | Phosphorylates serines and threonines, but also appears to possess tyrosine kinase activity (PubMed:20230784). Involved in DNA damage checkpoint control and for proper DNA damage repair (PubMed:20230784). In response to injury that includes DNA damage, NEK1 phosphorylates VDAC1 to limit mitochondrial cell death (PubMed:20230784). May be implicated in the control of meiosis (By similarity). Involved in cilium assembly (PubMed:21211617). {ECO:0000250|UniProtKB:P51954, ECO:0000269|PubMed:20230784, ECO:0000269|PubMed:21211617}. |
Download
reactome_id | name | p | -log10_p |
---|---|---|---|
R-HSA-3371453 | Regulation of HSF1-mediated heat shock response | 3.238841e-09 | 8.490 |
R-HSA-3371556 | Cellular response to heat stress | 2.915565e-08 | 7.535 |
R-HSA-3371568 | Attenuation phase | 7.935378e-07 | 6.100 |
R-HSA-3371571 | HSF1-dependent transactivation | 4.189208e-06 | 5.378 |
R-HSA-1169410 | Antiviral mechanism by IFN-stimulated genes | 1.590958e-05 | 4.798 |
R-HSA-428543 | Inactivation of CDC42 and RAC1 | 3.852518e-05 | 4.414 |
R-HSA-9706374 | FLT3 signaling through SRC family kinases | 1.156662e-04 | 3.937 |
R-HSA-70171 | Glycolysis | 3.363778e-04 | 3.473 |
R-HSA-5673000 | RAF activation | 4.471253e-04 | 3.350 |
R-HSA-3371511 | HSF1 activation | 5.536741e-04 | 3.257 |
R-HSA-913531 | Interferon Signaling | 5.158947e-04 | 3.287 |
R-HSA-389513 | Co-inhibition by CTLA4 | 6.223495e-04 | 3.206 |
R-HSA-70326 | Glucose metabolism | 9.796626e-04 | 3.009 |
R-HSA-68875 | Mitotic Prophase | 1.129993e-03 | 2.947 |
R-HSA-5683057 | MAPK family signaling cascades | 1.615458e-03 | 2.792 |
R-HSA-9833482 | PKR-mediated signaling | 2.433993e-03 | 2.614 |
R-HSA-6804757 | Regulation of TP53 Degradation | 4.409909e-03 | 2.356 |
R-HSA-450294 | MAP kinase activation | 4.296073e-03 | 2.367 |
R-HSA-74713 | IRS activation | 5.224202e-03 | 2.282 |
R-HSA-6811558 | PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | 5.287091e-03 | 2.277 |
R-HSA-5674499 | Negative feedback regulation of MAPK pathway | 6.756043e-03 | 2.170 |
R-HSA-8939245 | RUNX1 regulates transcription of genes involved in BCR signaling | 5.224202e-03 | 2.282 |
R-HSA-199418 | Negative regulation of the PI3K/AKT network | 7.115439e-03 | 2.148 |
R-HSA-6806003 | Regulation of TP53 Expression and Degradation | 5.576763e-03 | 2.254 |
R-HSA-5675221 | Negative regulation of MAPK pathway | 6.933526e-03 | 2.159 |
R-HSA-198753 | ERK/MAPK targets | 7.538689e-03 | 2.123 |
R-HSA-448424 | Interleukin-17 signaling | 7.114692e-03 | 2.148 |
R-HSA-164944 | Nef and signal transduction | 8.466255e-03 | 2.072 |
R-HSA-5663202 | Diseases of signal transduction by growth factor receptors and second messengers | 8.265654e-03 | 2.083 |
R-HSA-210746 | Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells | 8.466255e-03 | 2.072 |
R-HSA-4839726 | Chromatin organization | 8.595001e-03 | 2.066 |
R-HSA-1169408 | ISG15 antiviral mechanism | 9.140176e-03 | 2.039 |
R-HSA-1280215 | Cytokine Signaling in Immune system | 9.007843e-03 | 2.045 |
R-HSA-168164 | Toll Like Receptor 3 (TLR3) Cascade | 9.398262e-03 | 2.027 |
R-HSA-163767 | PP2A-mediated dephosphorylation of key metabolic factors | 1.034917e-02 | 1.985 |
R-HSA-112412 | SOS-mediated signalling | 1.034917e-02 | 1.985 |
R-HSA-5467340 | AXIN missense mutants destabilize the destruction complex | 1.949901e-02 | 1.710 |
R-HSA-5467348 | Truncations of AMER1 destabilize the destruction complex | 1.949901e-02 | 1.710 |
R-HSA-5467337 | APC truncation mutants have impaired AXIN binding | 1.949901e-02 | 1.710 |
R-HSA-5339716 | Signaling by GSK3beta mutants | 2.216487e-02 | 1.654 |
R-HSA-4839743 | Signaling by CTNNB1 phospho-site mutants | 2.497205e-02 | 1.603 |
R-HSA-5358749 | CTNNB1 S37 mutants aren't phosphorylated | 2.497205e-02 | 1.603 |
R-HSA-5358751 | CTNNB1 S45 mutants aren't phosphorylated | 2.497205e-02 | 1.603 |
R-HSA-5358752 | CTNNB1 T41 mutants aren't phosphorylated | 2.497205e-02 | 1.603 |
R-HSA-5358747 | CTNNB1 S33 mutants aren't phosphorylated | 2.497205e-02 | 1.603 |
R-HSA-5619107 | Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC... | 1.793246e-02 | 1.746 |
R-HSA-1855196 | IP3 and IP4 transport between cytosol and nucleus | 1.925722e-02 | 1.715 |
R-HSA-1855229 | IP6 and IP7 transport between cytosol and nucleus | 1.925722e-02 | 1.715 |
R-HSA-1855170 | IPs transport between nucleus and cytosol | 2.206511e-02 | 1.656 |
R-HSA-159227 | Transport of the SLBP independent Mature mRNA | 2.206511e-02 | 1.656 |
R-HSA-159230 | Transport of the SLBP Dependant Mature mRNA | 2.354831e-02 | 1.628 |
R-HSA-191859 | snRNP Assembly | 1.967414e-02 | 1.706 |
R-HSA-194441 | Metabolism of non-coding RNA | 1.967414e-02 | 1.706 |
R-HSA-198203 | PI3K/AKT activation | 1.697940e-02 | 1.770 |
R-HSA-2424491 | DAP12 signaling | 1.793246e-02 | 1.746 |
R-HSA-389356 | Co-stimulation by CD28 | 1.090419e-02 | 1.962 |
R-HSA-4791275 | Signaling by WNT in cancer | 2.063475e-02 | 1.685 |
R-HSA-4839744 | Signaling by APC mutants | 1.949901e-02 | 1.710 |
R-HSA-202670 | ERKs are inactivated | 2.216487e-02 | 1.654 |
R-HSA-4839748 | Signaling by AMER1 mutants | 2.216487e-02 | 1.654 |
R-HSA-4839735 | Signaling by AXIN mutants | 2.216487e-02 | 1.654 |
R-HSA-2219530 | Constitutive Signaling by Aberrant PI3K in Cancer | 2.195883e-02 | 1.658 |
R-HSA-74749 | Signal attenuation | 1.697940e-02 | 1.770 |
R-HSA-4641262 | Disassembly of the destruction complex and recruitment of AXIN to the membrane | 1.427342e-02 | 1.845 |
R-HSA-170822 | Regulation of Glucokinase by Glucokinase Regulatory Protein | 2.354831e-02 | 1.628 |
R-HSA-5684996 | MAPK1/MAPK3 signaling | 2.352666e-02 | 1.628 |
R-HSA-5673001 | RAF/MAP kinase cascade | 2.056730e-02 | 1.687 |
R-HSA-9022692 | Regulation of MECP2 expression and activity | 2.206511e-02 | 1.656 |
R-HSA-430116 | GP1b-IX-V activation signalling | 1.461109e-02 | 1.835 |
R-HSA-113501 | Inhibition of replication initiation of damaged DNA by RB1/E2F1 | 2.216487e-02 | 1.654 |
R-HSA-180746 | Nuclear import of Rev protein | 2.508434e-02 | 1.601 |
R-HSA-6784531 | tRNA processing in the nucleus | 2.264543e-02 | 1.645 |
R-HSA-422475 | Axon guidance | 1.329633e-02 | 1.876 |
R-HSA-2465910 | MASTL Facilitates Mitotic Progression | 1.461109e-02 | 1.835 |
R-HSA-428540 | Activation of RAC1 | 2.216487e-02 | 1.654 |
R-HSA-9675108 | Nervous system development | 2.249648e-02 | 1.648 |
R-HSA-381183 | ATF6 (ATF6-alpha) activates chaperone genes | 2.216487e-02 | 1.654 |
R-HSA-186712 | Regulation of beta-cell development | 1.967414e-02 | 1.706 |
R-HSA-166166 | MyD88-independent TLR4 cascade | 1.136111e-02 | 1.945 |
R-HSA-450282 | MAPK targets/ Nuclear events mediated by MAP kinases | 1.666034e-02 | 1.778 |
R-HSA-162909 | Host Interactions of HIV factors | 1.956490e-02 | 1.709 |
R-HSA-937061 | TRIF (TICAM1)-mediated TLR4 signaling | 1.136111e-02 | 1.945 |
R-HSA-9020558 | Interleukin-2 signaling | 1.949901e-02 | 1.710 |
R-HSA-376176 | Signaling by ROBO receptors | 2.100241e-02 | 1.678 |
R-HSA-210990 | PECAM1 interactions | 1.949901e-02 | 1.710 |
R-HSA-166520 | Signaling by NTRKs | 1.410850e-02 | 1.851 |
R-HSA-187037 | Signaling by NTRK1 (TRKA) | 2.278928e-02 | 1.642 |
R-HSA-2586552 | Signaling by Leptin | 1.697940e-02 | 1.770 |
R-HSA-2219528 | PI3K/AKT Signaling in Cancer | 1.612470e-02 | 1.793 |
R-HSA-69273 | Cyclin A/B1/B2 associated events during G2/M transition | 2.206511e-02 | 1.656 |
R-HSA-975871 | MyD88 cascade initiated on plasma membrane | 2.616589e-02 | 1.582 |
R-HSA-168142 | Toll Like Receptor 10 (TLR10) Cascade | 2.616589e-02 | 1.582 |
R-HSA-168176 | Toll Like Receptor 5 (TLR5) Cascade | 2.616589e-02 | 1.582 |
R-HSA-3301854 | Nuclear Pore Complex (NPC) Disassembly | 2.667314e-02 | 1.574 |
R-HSA-389359 | CD28 dependent Vav1 pathway | 2.791574e-02 | 1.554 |
R-HSA-381033 | ATF6 (ATF6-alpha) activates chaperones | 2.791574e-02 | 1.554 |
R-HSA-114604 | GPVI-mediated activation cascade | 2.831462e-02 | 1.548 |
R-HSA-5632968 | Defective Mismatch Repair Associated With MSH6 | 2.985215e-02 | 1.525 |
R-HSA-196299 | Beta-catenin phosphorylation cascade | 3.419393e-02 | 1.466 |
R-HSA-159231 | Transport of Mature mRNA Derived from an Intronless Transcript | 3.355359e-02 | 1.474 |
R-HSA-937072 | TRAF6-mediated induction of TAK1 complex within TLR4 complex | 3.419393e-02 | 1.466 |
R-HSA-1295596 | Spry regulation of FGF signaling | 3.419393e-02 | 1.466 |
R-HSA-180910 | Vpr-mediated nuclear import of PICs | 3.000863e-02 | 1.523 |
R-HSA-1433559 | Regulation of KIT signaling | 3.099123e-02 | 1.509 |
R-HSA-9933946 | Formation of the embryonic stem cell BAF (esBAF) complex | 3.419393e-02 | 1.466 |
R-HSA-165054 | Rev-mediated nuclear export of HIV RNA | 3.175502e-02 | 1.498 |
R-HSA-168276 | NS1 Mediated Effects on Host Pathways | 3.355359e-02 | 1.474 |
R-HSA-446353 | Cell-extracellular matrix interactions | 3.419393e-02 | 1.466 |
R-HSA-159234 | Transport of Mature mRNAs Derived from Intronless Transcripts | 3.540409e-02 | 1.451 |
R-HSA-177243 | Interactions of Rev with host cellular proteins | 3.540409e-02 | 1.451 |
R-HSA-176033 | Interactions of Vpr with host cellular proteins | 3.540409e-02 | 1.451 |
R-HSA-975138 | TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | 3.714167e-02 | 1.430 |
R-HSA-168271 | Transport of Ribonucleoproteins into the Host Nucleus | 3.730628e-02 | 1.428 |
R-HSA-9607240 | FLT3 Signaling | 3.730628e-02 | 1.428 |
R-HSA-9634600 | Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | 3.751934e-02 | 1.426 |
R-HSA-975155 | MyD88 dependent cascade initiated on endosome | 3.826010e-02 | 1.417 |
R-HSA-176034 | Interactions of Tat with host cellular proteins | 4.444371e-02 | 1.352 |
R-HSA-5339700 | Signaling by TCF7L2 mutants | 4.444371e-02 | 1.352 |
R-HSA-9649948 | Signaling downstream of RAS mutants | 4.978647e-02 | 1.303 |
R-HSA-6802946 | Signaling by moderate kinase activity BRAF mutants | 4.978647e-02 | 1.303 |
R-HSA-6802955 | Paradoxical activation of RAF signaling by kinase inactive BRAF | 4.978647e-02 | 1.303 |
R-HSA-6802949 | Signaling by RAS mutants | 4.978647e-02 | 1.303 |
R-HSA-5632928 | Defective Mismatch Repair Associated With MSH2 | 4.444371e-02 | 1.352 |
R-HSA-168333 | NEP/NS2 Interacts with the Cellular Export Machinery | 4.758125e-02 | 1.323 |
R-HSA-2172127 | DAP12 interactions | 4.542557e-02 | 1.343 |
R-HSA-2299718 | Condensation of Prophase Chromosomes | 4.978647e-02 | 1.303 |
R-HSA-168274 | Export of Viral Ribonucleoproteins from Nucleus | 4.978647e-02 | 1.303 |
R-HSA-166016 | Toll Like Receptor 4 (TLR4) Cascade | 4.217967e-02 | 1.375 |
R-HSA-3247509 | Chromatin modifying enzymes | 4.131298e-02 | 1.384 |
R-HSA-168181 | Toll Like Receptor 7/8 (TLR7/8) Cascade | 4.293867e-02 | 1.367 |
R-HSA-168138 | Toll Like Receptor 9 (TLR9) Cascade | 4.666406e-02 | 1.331 |
R-HSA-8864260 | Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | 4.542557e-02 | 1.343 |
R-HSA-8866910 | TFAP2 (AP-2) family regulates transcription of growth factors and their receptor... | 4.096309e-02 | 1.388 |
R-HSA-432142 | Platelet sensitization by LDL | 4.818858e-02 | 1.317 |
R-HSA-9754189 | Germ layer formation at gastrulation | 5.196206e-02 | 1.284 |
R-HSA-912631 | Regulation of signaling by CBL | 5.196206e-02 | 1.284 |
R-HSA-113510 | E2F mediated regulation of DNA replication | 5.196206e-02 | 1.284 |
R-HSA-1257604 | PIP3 activates AKT signaling | 5.248435e-02 | 1.280 |
R-HSA-166058 | MyD88:MAL(TIRAP) cascade initiated on plasma membrane | 5.328790e-02 | 1.273 |
R-HSA-168188 | Toll Like Receptor TLR6:TLR2 Cascade | 5.328790e-02 | 1.273 |
R-HSA-5687128 | MAPK6/MAPK4 signaling | 5.424042e-02 | 1.266 |
R-HSA-9934037 | Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | 5.583735e-02 | 1.253 |
R-HSA-9823730 | Formation of definitive endoderm | 5.583735e-02 | 1.253 |
R-HSA-168179 | Toll Like Receptor TLR1:TLR2 Cascade | 5.751173e-02 | 1.240 |
R-HSA-181438 | Toll Like Receptor 2 (TLR2) Cascade | 5.751173e-02 | 1.240 |
R-HSA-9665230 | Drug resistance in ERBB2 KD mutants | 5.881669e-02 | 1.230 |
R-HSA-9652282 | Drug-mediated inhibition of ERBB2 signaling | 5.881669e-02 | 1.230 |
R-HSA-9665737 | Drug resistance in ERBB2 TMD/JMD mutants | 5.881669e-02 | 1.230 |
R-HSA-9665245 | Resistance of ERBB2 KD mutants to tesevatinib | 5.881669e-02 | 1.230 |
R-HSA-9665251 | Resistance of ERBB2 KD mutants to lapatinib | 5.881669e-02 | 1.230 |
R-HSA-9665233 | Resistance of ERBB2 KD mutants to trastuzumab | 5.881669e-02 | 1.230 |
R-HSA-9665246 | Resistance of ERBB2 KD mutants to neratinib | 5.881669e-02 | 1.230 |
R-HSA-9665250 | Resistance of ERBB2 KD mutants to AEE788 | 5.881669e-02 | 1.230 |
R-HSA-9665249 | Resistance of ERBB2 KD mutants to afatinib | 5.881669e-02 | 1.230 |
R-HSA-9665244 | Resistance of ERBB2 KD mutants to sapitinib | 5.881669e-02 | 1.230 |
R-HSA-9665247 | Resistance of ERBB2 KD mutants to osimertinib | 5.881669e-02 | 1.230 |
R-HSA-8874177 | ATF6B (ATF6-beta) activates chaperones | 5.881669e-02 | 1.230 |
R-HSA-350054 | Notch-HLH transcription pathway | 6.803572e-02 | 1.167 |
R-HSA-9938206 | Developmental Lineage of Mammary Stem Cells | 6.803572e-02 | 1.167 |
R-HSA-429947 | Deadenylation of mRNA | 7.660821e-02 | 1.116 |
R-HSA-9839394 | TGFBR3 expression | 8.101595e-02 | 1.091 |
R-HSA-9843745 | Adipogenesis | 7.459425e-02 | 1.127 |
R-HSA-9670439 | Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT m... | 6.803572e-02 | 1.167 |
R-HSA-432722 | Golgi Associated Vesicle Biogenesis | 6.657070e-02 | 1.177 |
R-HSA-8875513 | MET interacts with TNS proteins | 7.297435e-02 | 1.137 |
R-HSA-429914 | Deadenylation-dependent mRNA decay | 8.273713e-02 | 1.082 |
R-HSA-5423599 | Diseases of Mismatch Repair (MMR) | 7.297435e-02 | 1.137 |
R-HSA-3214842 | HDMs demethylate histones | 8.101595e-02 | 1.091 |
R-HSA-5621575 | CD209 (DC-SIGN) signaling | 7.660821e-02 | 1.116 |
R-HSA-9669938 | Signaling by KIT in disease | 6.803572e-02 | 1.167 |
R-HSA-2980766 | Nuclear Envelope Breakdown | 7.717425e-02 | 1.113 |
R-HSA-164952 | The role of Nef in HIV-1 replication and disease pathogenesis | 7.228032e-02 | 1.141 |
R-HSA-9932451 | SWI/SNF chromatin remodelers | 8.101595e-02 | 1.091 |
R-HSA-9932444 | ATP-dependent chromatin remodelers | 8.101595e-02 | 1.091 |
R-HSA-9662361 | Sensory processing of sound by outer hair cells of the cochlea | 7.445717e-02 | 1.128 |
R-HSA-1266695 | Interleukin-7 signaling | 8.101595e-02 | 1.091 |
R-HSA-982772 | Growth hormone receptor signaling | 7.228032e-02 | 1.141 |
R-HSA-211163 | AKT-mediated inactivation of FOXO1A | 8.691991e-02 | 1.061 |
R-HSA-1251932 | PLCG1 events in ERBB2 signaling | 8.691991e-02 | 1.061 |
R-HSA-1306955 | GRB7 events in ERBB2 signaling | 8.691991e-02 | 1.061 |
R-HSA-9652169 | Signaling by MAP2K mutants | 8.691991e-02 | 1.061 |
R-HSA-8866911 | TFAP2 (AP-2) family regulates transcription of cell cycle factors | 8.691991e-02 | 1.061 |
R-HSA-3214847 | HATs acetylate histones | 8.761501e-02 | 1.057 |
R-HSA-168325 | Viral Messenger RNA Synthesis | 8.846741e-02 | 1.053 |
R-HSA-3928663 | EPHA-mediated growth cone collapse | 9.005762e-02 | 1.045 |
R-HSA-389357 | CD28 dependent PI3K/Akt signaling | 9.005762e-02 | 1.045 |
R-HSA-5654732 | Negative regulation of FGFR3 signaling | 9.468509e-02 | 1.024 |
R-HSA-9032759 | NTRK2 activates RAC1 | 1.006565e-01 | 0.997 |
R-HSA-9833576 | CDH11 homotypic and heterotypic interactions | 1.141873e-01 | 0.942 |
R-HSA-9022537 | Loss of MECP2 binding ability to the NCoR/SMRT complex | 1.141873e-01 | 0.942 |
R-HSA-9027283 | Erythropoietin activates STAT5 | 1.275154e-01 | 0.894 |
R-HSA-8951430 | RUNX3 regulates WNT signaling | 1.406437e-01 | 0.852 |
R-HSA-4411364 | Binding of TCF/LEF:CTNNB1 to target gene promoters | 1.406437e-01 | 0.852 |
R-HSA-9732724 | IFNG signaling activates MAPKs | 1.406437e-01 | 0.852 |
R-HSA-9726840 | SHOC2 M1731 mutant abolishes MRAS complex function | 1.406437e-01 | 0.852 |
R-HSA-9032500 | Activated NTRK2 signals through FYN | 1.535752e-01 | 0.814 |
R-HSA-444257 | RSK activation | 1.535752e-01 | 0.814 |
R-HSA-9660537 | Signaling by MRAS-complex mutants | 1.535752e-01 | 0.814 |
R-HSA-9768778 | Regulation of NPAS4 mRNA translation | 1.535752e-01 | 0.814 |
R-HSA-9726842 | Gain-of-function MRAS complexes activate RAF signaling | 1.535752e-01 | 0.814 |
R-HSA-9613354 | Lipophagy | 1.663130e-01 | 0.779 |
R-HSA-9700645 | ALK mutants bind TKIs | 1.663130e-01 | 0.779 |
R-HSA-110056 | MAPK3 (ERK1) activation | 1.788599e-01 | 0.747 |
R-HSA-9027277 | Erythropoietin activates Phospholipase C gamma (PLCG) | 1.788599e-01 | 0.747 |
R-HSA-9759811 | Regulation of CDH11 mRNA translation by microRNAs | 1.912186e-01 | 0.718 |
R-HSA-2197563 | NOTCH2 intracellular domain regulates transcription | 2.153832e-01 | 0.667 |
R-HSA-9634285 | Constitutive Signaling by Overexpressed ERBB2 | 2.153832e-01 | 0.667 |
R-HSA-9027276 | Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | 2.153832e-01 | 0.667 |
R-HSA-9820865 | Z-decay: degradation of maternal mRNAs by zygotically expressed factors | 2.153832e-01 | 0.667 |
R-HSA-399956 | CRMPs in Sema3A signaling | 2.388286e-01 | 0.622 |
R-HSA-8847993 | ERBB2 Activates PTK6 Signaling | 2.388286e-01 | 0.622 |
R-HSA-1663150 | The activation of arylsulfatases | 2.388286e-01 | 0.622 |
R-HSA-8948700 | Competing endogenous RNAs (ceRNAs) regulate PTEN translation | 2.502884e-01 | 0.602 |
R-HSA-9027284 | Erythropoietin activates RAS | 2.502884e-01 | 0.602 |
R-HSA-6785631 | ERBB2 Regulates Cell Motility | 2.502884e-01 | 0.602 |
R-HSA-442742 | CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | 1.187664e-01 | 0.925 |
R-HSA-1963640 | GRB2 events in ERBB2 signaling | 2.726949e-01 | 0.564 |
R-HSA-1963642 | PI3K events in ERBB2 signaling | 2.836468e-01 | 0.547 |
R-HSA-9665348 | Signaling by ERBB2 ECD mutants | 2.944345e-01 | 0.531 |
R-HSA-5674135 | MAP2K and MAPK activation | 1.705552e-01 | 0.768 |
R-HSA-9656223 | Signaling by RAF1 mutants | 1.705552e-01 | 0.768 |
R-HSA-112382 | Formation of RNA Pol II elongation complex | 2.308038e-01 | 0.637 |
R-HSA-201722 | Formation of the beta-catenin:TCF transactivating complex | 2.642635e-01 | 0.578 |
R-HSA-5419276 | Mitochondrial translation termination | 2.781807e-01 | 0.556 |
R-HSA-927802 | Nonsense-Mediated Decay (NMD) | 2.904600e-01 | 0.537 |
R-HSA-975957 | Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | 2.904600e-01 | 0.537 |
R-HSA-9844594 | Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | 1.598972e-01 | 0.796 |
R-HSA-9843743 | Transcriptional regulation of brown and beige adipocyte differentiation | 1.598972e-01 | 0.796 |
R-HSA-72202 | Transport of Mature Transcript to Cytoplasm | 1.573793e-01 | 0.803 |
R-HSA-3928664 | Ephrin signaling | 2.944345e-01 | 0.531 |
R-HSA-6802957 | Oncogenic MAPK signaling | 1.683081e-01 | 0.774 |
R-HSA-1227986 | Signaling by ERBB2 | 2.754339e-01 | 0.560 |
R-HSA-9762292 | Regulation of CDH11 function | 1.788599e-01 | 0.747 |
R-HSA-8876493 | InlA-mediated entry of Listeria monocytogenes into host cells | 1.912186e-01 | 0.718 |
R-HSA-9614657 | FOXO-mediated transcription of cell death genes | 2.944345e-01 | 0.531 |
R-HSA-399955 | SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | 2.615763e-01 | 0.582 |
R-HSA-159236 | Transport of Mature mRNA derived from an Intron-Containing Transcript | 1.260660e-01 | 0.899 |
R-HSA-5368286 | Mitochondrial translation initiation | 2.297516e-01 | 0.639 |
R-HSA-9609690 | HCMV Early Events | 2.288430e-01 | 0.640 |
R-HSA-195253 | Degradation of beta-catenin by the destruction complex | 1.161833e-01 | 0.935 |
R-HSA-8941856 | RUNX3 regulates NOTCH signaling | 2.153832e-01 | 0.667 |
R-HSA-4641265 | Repression of WNT target genes | 2.153832e-01 | 0.667 |
R-HSA-5358565 | Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | 2.836468e-01 | 0.547 |
R-HSA-426496 | Post-transcriptional silencing by small RNAs | 1.006565e-01 | 0.997 |
R-HSA-9764562 | Regulation of CDH1 mRNA translation by microRNAs | 2.388286e-01 | 0.622 |
R-HSA-418885 | DCC mediated attractive signaling | 2.502884e-01 | 0.602 |
R-HSA-6802948 | Signaling by high-kinase activity BRAF mutants | 1.441625e-01 | 0.841 |
R-HSA-9927418 | Developmental Lineage of Mammary Gland Luminal Epithelial Cells | 1.759282e-01 | 0.755 |
R-HSA-3928665 | EPH-ephrin mediated repulsion of cells | 2.031516e-01 | 0.692 |
R-HSA-2122947 | NOTCH1 Intracellular Domain Regulates Transcription | 2.141733e-01 | 0.669 |
R-HSA-75955 | RNA Polymerase II Transcription Elongation | 2.363670e-01 | 0.626 |
R-HSA-5389840 | Mitochondrial translation elongation | 2.218341e-01 | 0.654 |
R-HSA-174577 | Activation of C3 and C5 | 1.006565e-01 | 0.997 |
R-HSA-9614399 | Regulation of localization of FOXO transcription factors | 1.912186e-01 | 0.718 |
R-HSA-9937383 | Mitochondrial ribosome-associated quality control | 2.497628e-01 | 0.602 |
R-HSA-2428928 | IRS-related events triggered by IGF1R | 2.810166e-01 | 0.551 |
R-HSA-381340 | Transcriptional regulation of white adipocyte differentiation | 2.218341e-01 | 0.654 |
R-HSA-9820841 | M-decay: degradation of maternal mRNAs by maternally stored factors | 1.652109e-01 | 0.782 |
R-HSA-2644606 | Constitutive Signaling by NOTCH1 PEST Domain Mutants | 2.754339e-01 | 0.560 |
R-HSA-2894858 | Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | 2.754339e-01 | 0.560 |
R-HSA-2894862 | Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | 2.754339e-01 | 0.560 |
R-HSA-2644602 | Signaling by NOTCH1 PEST Domain Mutants in Cancer | 2.754339e-01 | 0.560 |
R-HSA-5576890 | Phase 3 - rapid repolarisation | 1.406437e-01 | 0.852 |
R-HSA-2470946 | Cohesin Loading onto Chromatin | 1.406437e-01 | 0.852 |
R-HSA-176974 | Unwinding of DNA | 1.663130e-01 | 0.779 |
R-HSA-9014325 | TICAM1,TRAF6-dependent induction of TAK1 complex | 1.788599e-01 | 0.747 |
R-HSA-380615 | Serotonin clearance from the synaptic cleft | 2.153832e-01 | 0.667 |
R-HSA-5654733 | Negative regulation of FGFR4 signaling | 9.937946e-02 | 1.003 |
R-HSA-9927432 | Developmental Lineage of Mammary Gland Myoepithelial Cells | 9.937946e-02 | 1.003 |
R-HSA-399954 | Sema3A PAK dependent Axon repulsion | 2.502884e-01 | 0.602 |
R-HSA-5576886 | Phase 4 - resting membrane potential | 2.615763e-01 | 0.582 |
R-HSA-5654727 | Negative regulation of FGFR2 signaling | 1.287858e-01 | 0.890 |
R-HSA-450408 | AUF1 (hnRNP D0) binds and destabilizes mRNA | 1.389939e-01 | 0.857 |
R-HSA-5621480 | Dectin-2 family | 2.586782e-01 | 0.587 |
R-HSA-1433557 | Signaling by SCF-KIT | 1.813276e-01 | 0.742 |
R-HSA-9613829 | Chaperone Mediated Autophagy | 2.944345e-01 | 0.531 |
R-HSA-5654726 | Negative regulation of FGFR1 signaling | 1.187664e-01 | 0.925 |
R-HSA-3134975 | Regulation of innate immune responses to cytosolic DNA | 2.726949e-01 | 0.564 |
R-HSA-112399 | IRS-mediated signalling | 2.586782e-01 | 0.587 |
R-HSA-9764561 | Regulation of CDH1 Function | 2.586782e-01 | 0.587 |
R-HSA-9759475 | Regulation of CDH11 Expression and Function | 9.937946e-02 | 1.003 |
R-HSA-373755 | Semaphorin interactions | 2.921706e-01 | 0.534 |
R-HSA-5358508 | Mismatch Repair | 2.944345e-01 | 0.531 |
R-HSA-9758919 | Epithelial-Mesenchymal Transition (EMT) during gastrulation | 1.141873e-01 | 0.942 |
R-HSA-9603381 | Activated NTRK3 signals through PI3K | 1.406437e-01 | 0.852 |
R-HSA-937042 | IRAK2 mediated activation of TAK1 complex | 1.663130e-01 | 0.779 |
R-HSA-975163 | IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | 2.388286e-01 | 0.622 |
R-HSA-69541 | Stabilization of p53 | 1.546164e-01 | 0.811 |
R-HSA-8856828 | Clathrin-mediated endocytosis | 2.289848e-01 | 0.640 |
R-HSA-9764260 | Regulation of Expression and Function of Type II Classical Cadherins | 1.187664e-01 | 0.925 |
R-HSA-983695 | Antigen activates B Cell Receptor (BCR) leading to generation of second messenge... | 2.061757e-01 | 0.686 |
R-HSA-388841 | Regulation of T cell activation by CD28 family | 2.427751e-01 | 0.615 |
R-HSA-3371497 | HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of lig... | 1.097656e-01 | 0.960 |
R-HSA-71737 | Pyrophosphate hydrolysis | 1.006565e-01 | 0.997 |
R-HSA-9617629 | Regulation of FOXO transcriptional activity by acetylation | 2.153832e-01 | 0.667 |
R-HSA-176407 | Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | 2.836468e-01 | 0.547 |
R-HSA-2559585 | Oncogene Induced Senescence | 1.338675e-01 | 0.873 |
R-HSA-9610379 | HCMV Late Events | 2.748643e-01 | 0.561 |
R-HSA-170968 | Frs2-mediated activation | 2.271945e-01 | 0.644 |
R-HSA-8853884 | Transcriptional Regulation by VENTX | 1.652109e-01 | 0.782 |
R-HSA-438064 | Post NMDA receptor activation events | 1.794506e-01 | 0.746 |
R-HSA-2644603 | Signaling by NOTCH1 in Cancer | 2.754339e-01 | 0.560 |
R-HSA-9842663 | Signaling by LTK | 2.153832e-01 | 0.667 |
R-HSA-162599 | Late Phase of HIV Life Cycle | 2.257830e-01 | 0.646 |
R-HSA-195721 | Signaling by WNT | 2.101178e-01 | 0.678 |
R-HSA-69563 | p53-Dependent G1 DNA Damage Response | 2.141733e-01 | 0.669 |
R-HSA-69580 | p53-Dependent G1/S DNA damage checkpoint | 2.141733e-01 | 0.669 |
R-HSA-442755 | Activation of NMDA receptors and postsynaptic events | 2.457382e-01 | 0.610 |
R-HSA-201681 | TCF dependent signaling in response to WNT | 1.940326e-01 | 0.712 |
R-HSA-199992 | trans-Golgi Network Vesicle Budding | 1.227385e-01 | 0.911 |
R-HSA-9839373 | Signaling by TGFBR3 | 1.976655e-01 | 0.704 |
R-HSA-9006925 | Intracellular signaling by second messengers | 1.019753e-01 | 0.992 |
R-HSA-8866376 | Reelin signalling pathway | 1.006565e-01 | 0.997 |
R-HSA-199920 | CREB phosphorylation | 1.275154e-01 | 0.894 |
R-HSA-198693 | AKT phosphorylates targets in the nucleus | 1.663130e-01 | 0.779 |
R-HSA-68884 | Mitotic Telophase/Cytokinesis | 2.033922e-01 | 0.692 |
R-HSA-1358803 | Downregulation of ERBB2:ERBB3 signaling | 2.153832e-01 | 0.667 |
R-HSA-446205 | Synthesis of GDP-mannose | 2.153832e-01 | 0.667 |
R-HSA-75892 | Platelet Adhesion to exposed collagen | 2.271945e-01 | 0.644 |
R-HSA-210744 | Regulation of gene expression in late stage (branching morphogenesis) pancreatic... | 2.615763e-01 | 0.582 |
R-HSA-9029569 | NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflu... | 2.642635e-01 | 0.578 |
R-HSA-5633007 | Regulation of TP53 Activity | 1.355865e-01 | 0.868 |
R-HSA-9733709 | Cardiogenesis | 1.187664e-01 | 0.925 |
R-HSA-169893 | Prolonged ERK activation events | 2.615763e-01 | 0.582 |
R-HSA-9758941 | Gastrulation | 2.484246e-01 | 0.605 |
R-HSA-9764302 | Regulation of CDH19 Expression and Function | 1.141873e-01 | 0.942 |
R-HSA-447041 | CHL1 interactions | 1.406437e-01 | 0.852 |
R-HSA-167590 | Nef Mediated CD4 Down-regulation | 1.406437e-01 | 0.852 |
R-HSA-9645460 | Alpha-protein kinase 1 signaling pathway | 1.912186e-01 | 0.718 |
R-HSA-9697154 | Disorders of Nervous System Development | 2.153832e-01 | 0.667 |
R-HSA-9005895 | Pervasive developmental disorders | 2.153832e-01 | 0.667 |
R-HSA-9005891 | Loss of function of MECP2 in Rett syndrome | 2.153832e-01 | 0.667 |
R-HSA-6804759 | Regulation of TP53 Activity through Association with Co-factors | 2.271945e-01 | 0.644 |
R-HSA-3270619 | IRF3-mediated induction of type I IFN | 2.502884e-01 | 0.602 |
R-HSA-5578749 | Transcriptional regulation by small RNAs | 1.227385e-01 | 0.911 |
R-HSA-9766229 | Degradation of CDH1 | 2.141733e-01 | 0.669 |
R-HSA-68886 | M Phase | 1.613660e-01 | 0.792 |
R-HSA-1650814 | Collagen biosynthesis and modifying enzymes | 1.097656e-01 | 0.960 |
R-HSA-5362517 | Signaling by Retinoic Acid | 2.754339e-01 | 0.560 |
R-HSA-162587 | HIV Life Cycle | 2.748643e-01 | 0.561 |
R-HSA-2151201 | Transcriptional activation of mitochondrial biogenesis | 1.537871e-01 | 0.813 |
R-HSA-9768759 | Regulation of NPAS4 gene expression | 2.836468e-01 | 0.547 |
R-HSA-69615 | G1/S DNA Damage Checkpoints | 2.921706e-01 | 0.534 |
R-HSA-162906 | HIV Infection | 1.746348e-01 | 0.758 |
R-HSA-5654743 | Signaling by FGFR4 | 1.813276e-01 | 0.742 |
R-HSA-1606341 | IRF3 mediated activation of type 1 IFN | 1.006565e-01 | 0.997 |
R-HSA-9675151 | Disorders of Developmental Biology | 2.726949e-01 | 0.564 |
R-HSA-9909505 | Modulation of host responses by IFN-stimulated genes | 2.836468e-01 | 0.547 |
R-HSA-109704 | PI3K Cascade | 2.197053e-01 | 0.658 |
R-HSA-1266738 | Developmental Biology | 1.789608e-01 | 0.747 |
R-HSA-5654741 | Signaling by FGFR3 | 1.921982e-01 | 0.716 |
R-HSA-9659379 | Sensory processing of sound | 1.466832e-01 | 0.834 |
R-HSA-76002 | Platelet activation, signaling and aggregation | 1.613995e-01 | 0.792 |
R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases | 2.564043e-01 | 0.591 |
R-HSA-5654736 | Signaling by FGFR1 | 2.530945e-01 | 0.597 |
R-HSA-2892245 | POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | 1.406437e-01 | 0.852 |
R-HSA-9828642 | Respiratory syncytial virus genome transcription | 2.388286e-01 | 0.622 |
R-HSA-1660517 | Synthesis of PIPs at the late endosome membrane | 2.836468e-01 | 0.547 |
R-HSA-9662360 | Sensory processing of sound by inner hair cells of the cochlea | 1.097656e-01 | 0.960 |
R-HSA-1474290 | Collagen formation | 2.100666e-01 | 0.678 |
R-HSA-1483249 | Inositol phosphate metabolism | 1.209792e-01 | 0.917 |
R-HSA-5684264 | MAP3K8 (TPL2)-dependent MAPK1/3 activation | 2.388286e-01 | 0.622 |
R-HSA-69236 | G1 Phase | 1.867516e-01 | 0.729 |
R-HSA-69231 | Cyclin D associated events in G1 | 1.867516e-01 | 0.729 |
R-HSA-8876725 | Protein methylation | 2.502884e-01 | 0.602 |
R-HSA-1640170 | Cell Cycle | 1.442602e-01 | 0.841 |
R-HSA-168898 | Toll-like Receptor Cascades | 1.020192e-01 | 0.991 |
R-HSA-8986944 | Transcriptional Regulation by MECP2 | 1.946072e-01 | 0.711 |
R-HSA-69278 | Cell Cycle, Mitotic | 1.831415e-01 | 0.737 |
R-HSA-264870 | Caspase-mediated cleavage of cytoskeletal proteins | 1.663130e-01 | 0.779 |
R-HSA-9772755 | Formation of WDR5-containing histone-modifying complexes | 1.338675e-01 | 0.873 |
R-HSA-1606322 | ZBP1(DAI) mediated induction of type I IFNs | 2.944345e-01 | 0.531 |
R-HSA-9705671 | SARS-CoV-2 activates/modulates innate and adaptive immune responses | 2.257830e-01 | 0.646 |
R-HSA-180024 | DARPP-32 events | 9.937946e-02 | 1.003 |
R-HSA-6804760 | Regulation of TP53 Activity through Methylation | 2.944345e-01 | 0.531 |
R-HSA-512988 | Interleukin-3, Interleukin-5 and GM-CSF signaling | 1.759282e-01 | 0.755 |
R-HSA-211000 | Gene Silencing by RNA | 1.084973e-01 | 0.965 |
R-HSA-2262752 | Cellular responses to stress | 1.629620e-01 | 0.788 |
R-HSA-9700206 | Signaling by ALK in cancer | 2.700232e-01 | 0.569 |
R-HSA-8953897 | Cellular responses to stimuli | 1.706191e-01 | 0.768 |
R-HSA-8983711 | OAS antiviral response | 2.153832e-01 | 0.667 |
R-HSA-936964 | Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | 2.726949e-01 | 0.564 |
R-HSA-164938 | Nef-mediates down modulation of cell surface receptors by recruiting them to cla... | 2.836468e-01 | 0.547 |
R-HSA-9725370 | Signaling by ALK fusions and activated point mutants | 2.700232e-01 | 0.569 |
R-HSA-198725 | Nuclear Events (kinase and transcription factor activation) | 1.227385e-01 | 0.911 |
R-HSA-9827857 | Specification of primordial germ cells | 2.836468e-01 | 0.547 |
R-HSA-451927 | Interleukin-2 family signaling | 1.598972e-01 | 0.796 |
R-HSA-5210891 | Uptake and function of anthrax toxins | 2.836468e-01 | 0.547 |
R-HSA-449147 | Signaling by Interleukins | 1.161083e-01 | 0.935 |
R-HSA-71387 | Metabolism of carbohydrates and carbohydrate derivatives | 2.974093e-01 | 0.527 |
R-HSA-2428924 | IGF1R signaling cascade | 2.977397e-01 | 0.526 |
R-HSA-74751 | Insulin receptor signalling cascade | 2.977397e-01 | 0.526 |
R-HSA-6802952 | Signaling by BRAF and RAF1 fusions | 3.033021e-01 | 0.518 |
R-HSA-2404192 | Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | 3.033021e-01 | 0.518 |
R-HSA-429958 | mRNA decay by 3' to 5' exoribonuclease | 3.050603e-01 | 0.516 |
R-HSA-937041 | IKK complex recruitment mediated by RIP1 | 3.050603e-01 | 0.516 |
R-HSA-500753 | Pyrimidine biosynthesis | 3.050603e-01 | 0.516 |
R-HSA-881907 | Gastrin-CREB signalling pathway via PKC and MAPK | 3.050603e-01 | 0.516 |
R-HSA-392517 | Rap1 signalling | 3.050603e-01 | 0.516 |
R-HSA-1834941 | STING mediated induction of host immune responses | 3.050603e-01 | 0.516 |
R-HSA-373760 | L1CAM interactions | 3.151205e-01 | 0.502 |
R-HSA-9909620 | Regulation of PD-L1(CD274) translation | 3.155268e-01 | 0.501 |
R-HSA-373753 | Nephrin family interactions | 3.155268e-01 | 0.501 |
R-HSA-416572 | Sema4D induced cell migration and growth-cone collapse | 3.155268e-01 | 0.501 |
R-HSA-445144 | Signal transduction by L1 | 3.155268e-01 | 0.501 |
R-HSA-1592230 | Mitochondrial biogenesis | 3.192378e-01 | 0.496 |
R-HSA-72306 | tRNA processing | 3.221061e-01 | 0.492 |
R-HSA-9705683 | SARS-CoV-2-host interactions | 3.235960e-01 | 0.490 |
R-HSA-5621481 | C-type lectin receptors (CLRs) | 3.255104e-01 | 0.487 |
R-HSA-9013695 | NOTCH4 Intracellular Domain Regulates Transcription | 3.258363e-01 | 0.487 |
R-HSA-450321 | JNK (c-Jun kinases) phosphorylation and activation mediated by activated human ... | 3.258363e-01 | 0.487 |
R-HSA-9824594 | Regulation of MITF-M-dependent genes involved in apoptosis | 3.258363e-01 | 0.487 |
R-HSA-438066 | Unblocking of NMDA receptors, glutamate binding and activation | 3.359911e-01 | 0.474 |
R-HSA-442982 | Ras activation upon Ca2+ influx through NMDA receptor | 3.359911e-01 | 0.474 |
R-HSA-9617828 | FOXO-mediated transcription of cell cycle genes | 3.359911e-01 | 0.474 |
R-HSA-9705462 | Inactivation of CSF3 (G-CSF) signaling | 3.359911e-01 | 0.474 |
R-HSA-8876384 | Listeria monocytogenes entry into host cells | 3.359911e-01 | 0.474 |
R-HSA-2995383 | Initiation of Nuclear Envelope (NE) Reformation | 3.359911e-01 | 0.474 |
R-HSA-9617324 | Negative regulation of NMDA receptor-mediated neuronal transmission | 3.359911e-01 | 0.474 |
R-HSA-450302 | activated TAK1 mediates p38 MAPK activation | 3.359911e-01 | 0.474 |
R-HSA-9825892 | Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | 3.359911e-01 | 0.474 |
R-HSA-9034015 | Signaling by NTRK3 (TRKC) | 3.359911e-01 | 0.474 |
R-HSA-9924644 | Developmental Lineages of the Mammary Gland | 3.419666e-01 | 0.466 |
R-HSA-450531 | Regulation of mRNA stability by proteins that bind AU-rich elements | 3.419666e-01 | 0.466 |
R-HSA-9816359 | Maternal to zygotic transition (MZT) | 3.439404e-01 | 0.464 |
R-HSA-112409 | RAF-independent MAPK1/3 activation | 3.459935e-01 | 0.461 |
R-HSA-71384 | Ethanol oxidation | 3.459935e-01 | 0.461 |
R-HSA-166208 | mTORC1-mediated signalling | 3.459935e-01 | 0.461 |
R-HSA-4086398 | Ca2+ pathway | 3.474400e-01 | 0.459 |
R-HSA-162582 | Signal Transduction | 3.481737e-01 | 0.458 |
R-HSA-674695 | RNA Polymerase II Pre-transcription Events | 3.528984e-01 | 0.452 |
R-HSA-8943723 | Regulation of PTEN mRNA translation | 3.558460e-01 | 0.449 |
R-HSA-5674400 | Constitutive Signaling by AKT1 E17K in Cancer | 3.558460e-01 | 0.449 |
R-HSA-69206 | G1/S Transition | 3.562703e-01 | 0.448 |
R-HSA-1980143 | Signaling by NOTCH1 | 3.637667e-01 | 0.439 |
R-HSA-114608 | Platelet degranulation | 3.644743e-01 | 0.438 |
R-HSA-9665686 | Signaling by ERBB2 TMD/JMD mutants | 3.655505e-01 | 0.437 |
R-HSA-202430 | Translocation of ZAP-70 to Immunological synapse | 3.655505e-01 | 0.437 |
R-HSA-110314 | Recognition of DNA damage by PCNA-containing replication complex | 3.655505e-01 | 0.437 |
R-HSA-9024446 | NR1H2 and NR1H3-mediated signaling | 3.691753e-01 | 0.433 |
R-HSA-6796648 | TP53 Regulates Transcription of DNA Repair Genes | 3.745658e-01 | 0.426 |
R-HSA-9620244 | Long-term potentiation | 3.751095e-01 | 0.426 |
R-HSA-400685 | Sema4D in semaphorin signaling | 3.751095e-01 | 0.426 |
R-HSA-1660516 | Synthesis of PIPs at the early endosome membrane | 3.751095e-01 | 0.426 |
R-HSA-8934593 | Regulation of RUNX1 Expression and Activity | 3.845250e-01 | 0.415 |
R-HSA-9615933 | Postmitotic nuclear pore complex (NPC) reformation | 3.845250e-01 | 0.415 |
R-HSA-1660514 | Synthesis of PIPs at the Golgi membrane | 3.845250e-01 | 0.415 |
R-HSA-525793 | Myogenesis | 3.845250e-01 | 0.415 |
R-HSA-3295583 | TRP channels | 3.845250e-01 | 0.415 |
R-HSA-9845614 | Sphingolipid catabolism | 3.845250e-01 | 0.415 |
R-HSA-2995410 | Nuclear Envelope (NE) Reassembly | 3.852899e-01 | 0.414 |
R-HSA-5654738 | Signaling by FGFR2 | 3.852899e-01 | 0.414 |
R-HSA-9609646 | HCMV Infection | 3.891137e-01 | 0.410 |
R-HSA-76005 | Response to elevated platelet cytosolic Ca2+ | 3.930367e-01 | 0.406 |
R-HSA-167243 | Tat-mediated HIV elongation arrest and recovery | 3.937993e-01 | 0.405 |
R-HSA-167238 | Pausing and recovery of Tat-mediated HIV elongation | 3.937993e-01 | 0.405 |
R-HSA-202427 | Phosphorylation of CD3 and TCR zeta chains | 3.937993e-01 | 0.405 |
R-HSA-73728 | RNA Polymerase I Promoter Opening | 3.937993e-01 | 0.405 |
R-HSA-5357956 | TNFR1-induced NF-kappa-B signaling pathway | 3.937993e-01 | 0.405 |
R-HSA-9006115 | Signaling by NTRK2 (TRKB) | 3.937993e-01 | 0.405 |
R-HSA-1483213 | Synthesis of PE | 3.937993e-01 | 0.405 |
R-HSA-6785807 | Interleukin-4 and Interleukin-13 signaling | 3.971372e-01 | 0.401 |
R-HSA-1500931 | Cell-Cell communication | 4.002051e-01 | 0.398 |
R-HSA-167287 | HIV elongation arrest and recovery | 4.029343e-01 | 0.395 |
R-HSA-167290 | Pausing and recovery of HIV elongation | 4.029343e-01 | 0.395 |
R-HSA-9619483 | Activation of AMPK downstream of NMDARs | 4.029343e-01 | 0.395 |
R-HSA-3858494 | Beta-catenin independent WNT signaling | 4.092161e-01 | 0.388 |
R-HSA-9006335 | Signaling by Erythropoietin | 4.119323e-01 | 0.385 |
R-HSA-9664565 | Signaling by ERBB2 KD Mutants | 4.119323e-01 | 0.385 |
R-HSA-9615710 | Late endosomal microautophagy | 4.119323e-01 | 0.385 |
R-HSA-9674555 | Signaling by CSF3 (G-CSF) | 4.119323e-01 | 0.385 |
R-HSA-210745 | Regulation of gene expression in beta cells | 4.119323e-01 | 0.385 |
R-HSA-69620 | Cell Cycle Checkpoints | 4.129360e-01 | 0.384 |
R-HSA-9820952 | Respiratory Syncytial Virus Infection Pathway | 4.132413e-01 | 0.384 |
R-HSA-141424 | Amplification of signal from the kinetochores | 4.169632e-01 | 0.380 |
R-HSA-141444 | Amplification of signal from unattached kinetochores via a MAD2 inhibitory si... | 4.169632e-01 | 0.380 |
R-HSA-5368287 | Mitochondrial translation | 4.172579e-01 | 0.380 |
R-HSA-1227990 | Signaling by ERBB2 in Cancer | 4.207952e-01 | 0.376 |
R-HSA-9013508 | NOTCH3 Intracellular Domain Regulates Transcription | 4.207952e-01 | 0.376 |
R-HSA-68962 | Activation of the pre-replicative complex | 4.207952e-01 | 0.376 |
R-HSA-1250196 | SHC1 events in ERBB2 signaling | 4.207952e-01 | 0.376 |
R-HSA-8863795 | Downregulation of ERBB2 signaling | 4.207952e-01 | 0.376 |
R-HSA-888590 | GABA synthesis, release, reuptake and degradation | 4.207952e-01 | 0.376 |
R-HSA-112311 | Neurotransmitter clearance | 4.207952e-01 | 0.376 |
R-HSA-9933387 | RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | 4.207952e-01 | 0.376 |
R-HSA-69190 | DNA strand elongation | 4.381238e-01 | 0.358 |
R-HSA-111465 | Apoptotic cleavage of cellular proteins | 4.381238e-01 | 0.358 |
R-HSA-5083635 | Defective B3GALTL causes PpS | 4.465935e-01 | 0.350 |
R-HSA-9930044 | Nuclear RNA decay | 4.465935e-01 | 0.350 |
R-HSA-6804758 | Regulation of TP53 Activity through Acetylation | 4.465935e-01 | 0.350 |
R-HSA-176187 | Activation of ATR in response to replication stress | 4.465935e-01 | 0.350 |
R-HSA-354192 | Integrin signaling | 4.465935e-01 | 0.350 |
R-HSA-1855204 | Synthesis of IP3 and IP4 in the cytosol | 4.465935e-01 | 0.350 |
R-HSA-1912408 | Pre-NOTCH Transcription and Translation | 4.477985e-01 | 0.349 |
R-HSA-453279 | Mitotic G1 phase and G1/S transition | 4.529724e-01 | 0.344 |
R-HSA-5696394 | DNA Damage Recognition in GG-NER | 4.549361e-01 | 0.342 |
R-HSA-390471 | Association of TriC/CCT with target proteins during biosynthesis | 4.549361e-01 | 0.342 |
R-HSA-3700989 | Transcriptional Regulation by TP53 | 4.561895e-01 | 0.341 |
R-HSA-2682334 | EPH-Ephrin signaling | 4.578737e-01 | 0.339 |
R-HSA-74752 | Signaling by Insulin receptor | 4.578737e-01 | 0.339 |
R-HSA-2029481 | FCGR activation | 4.628716e-01 | 0.335 |
R-HSA-5696400 | Dual Incision in GG-NER | 4.631534e-01 | 0.334 |
R-HSA-9680350 | Signaling by CSF1 (M-CSF) in myeloid cells | 4.631534e-01 | 0.334 |
R-HSA-1980145 | Signaling by NOTCH2 | 4.631534e-01 | 0.334 |
R-HSA-168638 | NOD1/2 Signaling Pathway | 4.631534e-01 | 0.334 |
R-HSA-983170 | Antigen Presentation: Folding, assembly and peptide loading of class I MHC | 4.631534e-01 | 0.334 |
R-HSA-9843970 | Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | 4.631534e-01 | 0.334 |
R-HSA-5365859 | RA biosynthesis pathway | 4.631534e-01 | 0.334 |
R-HSA-2142845 | Hyaluronan metabolism | 4.631534e-01 | 0.334 |
R-HSA-1368108 | BMAL1:CLOCK,NPAS2 activates circadian expression | 4.631534e-01 | 0.334 |
R-HSA-169911 | Regulation of Apoptosis | 4.712474e-01 | 0.327 |
R-HSA-9860927 | Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZ... | 4.712474e-01 | 0.327 |
R-HSA-187687 | Signalling to ERKs | 4.712474e-01 | 0.327 |
R-HSA-381042 | PERK regulates gene expression | 4.712474e-01 | 0.327 |
R-HSA-917977 | Transferrin endocytosis and recycling | 4.712474e-01 | 0.327 |
R-HSA-446728 | Cell junction organization | 4.717341e-01 | 0.326 |
R-HSA-72203 | Processing of Capped Intron-Containing Pre-mRNA | 4.746311e-01 | 0.324 |
R-HSA-432720 | Lysosome Vesicle Biogenesis | 4.792197e-01 | 0.319 |
R-HSA-8853659 | RET signaling | 4.792197e-01 | 0.319 |
R-HSA-2730905 | Role of LAT2/NTAL/LAB on calcium mobilization | 4.825898e-01 | 0.316 |
R-HSA-5607764 | CLEC7A (Dectin-1) signaling | 4.825898e-01 | 0.316 |
R-HSA-9917777 | Epigenetic regulation by WDR5-containing histone modifying complexes | 4.839473e-01 | 0.315 |
R-HSA-5173214 | O-glycosylation of TSR domain-containing proteins | 4.870724e-01 | 0.312 |
R-HSA-1296072 | Voltage gated Potassium channels | 4.870724e-01 | 0.312 |
R-HSA-3769402 | Deactivation of the beta-catenin transactivating complex | 4.870724e-01 | 0.312 |
R-HSA-2173796 | SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | 4.870724e-01 | 0.312 |
R-HSA-8948216 | Collagen chain trimerization | 4.870724e-01 | 0.312 |
R-HSA-8878159 | Transcriptional regulation by RUNX3 | 4.874496e-01 | 0.312 |
R-HSA-168273 | Influenza Viral RNA Transcription and Replication | 4.877613e-01 | 0.312 |
R-HSA-9694516 | SARS-CoV-2 Infection | 4.878179e-01 | 0.312 |
R-HSA-190236 | Signaling by FGFR | 4.922810e-01 | 0.308 |
R-HSA-8875878 | MET promotes cell motility | 4.948071e-01 | 0.306 |
R-HSA-452723 | Transcriptional regulation of pluripotent stem cells | 4.948071e-01 | 0.306 |
R-HSA-983705 | Signaling by the B Cell Receptor (BCR) | 4.991212e-01 | 0.302 |
R-HSA-69618 | Mitotic Spindle Checkpoint | 5.018574e-01 | 0.299 |
R-HSA-167200 | Formation of HIV-1 elongation complex containing HIV-1 Tat | 5.024257e-01 | 0.299 |
R-HSA-381771 | Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | 5.024257e-01 | 0.299 |
R-HSA-9931509 | Expression of BMAL (ARNTL), CLOCK, and NPAS2 | 5.024257e-01 | 0.299 |
R-HSA-201556 | Signaling by ALK | 5.024257e-01 | 0.299 |
R-HSA-9820965 | Respiratory syncytial virus (RSV) genome replication, transcription and translat... | 5.024257e-01 | 0.299 |
R-HSA-877300 | Interferon gamma signaling | 5.028797e-01 | 0.299 |
R-HSA-9020702 | Interleukin-1 signaling | 5.066020e-01 | 0.295 |
R-HSA-9006936 | Signaling by TGFB family members | 5.066238e-01 | 0.295 |
R-HSA-167246 | Tat-mediated elongation of the HIV-1 transcript | 5.099299e-01 | 0.292 |
R-HSA-167152 | Formation of HIV elongation complex in the absence of HIV Tat | 5.099299e-01 | 0.292 |
R-HSA-5696395 | Formation of Incision Complex in GG-NER | 5.099299e-01 | 0.292 |
R-HSA-167169 | HIV Transcription Elongation | 5.099299e-01 | 0.292 |
R-HSA-202433 | Generation of second messenger molecules | 5.099299e-01 | 0.292 |
R-HSA-2559580 | Oxidative Stress Induced Senescence | 5.113172e-01 | 0.291 |
R-HSA-8878171 | Transcriptional regulation by RUNX1 | 5.127353e-01 | 0.290 |
R-HSA-3214841 | PKMTs methylate histone lysines | 5.173213e-01 | 0.286 |
R-HSA-9821002 | Chromatin modifications during the maternal to zygotic transition (MZT) | 5.173213e-01 | 0.286 |
R-HSA-9694548 | Maturation of spike protein | 5.173213e-01 | 0.286 |
R-HSA-5218920 | VEGFR2 mediated vascular permeability | 5.173213e-01 | 0.286 |
R-HSA-9860931 | Response of endothelial cells to shear stress | 5.206589e-01 | 0.283 |
R-HSA-111885 | Opioid Signalling | 5.206589e-01 | 0.283 |
R-HSA-9615017 | FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | 5.246017e-01 | 0.280 |
R-HSA-442660 | SLC-mediated transport of neurotransmitters | 5.246017e-01 | 0.280 |
R-HSA-9609736 | Assembly and cell surface presentation of NMDA receptors | 5.246017e-01 | 0.280 |
R-HSA-9833110 | RSV-host interactions | 5.252850e-01 | 0.280 |
R-HSA-379716 | Cytosolic tRNA aminoacylation | 5.317727e-01 | 0.274 |
R-HSA-400508 | Incretin synthesis, secretion, and inactivation | 5.317727e-01 | 0.274 |
R-HSA-165159 | MTOR signalling | 5.317727e-01 | 0.274 |
R-HSA-5619102 | SLC transporter disorders | 5.324153e-01 | 0.274 |
R-HSA-418346 | Platelet homeostasis | 5.344469e-01 | 0.272 |
R-HSA-8953854 | Metabolism of RNA | 5.365802e-01 | 0.270 |
R-HSA-74160 | Gene expression (Transcription) | 5.409633e-01 | 0.267 |
R-HSA-9734779 | Developmental Cell Lineages of the Integumentary System | 5.434875e-01 | 0.265 |
R-HSA-2672351 | Stimuli-sensing channels | 5.434875e-01 | 0.265 |
R-HSA-373752 | Netrin-1 signaling | 5.457932e-01 | 0.263 |
R-HSA-3928662 | EPHB-mediated forward signaling | 5.457932e-01 | 0.263 |
R-HSA-9648025 | EML4 and NUDC in mitotic spindle formation | 5.479621e-01 | 0.261 |
R-HSA-4608870 | Asymmetric localization of PCP proteins | 5.526458e-01 | 0.258 |
R-HSA-76009 | Platelet Aggregation (Plug Formation) | 5.526458e-01 | 0.258 |
R-HSA-9764274 | Regulation of Expression and Function of Type I Classical Cadherins | 5.574374e-01 | 0.254 |
R-HSA-9764265 | Regulation of CDH1 Expression and Function | 5.574374e-01 | 0.254 |
R-HSA-6781823 | Formation of TC-NER Pre-Incision Complex | 5.593955e-01 | 0.252 |
R-HSA-9861718 | Regulation of pyruvate metabolism | 5.593955e-01 | 0.252 |
R-HSA-9675135 | Diseases of DNA repair | 5.593955e-01 | 0.252 |
R-HSA-75153 | Apoptotic execution phase | 5.593955e-01 | 0.252 |
R-HSA-1912422 | Pre-NOTCH Expression and Processing | 5.655526e-01 | 0.248 |
R-HSA-445989 | TAK1-dependent IKK and NF-kappa-B activation | 5.660437e-01 | 0.247 |
R-HSA-437239 | Recycling pathway of L1 | 5.660437e-01 | 0.247 |
R-HSA-9855142 | Cellular responses to mechanical stimuli | 5.698729e-01 | 0.244 |
R-HSA-70263 | Gluconeogenesis | 5.725921e-01 | 0.242 |
R-HSA-425410 | Metal ion SLC transporters | 5.725921e-01 | 0.242 |
R-HSA-168255 | Influenza Infection | 5.782382e-01 | 0.238 |
R-HSA-73893 | DNA Damage Bypass | 5.790420e-01 | 0.237 |
R-HSA-2559583 | Cellular Senescence | 5.816452e-01 | 0.235 |
R-HSA-4420097 | VEGFA-VEGFR2 Pathway | 5.826475e-01 | 0.235 |
R-HSA-1234176 | Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | 5.916525e-01 | 0.228 |
R-HSA-112315 | Transmission across Chemical Synapses | 5.955869e-01 | 0.225 |
R-HSA-212165 | Epigenetic regulation of gene expression | 5.955869e-01 | 0.225 |
R-HSA-68949 | Orc1 removal from chromatin | 5.978159e-01 | 0.223 |
R-HSA-6794361 | Neurexins and neuroligins | 5.978159e-01 | 0.223 |
R-HSA-9634815 | Transcriptional Regulation by NPAS4 | 5.978159e-01 | 0.223 |
R-HSA-9692916 | SARS-CoV-1 activates/modulates innate immune responses | 5.978159e-01 | 0.223 |
R-HSA-5339562 | Uptake and actions of bacterial toxins | 5.978159e-01 | 0.223 |
R-HSA-69275 | G2/M Transition | 6.017201e-01 | 0.221 |
R-HSA-212436 | Generic Transcription Pathway | 6.028970e-01 | 0.220 |
R-HSA-1221632 | Meiotic synapsis | 6.038867e-01 | 0.219 |
R-HSA-8956320 | Nucleotide biosynthesis | 6.038867e-01 | 0.219 |
R-HSA-2500257 | Resolution of Sister Chromatid Cohesion | 6.073553e-01 | 0.217 |
R-HSA-453274 | Mitotic G2-G2/M phases | 6.082701e-01 | 0.216 |
R-HSA-72649 | Translation initiation complex formation | 6.098662e-01 | 0.215 |
R-HSA-9754678 | SARS-CoV-2 modulates host translation machinery | 6.098662e-01 | 0.215 |
R-HSA-112316 | Neuronal System | 6.123996e-01 | 0.213 |
R-HSA-9012852 | Signaling by NOTCH3 | 6.157558e-01 | 0.211 |
R-HSA-6811436 | COPI-independent Golgi-to-ER retrograde traffic | 6.157558e-01 | 0.211 |
R-HSA-3214815 | HDACs deacetylate histones | 6.157558e-01 | 0.211 |
R-HSA-6782210 | Gap-filling DNA repair synthesis and ligation in TC-NER | 6.215569e-01 | 0.207 |
R-HSA-72702 | Ribosomal scanning and start codon recognition | 6.215569e-01 | 0.207 |
R-HSA-193648 | NRAGE signals death through JNK | 6.215569e-01 | 0.207 |
R-HSA-2173793 | Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | 6.215569e-01 | 0.207 |
R-HSA-75893 | TNF signaling | 6.215569e-01 | 0.207 |
R-HSA-194138 | Signaling by VEGF | 6.270880e-01 | 0.203 |
R-HSA-9664323 | FCGR3A-mediated IL10 synthesis | 6.309413e-01 | 0.200 |
R-HSA-6782135 | Dual incision in TC-NER | 6.328986e-01 | 0.199 |
R-HSA-72662 | Activation of the mRNA upon binding of the cap-binding complex and eIFs, and sub... | 6.328986e-01 | 0.199 |
R-HSA-9759476 | Regulation of Homotypic Cell-Cell Adhesion | 6.337499e-01 | 0.198 |
R-HSA-2022090 | Assembly of collagen fibrils and other multimeric structures | 6.384419e-01 | 0.195 |
R-HSA-379724 | tRNA Aminoacylation | 6.439018e-01 | 0.191 |
R-HSA-983189 | Kinesins | 6.439018e-01 | 0.191 |
R-HSA-1660661 | Sphingolipid de novo biosynthesis | 6.439018e-01 | 0.191 |
R-HSA-389948 | Co-inhibition by PD-1 | 6.460529e-01 | 0.190 |
R-HSA-9679506 | SARS-CoV Infections | 6.471905e-01 | 0.189 |
R-HSA-428157 | Sphingolipid metabolism | 6.490828e-01 | 0.188 |
R-HSA-1442490 | Collagen degradation | 6.492796e-01 | 0.188 |
R-HSA-9793380 | Formation of paraxial mesoderm | 6.492796e-01 | 0.188 |
R-HSA-1474165 | Reproduction | 6.497446e-01 | 0.187 |
R-HSA-5576891 | Cardiac conduction | 6.534131e-01 | 0.185 |
R-HSA-375165 | NCAM signaling for neurite out-growth | 6.545765e-01 | 0.184 |
R-HSA-9707616 | Heme signaling | 6.545765e-01 | 0.184 |
R-HSA-1660499 | Synthesis of PIPs at the plasma membrane | 6.545765e-01 | 0.184 |
R-HSA-2454202 | Fc epsilon receptor (FCERI) signaling | 6.550874e-01 | 0.184 |
R-HSA-8856688 | Golgi-to-ER retrograde transport | 6.570510e-01 | 0.182 |
R-HSA-2426168 | Activation of gene expression by SREBF (SREBP) | 6.597937e-01 | 0.181 |
R-HSA-8848021 | Signaling by PTK6 | 6.597937e-01 | 0.181 |
R-HSA-9006927 | Signaling by Non-Receptor Tyrosine Kinases | 6.597937e-01 | 0.181 |
R-HSA-168643 | Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signali... | 6.649325e-01 | 0.177 |
R-HSA-1234174 | Cellular response to hypoxia | 6.699939e-01 | 0.174 |
R-HSA-9824446 | Viral Infection Pathways | 6.711635e-01 | 0.173 |
R-HSA-9018519 | Estrogen-dependent gene expression | 6.747854e-01 | 0.171 |
R-HSA-163685 | Integration of energy metabolism | 6.747854e-01 | 0.171 |
R-HSA-9909649 | Regulation of PD-L1(CD274) transcription | 6.749792e-01 | 0.171 |
R-HSA-72766 | Translation | 6.789919e-01 | 0.168 |
R-HSA-112314 | Neurotransmitter receptors and postsynaptic signal transmission | 6.840062e-01 | 0.165 |
R-HSA-167172 | Transcription of the HIV genome | 6.847259e-01 | 0.164 |
R-HSA-8936459 | RUNX1 regulates genes involved in megakaryocyte differentiation and platelet fun... | 6.847259e-01 | 0.164 |
R-HSA-381119 | Unfolded Protein Response (UPR) | 6.850654e-01 | 0.164 |
R-HSA-9730414 | MITF-M-regulated melanocyte development | 6.867969e-01 | 0.163 |
R-HSA-9664417 | Leishmania phagocytosis | 6.884327e-01 | 0.162 |
R-HSA-9664422 | FCGR3A-mediated phagocytosis | 6.884327e-01 | 0.162 |
R-HSA-9664407 | Parasite infection | 6.884327e-01 | 0.162 |
R-HSA-73857 | RNA Polymerase II Transcription | 6.899198e-01 | 0.161 |
R-HSA-9006931 | Signaling by Nuclear Receptors | 6.908622e-01 | 0.161 |
R-HSA-1834949 | Cytosolic sensors of pathogen-associated DNA | 6.941814e-01 | 0.159 |
R-HSA-9840310 | Glycosphingolipid catabolism | 6.941814e-01 | 0.159 |
R-HSA-68882 | Mitotic Anaphase | 6.950587e-01 | 0.158 |
R-HSA-2555396 | Mitotic Metaphase and Anaphase | 6.977760e-01 | 0.156 |
R-HSA-427413 | NoRC negatively regulates rRNA expression | 6.988028e-01 | 0.156 |
R-HSA-3906995 | Diseases associated with O-glycosylation of proteins | 6.988028e-01 | 0.156 |
R-HSA-9856649 | Transcriptional and post-translational regulation of MITF-M expression and activ... | 6.988028e-01 | 0.156 |
R-HSA-174143 | APC/C-mediated degradation of cell cycle proteins | 6.988028e-01 | 0.156 |
R-HSA-453276 | Regulation of mitotic cell cycle | 6.988028e-01 | 0.156 |
R-HSA-418990 | Adherens junctions interactions | 7.004751e-01 | 0.155 |
R-HSA-69052 | Switching of origins to a post-replicative state | 7.078378e-01 | 0.150 |
R-HSA-204998 | Cell death signalling via NRAGE, NRIF and NADE | 7.078378e-01 | 0.150 |
R-HSA-8951664 | Neddylation | 7.084628e-01 | 0.150 |
R-HSA-9013694 | Signaling by NOTCH4 | 7.122536e-01 | 0.147 |
R-HSA-6781827 | Transcription-Coupled Nucleotide Excision Repair (TC-NER) | 7.166029e-01 | 0.145 |
R-HSA-917937 | Iron uptake and transport | 7.166029e-01 | 0.145 |
R-HSA-5689603 | UCH proteinases | 7.208867e-01 | 0.142 |
R-HSA-73854 | RNA Polymerase I Promoter Clearance | 7.208867e-01 | 0.142 |
R-HSA-9856651 | MITF-M-dependent gene expression | 7.235521e-01 | 0.141 |
R-HSA-9694635 | Translation of Structural Proteins | 7.251061e-01 | 0.140 |
R-HSA-383280 | Nuclear Receptor transcription pathway | 7.292619e-01 | 0.137 |
R-HSA-4086400 | PCP/CE pathway | 7.292619e-01 | 0.137 |
R-HSA-73864 | RNA Polymerase I Transcription | 7.292619e-01 | 0.137 |
R-HSA-416482 | G alpha (12/13) signalling events | 7.292619e-01 | 0.137 |
R-HSA-216083 | Integrin cell surface interactions | 7.292619e-01 | 0.137 |
R-HSA-9010553 | Regulation of expression of SLITs and ROBOs | 7.295675e-01 | 0.137 |
R-HSA-446652 | Interleukin-1 family signaling | 7.295675e-01 | 0.137 |
R-HSA-6798695 | Neutrophil degranulation | 7.332445e-01 | 0.135 |
R-HSA-1655829 | Regulation of cholesterol biosynthesis by SREBP (SREBF) | 7.333552e-01 | 0.135 |
R-HSA-73887 | Death Receptor Signaling | 7.354719e-01 | 0.133 |
R-HSA-5250941 | Negative epigenetic regulation of rRNA expression | 7.373868e-01 | 0.132 |
R-HSA-9856530 | High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR... | 7.373868e-01 | 0.132 |
R-HSA-6806834 | Signaling by MET | 7.373868e-01 | 0.132 |
R-HSA-1989781 | PPARA activates gene expression | 7.383830e-01 | 0.132 |
R-HSA-400206 | Regulation of lipid metabolism by PPARalpha | 7.441234e-01 | 0.128 |
R-HSA-2559582 | Senescence-Associated Secretory Phenotype (SASP) | 7.452688e-01 | 0.128 |
R-HSA-168249 | Innate Immune System | 7.471173e-01 | 0.127 |
R-HSA-9707564 | Cytoprotection by HMOX1 | 7.491210e-01 | 0.125 |
R-HSA-5696399 | Global Genome Nucleotide Excision Repair (GG-NER) | 7.529151e-01 | 0.123 |
R-HSA-8939236 | RUNX1 regulates transcription of genes involved in differentiation of HSCs | 7.529151e-01 | 0.123 |
R-HSA-157118 | Signaling by NOTCH | 7.552987e-01 | 0.122 |
R-HSA-6794362 | Protein-protein interactions at synapses | 7.566522e-01 | 0.121 |
R-HSA-1500620 | Meiosis | 7.566522e-01 | 0.121 |
R-HSA-109581 | Apoptosis | 7.580056e-01 | 0.120 |
R-HSA-8876198 | RAB GEFs exchange GTP for GDP on RABs | 7.603329e-01 | 0.119 |
R-HSA-2467813 | Separation of Sister Chromatids | 7.633743e-01 | 0.117 |
R-HSA-6807505 | RNA polymerase II transcribes snRNA genes | 7.639582e-01 | 0.117 |
R-HSA-163841 | Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | 7.639582e-01 | 0.117 |
R-HSA-6804756 | Regulation of TP53 Activity through Phosphorylation | 7.639582e-01 | 0.117 |
R-HSA-390466 | Chaperonin-mediated protein folding | 7.675288e-01 | 0.115 |
R-HSA-70268 | Pyruvate metabolism | 7.675288e-01 | 0.115 |
R-HSA-5619115 | Disorders of transmembrane transporters | 7.709627e-01 | 0.113 |
R-HSA-9663891 | Selective autophagy | 7.710457e-01 | 0.113 |
R-HSA-112310 | Neurotransmitter release cycle | 7.779213e-01 | 0.109 |
R-HSA-202424 | Downstream TCR signaling | 7.779213e-01 | 0.109 |
R-HSA-421270 | Cell-cell junction organization | 7.795418e-01 | 0.108 |
R-HSA-109582 | Hemostasis | 7.812573e-01 | 0.107 |
R-HSA-975956 | Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | 7.845912e-01 | 0.105 |
R-HSA-381070 | IRE1alpha activates chaperones | 7.845912e-01 | 0.105 |
R-HSA-9909648 | Regulation of PD-L1(CD274) expression | 7.862762e-01 | 0.104 |
R-HSA-391251 | Protein folding | 7.878510e-01 | 0.104 |
R-HSA-9772573 | Late SARS-CoV-2 Infection Events | 7.878510e-01 | 0.104 |
R-HSA-5688426 | Deubiquitination | 7.878560e-01 | 0.104 |
R-HSA-9662851 | Anti-inflammatory response favouring Leishmania parasite infection | 7.886973e-01 | 0.103 |
R-HSA-9664433 | Leishmania parasite growth and survival | 7.886973e-01 | 0.103 |
R-HSA-5689880 | Ub-specific processing proteases | 7.886973e-01 | 0.103 |
R-HSA-168256 | Immune System | 7.907284e-01 | 0.102 |
R-HSA-68867 | Assembly of the pre-replicative complex | 7.910616e-01 | 0.102 |
R-HSA-2029480 | Fcgamma receptor (FCGR) dependent phagocytosis | 7.910942e-01 | 0.102 |
R-HSA-9837999 | Mitochondrial protein degradation | 7.942238e-01 | 0.100 |
R-HSA-9954709 | Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | 8.004060e-01 | 0.097 |
R-HSA-6811434 | COPI-dependent Golgi-to-ER retrograde traffic | 8.034274e-01 | 0.095 |
R-HSA-1296071 | Potassium Channels | 8.034274e-01 | 0.095 |
R-HSA-170834 | Signaling by TGF-beta Receptor Complex | 8.064032e-01 | 0.093 |
R-HSA-9614085 | FOXO-mediated transcription | 8.122209e-01 | 0.090 |
R-HSA-193704 | p75 NTR receptor-mediated signalling | 8.122209e-01 | 0.090 |
R-HSA-1483255 | PI Metabolism | 8.206226e-01 | 0.086 |
R-HSA-9842860 | Regulation of endogenous retroelements | 8.206226e-01 | 0.086 |
R-HSA-983712 | Ion channel transport | 8.242754e-01 | 0.084 |
R-HSA-5617472 | Activation of anterior HOX genes in hindbrain development during early embryogen... | 8.286499e-01 | 0.082 |
R-HSA-5619507 | Activation of HOX genes during differentiation | 8.286499e-01 | 0.082 |
R-HSA-5696398 | Nucleotide Excision Repair | 8.312453e-01 | 0.080 |
R-HSA-68877 | Mitotic Prometaphase | 8.322898e-01 | 0.080 |
R-HSA-9692914 | SARS-CoV-1-host interactions | 8.338016e-01 | 0.079 |
R-HSA-72163 | mRNA Splicing - Major Pathway | 8.342413e-01 | 0.079 |
R-HSA-69239 | Synthesis of DNA | 8.363193e-01 | 0.078 |
R-HSA-72706 | GTP hydrolysis and joining of the 60S ribosomal subunit | 8.387991e-01 | 0.076 |
R-HSA-156827 | L13a-mediated translational silencing of Ceruloplasmin expression | 8.387991e-01 | 0.076 |
R-HSA-69002 | DNA Replication Pre-Initiation | 8.412414e-01 | 0.075 |
R-HSA-202403 | TCR signaling | 8.436468e-01 | 0.074 |
R-HSA-6811442 | Intra-Golgi and retrograde Golgi-to-ER traffic | 8.455274e-01 | 0.073 |
R-HSA-2871796 | FCERI mediated MAPK activation | 8.483494e-01 | 0.071 |
R-HSA-72172 | mRNA Splicing | 8.543963e-01 | 0.068 |
R-HSA-166663 | Initial triggering of complement | 8.551404e-01 | 0.068 |
R-HSA-5357801 | Programmed Cell Death | 8.561136e-01 | 0.067 |
R-HSA-5628897 | TP53 Regulates Metabolic Genes | 8.573361e-01 | 0.067 |
R-HSA-2029485 | Role of phospholipids in phagocytosis | 8.594987e-01 | 0.066 |
R-HSA-2871809 | FCERI mediated Ca+2 mobilization | 8.594987e-01 | 0.066 |
R-HSA-72737 | Cap-dependent Translation Initiation | 8.616286e-01 | 0.065 |
R-HSA-72613 | Eukaryotic Translation Initiation | 8.616286e-01 | 0.065 |
R-HSA-9007101 | Rab regulation of trafficking | 8.637263e-01 | 0.064 |
R-HSA-2980736 | Peptide hormone metabolism | 8.637263e-01 | 0.064 |
R-HSA-397014 | Muscle contraction | 8.676276e-01 | 0.062 |
R-HSA-1660662 | Glycosphingolipid metabolism | 8.756640e-01 | 0.058 |
R-HSA-977606 | Regulation of Complement cascade | 8.794070e-01 | 0.056 |
R-HSA-9851695 | Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | 8.812363e-01 | 0.055 |
R-HSA-9841922 | MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesi... | 8.812363e-01 | 0.055 |
R-HSA-9818564 | Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | 8.812363e-01 | 0.055 |
R-HSA-69481 | G2/M Checkpoints | 8.848122e-01 | 0.053 |
R-HSA-1852241 | Organelle biogenesis and maintenance | 8.901341e-01 | 0.051 |
R-HSA-446219 | Synthesis of substrates in N-glycan biosythesis | 8.932900e-01 | 0.049 |
R-HSA-9909396 | Circadian clock | 8.949094e-01 | 0.048 |
R-HSA-1474228 | Degradation of the extracellular matrix | 8.949094e-01 | 0.048 |
R-HSA-8939211 | ESR-mediated signaling | 9.021893e-01 | 0.045 |
R-HSA-202733 | Cell surface interactions at the vascular wall | 9.021893e-01 | 0.045 |
R-HSA-1474244 | Extracellular matrix organization | 9.022516e-01 | 0.045 |
R-HSA-5173105 | O-linked glycosylation | 9.041248e-01 | 0.044 |
R-HSA-9948299 | Ribosome-associated quality control | 9.055805e-01 | 0.043 |
R-HSA-6807070 | PTEN Regulation | 9.070141e-01 | 0.042 |
R-HSA-2029482 | Regulation of actin dynamics for phagocytic cup formation | 9.098167e-01 | 0.041 |
R-HSA-1632852 | Macroautophagy | 9.098167e-01 | 0.041 |
R-HSA-2871837 | FCERI mediated NF-kB activation | 9.151719e-01 | 0.038 |
R-HSA-166658 | Complement cascade | 9.164605e-01 | 0.038 |
R-HSA-69242 | S Phase | 9.202104e-01 | 0.036 |
R-HSA-9679191 | Potential therapeutics for SARS | 9.226167e-01 | 0.035 |
R-HSA-69306 | DNA Replication | 9.260914e-01 | 0.033 |
R-HSA-9734767 | Developmental Cell Lineages | 9.290943e-01 | 0.032 |
R-HSA-9612973 | Autophagy | 9.294106e-01 | 0.032 |
R-HSA-416476 | G alpha (q) signalling events | 9.299752e-01 | 0.032 |
R-HSA-446193 | Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, L... | 9.304837e-01 | 0.031 |
R-HSA-2408522 | Selenoamino acid metabolism | 9.375538e-01 | 0.028 |
R-HSA-199991 | Membrane Trafficking | 9.416963e-01 | 0.026 |
R-HSA-9824443 | Parasitic Infection Pathways | 9.434593e-01 | 0.025 |
R-HSA-9658195 | Leishmania infection | 9.434593e-01 | 0.025 |
R-HSA-983231 | Factors involved in megakaryocyte development and platelet production | 9.480476e-01 | 0.023 |
R-HSA-9678108 | SARS-CoV-1 Infection | 9.480476e-01 | 0.023 |
R-HSA-1483257 | Phospholipid metabolism | 9.526774e-01 | 0.021 |
R-HSA-3781865 | Diseases of glycosylation | 9.547477e-01 | 0.020 |
R-HSA-418594 | G alpha (i) signalling events | 9.584007e-01 | 0.018 |
R-HSA-1630316 | Glycosaminoglycan metabolism | 9.605868e-01 | 0.017 |
R-HSA-1280218 | Adaptive Immune System | 9.648129e-01 | 0.016 |
R-HSA-5663205 | Infectious disease | 9.657519e-01 | 0.015 |
R-HSA-1483206 | Glycerophospholipid biosynthesis | 9.661984e-01 | 0.015 |
R-HSA-1643685 | Disease | 9.788091e-01 | 0.009 |
R-HSA-73894 | DNA Repair | 9.796741e-01 | 0.009 |
R-HSA-15869 | Metabolism of nucleotides | 9.799634e-01 | 0.009 |
R-HSA-9824439 | Bacterial Infection Pathways | 9.865433e-01 | 0.006 |
R-HSA-5653656 | Vesicle-mediated transport | 9.874840e-01 | 0.005 |
R-HSA-425407 | SLC-mediated transmembrane transport | 9.877490e-01 | 0.005 |
R-HSA-9711123 | Cellular response to chemical stress | 9.877644e-01 | 0.005 |
R-HSA-211945 | Phase I - Functionalization of compounds | 9.895142e-01 | 0.005 |
R-HSA-597592 | Post-translational protein modification | 9.927586e-01 | 0.003 |
R-HSA-388396 | GPCR downstream signalling | 9.936299e-01 | 0.003 |
R-HSA-392499 | Metabolism of proteins | 9.938176e-01 | 0.003 |
R-HSA-8957322 | Metabolism of steroids | 9.948509e-01 | 0.002 |
R-HSA-1428517 | Aerobic respiration and respiratory electron transport | 9.960431e-01 | 0.002 |
R-HSA-372790 | Signaling by GPCR | 9.975206e-01 | 0.001 |
R-HSA-983169 | Class I MHC mediated antigen processing & presentation | 9.979699e-01 | 0.001 |
R-HSA-446203 | Asparagine N-linked glycosylation | 9.988936e-01 | 0.000 |
R-HSA-5668914 | Diseases of metabolism | 9.989765e-01 | 0.000 |
R-HSA-211859 | Biological oxidations | 9.997718e-01 | 0.000 |
R-HSA-382551 | Transport of small molecules | 9.998683e-01 | 0.000 |
R-HSA-71291 | Metabolism of amino acids and derivatives | 9.999488e-01 | 0.000 |
R-HSA-556833 | Metabolism of lipids | 9.999836e-01 | 0.000 |
R-HSA-9709957 | Sensory Perception | 9.999959e-01 | 0.000 |
R-HSA-9752946 | Expression and translocation of olfactory receptors | 9.999968e-01 | 0.000 |
R-HSA-381753 | Olfactory Signaling Pathway | 9.999990e-01 | 0.000 |
R-HSA-1430728 | Metabolism | 1.000000e+00 | 0.000 |
Download
kinase | JSD_mean | pearson_surrounding | kinase_max_IC_position | max_position_JSD |
---|---|---|---|---|
CDK18 |
0.891 | 0.856 | 1 | 0.868 |
P38G |
0.890 | 0.886 | 1 | 0.903 |
CDK17 |
0.888 | 0.865 | 1 | 0.893 |
HIPK2 |
0.886 | 0.783 | 1 | 0.856 |
CDK19 |
0.885 | 0.818 | 1 | 0.865 |
KIS |
0.883 | 0.760 | 1 | 0.810 |
JNK2 |
0.882 | 0.881 | 1 | 0.869 |
CDK8 |
0.881 | 0.819 | 1 | 0.837 |
P38D |
0.880 | 0.858 | 1 | 0.903 |
CDK16 |
0.880 | 0.827 | 1 | 0.881 |
CDK13 |
0.879 | 0.839 | 1 | 0.851 |
CDK12 |
0.879 | 0.845 | 1 | 0.870 |
CDK7 |
0.878 | 0.818 | 1 | 0.834 |
DYRK2 |
0.877 | 0.777 | 1 | 0.780 |
ERK1 |
0.877 | 0.830 | 1 | 0.846 |
CDK3 |
0.877 | 0.742 | 1 | 0.888 |
JNK3 |
0.875 | 0.869 | 1 | 0.849 |
CDK9 |
0.875 | 0.834 | 1 | 0.845 |
CDK1 |
0.875 | 0.807 | 1 | 0.853 |
CDK5 |
0.875 | 0.806 | 1 | 0.805 |
DYRK4 |
0.874 | 0.784 | 1 | 0.869 |
P38B |
0.872 | 0.827 | 1 | 0.832 |
CDK14 |
0.870 | 0.828 | 1 | 0.833 |
CDK10 |
0.867 | 0.779 | 1 | 0.847 |
HIPK1 |
0.867 | 0.718 | 1 | 0.764 |
DYRK1B |
0.867 | 0.753 | 1 | 0.827 |
P38A |
0.865 | 0.804 | 1 | 0.770 |
ERK2 |
0.862 | 0.819 | 1 | 0.806 |
HIPK4 |
0.861 | 0.504 | 1 | 0.578 |
CLK3 |
0.859 | 0.497 | 1 | 0.549 |
CDK4 |
0.859 | 0.816 | 1 | 0.876 |
NLK |
0.858 | 0.749 | 1 | 0.588 |
DYRK1A |
0.857 | 0.631 | 1 | 0.748 |
CDK6 |
0.857 | 0.789 | 1 | 0.850 |
HIPK3 |
0.856 | 0.698 | 1 | 0.734 |
JNK1 |
0.856 | 0.780 | 1 | 0.870 |
DYRK3 |
0.852 | 0.592 | 1 | 0.730 |
SRPK1 |
0.850 | 0.363 | -3 | 0.780 |
CLK1 |
0.846 | 0.446 | -3 | 0.769 |
CLK4 |
0.845 | 0.424 | -3 | 0.793 |
ERK5 |
0.845 | 0.409 | 1 | 0.487 |
CLK2 |
0.845 | 0.444 | -3 | 0.768 |
CDK2 |
0.845 | 0.610 | 1 | 0.740 |
SRPK2 |
0.840 | 0.293 | -3 | 0.699 |
MTOR |
0.839 | 0.243 | 1 | 0.386 |
PRP4 |
0.838 | 0.528 | -3 | 0.876 |
ICK |
0.836 | 0.367 | -3 | 0.868 |
MAK |
0.834 | 0.498 | -2 | 0.751 |
COT |
0.831 | -0.050 | 2 | 0.851 |
CDKL5 |
0.829 | 0.169 | -3 | 0.824 |
SRPK3 |
0.829 | 0.255 | -3 | 0.751 |
CDKL1 |
0.826 | 0.142 | -3 | 0.831 |
CDC7 |
0.824 | -0.089 | 1 | 0.227 |
MOK |
0.823 | 0.461 | 1 | 0.646 |
TBK1 |
0.823 | -0.124 | 1 | 0.187 |
ERK7 |
0.823 | 0.313 | 2 | 0.592 |
NDR2 |
0.822 | 0.011 | -3 | 0.860 |
MOS |
0.821 | -0.018 | 1 | 0.265 |
PRPK |
0.821 | -0.079 | -1 | 0.864 |
IKKE |
0.820 | -0.129 | 1 | 0.190 |
GCN2 |
0.820 | -0.138 | 2 | 0.781 |
PIM3 |
0.820 | -0.009 | -3 | 0.856 |
PKN3 |
0.820 | -0.004 | -3 | 0.861 |
ULK2 |
0.819 | -0.121 | 2 | 0.764 |
SKMLCK |
0.819 | 0.023 | -2 | 0.915 |
NEK6 |
0.819 | -0.027 | -2 | 0.874 |
PRKD1 |
0.819 | 0.019 | -3 | 0.861 |
CAMK1B |
0.818 | -0.009 | -3 | 0.889 |
RSK2 |
0.818 | 0.033 | -3 | 0.793 |
ATR |
0.818 | -0.042 | 1 | 0.258 |
WNK1 |
0.818 | -0.031 | -2 | 0.905 |
MST4 |
0.818 | -0.011 | 2 | 0.828 |
PDHK4 |
0.817 | -0.135 | 1 | 0.277 |
RAF1 |
0.817 | -0.171 | 1 | 0.211 |
AURC |
0.816 | 0.085 | -2 | 0.754 |
DSTYK |
0.816 | -0.108 | 2 | 0.857 |
P90RSK |
0.816 | 0.027 | -3 | 0.805 |
BMPR2 |
0.815 | -0.131 | -2 | 0.886 |
PKCD |
0.815 | 0.022 | 2 | 0.769 |
NDR1 |
0.815 | -0.019 | -3 | 0.858 |
RSK3 |
0.815 | 0.020 | -3 | 0.791 |
CAMLCK |
0.814 | 0.036 | -2 | 0.898 |
NIK |
0.814 | -0.024 | -3 | 0.909 |
PDHK1 |
0.814 | -0.133 | 1 | 0.256 |
TGFBR2 |
0.813 | -0.064 | -2 | 0.809 |
PKN2 |
0.813 | -0.022 | -3 | 0.868 |
CHAK2 |
0.813 | -0.035 | -1 | 0.873 |
IKKB |
0.813 | -0.160 | -2 | 0.752 |
PRKD2 |
0.812 | 0.020 | -3 | 0.794 |
NUAK2 |
0.812 | 0.007 | -3 | 0.859 |
RIPK3 |
0.812 | -0.097 | 3 | 0.841 |
NEK7 |
0.812 | -0.134 | -3 | 0.881 |
DAPK2 |
0.812 | 0.008 | -3 | 0.896 |
IRE1 |
0.812 | -0.038 | 1 | 0.201 |
PIM1 |
0.811 | 0.033 | -3 | 0.802 |
PKACG |
0.811 | 0.017 | -2 | 0.802 |
NEK9 |
0.810 | -0.097 | 2 | 0.828 |
P70S6KB |
0.810 | 0.015 | -3 | 0.819 |
PKCA |
0.810 | 0.040 | 2 | 0.720 |
PKCB |
0.809 | 0.019 | 2 | 0.733 |
MNK2 |
0.809 | 0.028 | -2 | 0.865 |
HUNK |
0.808 | -0.113 | 2 | 0.788 |
ULK1 |
0.808 | -0.136 | -3 | 0.870 |
MLK1 |
0.808 | -0.128 | 2 | 0.799 |
CAMK2G |
0.807 | -0.111 | 2 | 0.766 |
PKCZ |
0.807 | 0.018 | 2 | 0.777 |
LATS2 |
0.807 | -0.028 | -5 | 0.759 |
MLK2 |
0.807 | -0.069 | 2 | 0.798 |
PAK6 |
0.807 | 0.061 | -2 | 0.778 |
PAK1 |
0.806 | 0.013 | -2 | 0.840 |
AMPKA1 |
0.806 | -0.057 | -3 | 0.877 |
MARK4 |
0.806 | -0.061 | 4 | 0.826 |
GRK5 |
0.806 | -0.140 | -3 | 0.885 |
PAK3 |
0.805 | -0.008 | -2 | 0.836 |
WNK3 |
0.805 | -0.164 | 1 | 0.210 |
NIM1 |
0.805 | -0.050 | 3 | 0.839 |
PKCG |
0.805 | 0.001 | 2 | 0.727 |
SGK3 |
0.805 | 0.041 | -3 | 0.788 |
BCKDK |
0.805 | -0.127 | -1 | 0.816 |
IRE2 |
0.804 | -0.044 | 2 | 0.744 |
CAMK2D |
0.804 | -0.082 | -3 | 0.870 |
MNK1 |
0.804 | 0.028 | -2 | 0.868 |
MAPKAPK3 |
0.804 | -0.054 | -3 | 0.801 |
PKACB |
0.804 | 0.065 | -2 | 0.764 |
IKKA |
0.804 | -0.086 | -2 | 0.734 |
PHKG1 |
0.804 | -0.034 | -3 | 0.850 |
DNAPK |
0.804 | -0.025 | 1 | 0.236 |
PKR |
0.803 | -0.028 | 1 | 0.225 |
VRK2 |
0.803 | 0.114 | 1 | 0.315 |
MASTL |
0.803 | -0.140 | -2 | 0.817 |
PKG2 |
0.803 | 0.043 | -2 | 0.756 |
AKT2 |
0.803 | 0.058 | -3 | 0.708 |
MLK3 |
0.802 | -0.048 | 2 | 0.728 |
GRK1 |
0.802 | -0.035 | -2 | 0.772 |
AMPKA2 |
0.802 | -0.039 | -3 | 0.842 |
AURB |
0.802 | 0.044 | -2 | 0.749 |
NEK2 |
0.802 | -0.065 | 2 | 0.811 |
RIPK1 |
0.802 | -0.152 | 1 | 0.200 |
LATS1 |
0.801 | 0.020 | -3 | 0.871 |
BMPR1B |
0.801 | -0.047 | 1 | 0.195 |
PINK1 |
0.801 | 0.167 | 1 | 0.409 |
MSK2 |
0.801 | -0.008 | -3 | 0.771 |
TSSK1 |
0.800 | -0.045 | -3 | 0.892 |
ANKRD3 |
0.800 | -0.151 | 1 | 0.228 |
PKCH |
0.800 | -0.018 | 2 | 0.715 |
ALK4 |
0.800 | -0.061 | -2 | 0.828 |
PRKD3 |
0.800 | -0.006 | -3 | 0.771 |
RSK4 |
0.800 | 0.025 | -3 | 0.759 |
TTBK2 |
0.800 | -0.155 | 2 | 0.695 |
TGFBR1 |
0.799 | -0.051 | -2 | 0.801 |
MAPKAPK2 |
0.798 | -0.037 | -3 | 0.750 |
MELK |
0.798 | -0.056 | -3 | 0.830 |
MPSK1 |
0.798 | 0.052 | 1 | 0.260 |
GSK3A |
0.798 | 0.196 | 4 | 0.441 |
ATM |
0.797 | -0.087 | 1 | 0.224 |
DLK |
0.797 | -0.213 | 1 | 0.230 |
YSK4 |
0.797 | -0.128 | 1 | 0.198 |
TLK2 |
0.796 | -0.094 | 1 | 0.199 |
MSK1 |
0.796 | 0.015 | -3 | 0.773 |
TSSK2 |
0.796 | -0.100 | -5 | 0.765 |
PAK2 |
0.796 | -0.025 | -2 | 0.824 |
CHAK1 |
0.795 | -0.113 | 2 | 0.760 |
NUAK1 |
0.795 | -0.044 | -3 | 0.808 |
GRK6 |
0.795 | -0.158 | 1 | 0.212 |
CAMK4 |
0.795 | -0.102 | -3 | 0.841 |
GRK7 |
0.795 | -0.021 | 1 | 0.232 |
AURA |
0.795 | 0.032 | -2 | 0.728 |
PLK1 |
0.794 | -0.125 | -2 | 0.821 |
PKCT |
0.794 | -0.002 | 2 | 0.721 |
SMG1 |
0.794 | -0.080 | 1 | 0.240 |
PIM2 |
0.794 | 0.027 | -3 | 0.768 |
MEKK1 |
0.794 | -0.072 | 1 | 0.225 |
QSK |
0.793 | -0.042 | 4 | 0.803 |
PRKX |
0.793 | 0.062 | -3 | 0.690 |
MLK4 |
0.793 | -0.094 | 2 | 0.709 |
MST3 |
0.793 | -0.014 | 2 | 0.827 |
GRK4 |
0.792 | -0.172 | -2 | 0.824 |
AKT1 |
0.792 | 0.041 | -3 | 0.726 |
IRAK4 |
0.792 | -0.073 | 1 | 0.187 |
PLK4 |
0.792 | -0.095 | 2 | 0.599 |
DCAMKL1 |
0.792 | -0.027 | -3 | 0.807 |
WNK4 |
0.791 | -0.076 | -2 | 0.885 |
QIK |
0.791 | -0.107 | -3 | 0.860 |
MYLK4 |
0.790 | -0.013 | -2 | 0.846 |
PERK |
0.790 | -0.106 | -2 | 0.838 |
CAMK2A |
0.790 | -0.041 | 2 | 0.748 |
CAMK2B |
0.790 | -0.077 | 2 | 0.725 |
MEK1 |
0.790 | -0.163 | 2 | 0.798 |
PAK5 |
0.790 | 0.026 | -2 | 0.713 |
PKCI |
0.790 | 0.015 | 2 | 0.746 |
NEK5 |
0.790 | -0.078 | 1 | 0.201 |
ZAK |
0.789 | -0.125 | 1 | 0.217 |
DRAK1 |
0.789 | -0.120 | 1 | 0.182 |
TAO3 |
0.789 | -0.026 | 1 | 0.242 |
PAK4 |
0.788 | 0.039 | -2 | 0.728 |
ACVR2A |
0.788 | -0.108 | -2 | 0.798 |
SIK |
0.788 | -0.060 | -3 | 0.784 |
ACVR2B |
0.788 | -0.109 | -2 | 0.805 |
PKACA |
0.788 | 0.044 | -2 | 0.722 |
PHKG2 |
0.787 | -0.057 | -3 | 0.822 |
HRI |
0.787 | -0.138 | -2 | 0.857 |
MEKK2 |
0.787 | -0.091 | 2 | 0.783 |
ALK2 |
0.787 | -0.092 | -2 | 0.805 |
MAPKAPK5 |
0.786 | -0.089 | -3 | 0.751 |
MEK5 |
0.786 | -0.139 | 2 | 0.793 |
FAM20C |
0.786 | -0.052 | 2 | 0.536 |
PKCE |
0.786 | 0.029 | 2 | 0.717 |
BRSK2 |
0.786 | -0.096 | -3 | 0.841 |
CAMK1G |
0.785 | -0.056 | -3 | 0.785 |
SMMLCK |
0.784 | -0.009 | -3 | 0.846 |
MARK3 |
0.784 | -0.064 | 4 | 0.754 |
P70S6K |
0.784 | -0.019 | -3 | 0.732 |
LKB1 |
0.784 | -0.007 | -3 | 0.889 |
PDK1 |
0.783 | -0.037 | 1 | 0.246 |
BRSK1 |
0.783 | -0.081 | -3 | 0.816 |
GSK3B |
0.783 | 0.047 | 4 | 0.434 |
BRAF |
0.783 | -0.137 | -4 | 0.842 |
MARK2 |
0.782 | -0.076 | 4 | 0.724 |
SNRK |
0.782 | -0.145 | 2 | 0.656 |
PLK3 |
0.782 | -0.142 | 2 | 0.724 |
BMPR1A |
0.781 | -0.077 | 1 | 0.189 |
MEKK3 |
0.781 | -0.177 | 1 | 0.217 |
TAO2 |
0.781 | -0.037 | 2 | 0.828 |
DCAMKL2 |
0.781 | -0.060 | -3 | 0.828 |
AKT3 |
0.781 | 0.045 | -3 | 0.646 |
PKN1 |
0.781 | -0.011 | -3 | 0.750 |
MEKK6 |
0.781 | -0.049 | 1 | 0.219 |
GRK2 |
0.780 | -0.102 | -2 | 0.713 |
MAP3K15 |
0.780 | -0.063 | 1 | 0.224 |
SGK1 |
0.780 | 0.057 | -3 | 0.627 |
GAK |
0.780 | -0.033 | 1 | 0.254 |
TLK1 |
0.780 | -0.151 | -2 | 0.836 |
NEK11 |
0.780 | -0.114 | 1 | 0.234 |
CHK1 |
0.779 | -0.105 | -3 | 0.836 |
NEK4 |
0.779 | -0.102 | 1 | 0.188 |
DAPK3 |
0.778 | 0.001 | -3 | 0.821 |
NEK8 |
0.778 | -0.131 | 2 | 0.808 |
SSTK |
0.778 | -0.062 | 4 | 0.804 |
HGK |
0.777 | -0.046 | 3 | 0.910 |
TNIK |
0.777 | -0.019 | 3 | 0.906 |
PASK |
0.777 | -0.059 | -3 | 0.872 |
GCK |
0.777 | -0.061 | 1 | 0.212 |
KHS1 |
0.776 | -0.009 | 1 | 0.206 |
ROCK2 |
0.776 | 0.035 | -3 | 0.812 |
CK1E |
0.776 | -0.035 | -3 | 0.560 |
LOK |
0.776 | -0.037 | -2 | 0.789 |
MRCKB |
0.775 | 0.030 | -3 | 0.761 |
MINK |
0.775 | -0.084 | 1 | 0.192 |
PBK |
0.774 | -0.017 | 1 | 0.227 |
VRK1 |
0.774 | -0.081 | 2 | 0.826 |
NEK1 |
0.774 | -0.090 | 1 | 0.186 |
HPK1 |
0.774 | -0.055 | 1 | 0.212 |
TTBK1 |
0.773 | -0.163 | 2 | 0.611 |
MARK1 |
0.773 | -0.113 | 4 | 0.774 |
CK1G1 |
0.773 | -0.057 | -3 | 0.558 |
LRRK2 |
0.773 | -0.013 | 2 | 0.833 |
KHS2 |
0.772 | 0.000 | 1 | 0.217 |
BUB1 |
0.772 | 0.008 | -5 | 0.720 |
CAMKK1 |
0.772 | -0.170 | -2 | 0.762 |
CAMKK2 |
0.771 | -0.125 | -2 | 0.766 |
DAPK1 |
0.771 | -0.007 | -3 | 0.805 |
CAMK1D |
0.771 | -0.044 | -3 | 0.700 |
YSK1 |
0.770 | -0.059 | 2 | 0.803 |
IRAK1 |
0.770 | -0.198 | -1 | 0.787 |
NEK3 |
0.770 | -0.047 | 1 | 0.220 |
MRCKA |
0.770 | 0.003 | -3 | 0.775 |
HASPIN |
0.769 | 0.017 | -1 | 0.717 |
EEF2K |
0.769 | -0.076 | 3 | 0.860 |
MST2 |
0.769 | -0.137 | 1 | 0.202 |
SBK |
0.769 | 0.098 | -3 | 0.583 |
CK1D |
0.769 | -0.016 | -3 | 0.511 |
DMPK1 |
0.768 | 0.056 | -3 | 0.777 |
CHK2 |
0.766 | -0.028 | -3 | 0.656 |
SLK |
0.765 | -0.069 | -2 | 0.722 |
PKG1 |
0.765 | 0.009 | -2 | 0.681 |
STK33 |
0.764 | -0.117 | 2 | 0.581 |
ROCK1 |
0.764 | 0.022 | -3 | 0.778 |
CK1A2 |
0.764 | -0.038 | -3 | 0.508 |
CAMK1A |
0.763 | -0.026 | -3 | 0.677 |
GRK3 |
0.763 | -0.106 | -2 | 0.667 |
MST1 |
0.762 | -0.149 | 1 | 0.192 |
TAK1 |
0.762 | -0.186 | 1 | 0.197 |
BIKE |
0.762 | -0.023 | 1 | 0.234 |
CK2A2 |
0.761 | -0.084 | 1 | 0.172 |
CRIK |
0.760 | 0.025 | -3 | 0.723 |
RIPK2 |
0.760 | -0.196 | 1 | 0.194 |
MEK2 |
0.760 | -0.179 | 2 | 0.778 |
MYO3B |
0.759 | -0.021 | 2 | 0.814 |
AAK1 |
0.758 | 0.014 | 1 | 0.228 |
TTK |
0.758 | -0.055 | -2 | 0.839 |
TAO1 |
0.757 | -0.057 | 1 | 0.212 |
OSR1 |
0.757 | -0.067 | 2 | 0.773 |
ASK1 |
0.756 | -0.098 | 1 | 0.226 |
CK2A1 |
0.753 | -0.091 | 1 | 0.165 |
PDHK3_TYR |
0.753 | 0.138 | 4 | 0.890 |
PLK2 |
0.751 | -0.111 | -3 | 0.798 |
MYO3A |
0.751 | -0.074 | 1 | 0.210 |
LIMK2_TYR |
0.751 | 0.164 | -3 | 0.925 |
PKMYT1_TYR |
0.749 | 0.155 | 3 | 0.924 |
TESK1_TYR |
0.746 | 0.044 | 3 | 0.933 |
PDHK4_TYR |
0.742 | 0.025 | 2 | 0.832 |
MAP2K4_TYR |
0.742 | 0.003 | -1 | 0.872 |
MAP2K7_TYR |
0.740 | -0.068 | 2 | 0.820 |
MAP2K6_TYR |
0.739 | -0.002 | -1 | 0.876 |
RET |
0.739 | -0.075 | 1 | 0.237 |
YANK3 |
0.739 | -0.064 | 2 | 0.373 |
LIMK1_TYR |
0.738 | 0.026 | 2 | 0.824 |
PINK1_TYR |
0.737 | -0.120 | 1 | 0.267 |
MST1R |
0.737 | -0.054 | 3 | 0.899 |
TNNI3K_TYR |
0.736 | 0.030 | 1 | 0.251 |
STLK3 |
0.736 | -0.174 | 1 | 0.196 |
ALPHAK3 |
0.736 | -0.133 | -1 | 0.757 |
JAK2 |
0.735 | -0.080 | 1 | 0.248 |
CSF1R |
0.735 | -0.053 | 3 | 0.877 |
PDHK1_TYR |
0.735 | -0.081 | -1 | 0.880 |
TYK2 |
0.735 | -0.139 | 1 | 0.223 |
BMPR2_TYR |
0.734 | -0.031 | -1 | 0.831 |
ROS1 |
0.734 | -0.072 | 3 | 0.864 |
NEK10_TYR |
0.733 | -0.070 | 1 | 0.214 |
TYRO3 |
0.731 | -0.114 | 3 | 0.882 |
TNK1 |
0.731 | -0.015 | 3 | 0.872 |
JAK1 |
0.731 | -0.048 | 1 | 0.217 |
ABL2 |
0.730 | -0.076 | -1 | 0.808 |
DDR1 |
0.729 | -0.099 | 4 | 0.821 |
FGR |
0.728 | -0.112 | 1 | 0.191 |
YES1 |
0.728 | -0.077 | -1 | 0.855 |
EPHA6 |
0.728 | -0.099 | -1 | 0.817 |
FGFR1 |
0.728 | -0.013 | 3 | 0.847 |
ABL1 |
0.727 | -0.076 | -1 | 0.809 |
JAK3 |
0.727 | -0.110 | 1 | 0.237 |
CK1A |
0.727 | -0.059 | -3 | 0.416 |
FGFR2 |
0.727 | -0.032 | 3 | 0.865 |
EPHB4 |
0.726 | -0.120 | -1 | 0.802 |
TNK2 |
0.725 | -0.079 | 3 | 0.832 |
KDR |
0.725 | -0.055 | 3 | 0.841 |
TXK |
0.725 | -0.078 | 1 | 0.193 |
PDGFRB |
0.724 | -0.149 | 3 | 0.885 |
KIT |
0.722 | -0.111 | 3 | 0.875 |
FLT3 |
0.722 | -0.140 | 3 | 0.879 |
LCK |
0.721 | -0.083 | -1 | 0.806 |
BLK |
0.721 | -0.064 | -1 | 0.812 |
TEK |
0.721 | -0.013 | 3 | 0.822 |
ITK |
0.720 | -0.124 | -1 | 0.785 |
FER |
0.720 | -0.178 | 1 | 0.208 |
HCK |
0.720 | -0.130 | -1 | 0.806 |
INSRR |
0.719 | -0.140 | 3 | 0.831 |
DDR2 |
0.719 | -0.007 | 3 | 0.807 |
AXL |
0.718 | -0.129 | 3 | 0.862 |
PDGFRA |
0.718 | -0.167 | 3 | 0.884 |
MET |
0.716 | -0.111 | 3 | 0.870 |
SRMS |
0.716 | -0.175 | 1 | 0.188 |
MERTK |
0.715 | -0.132 | 3 | 0.864 |
EPHB1 |
0.714 | -0.187 | 1 | 0.196 |
FGFR3 |
0.714 | -0.067 | 3 | 0.838 |
WEE1_TYR |
0.714 | -0.080 | -1 | 0.743 |
EPHB3 |
0.713 | -0.162 | -1 | 0.788 |
EPHA4 |
0.713 | -0.130 | 2 | 0.719 |
EPHB2 |
0.711 | -0.166 | -1 | 0.776 |
ALK |
0.711 | -0.146 | 3 | 0.804 |
TEC |
0.711 | -0.137 | -1 | 0.725 |
FLT1 |
0.710 | -0.136 | -1 | 0.799 |
FYN |
0.710 | -0.093 | -1 | 0.777 |
BMX |
0.710 | -0.124 | -1 | 0.673 |
FLT4 |
0.710 | -0.137 | 3 | 0.841 |
ERBB2 |
0.709 | -0.160 | 1 | 0.210 |
EPHA1 |
0.708 | -0.138 | 3 | 0.857 |
FRK |
0.708 | -0.142 | -1 | 0.808 |
NTRK1 |
0.708 | -0.201 | -1 | 0.804 |
PTK2B |
0.707 | -0.098 | -1 | 0.786 |
LTK |
0.707 | -0.160 | 3 | 0.828 |
PTK6 |
0.707 | -0.185 | -1 | 0.750 |
CK1G3 |
0.707 | -0.064 | -3 | 0.368 |
INSR |
0.707 | -0.150 | 3 | 0.821 |
NTRK2 |
0.707 | -0.193 | 3 | 0.847 |
NTRK3 |
0.706 | -0.140 | -1 | 0.754 |
BTK |
0.706 | -0.216 | -1 | 0.758 |
EPHA7 |
0.705 | -0.145 | 2 | 0.724 |
EGFR |
0.705 | -0.114 | 1 | 0.188 |
SRC |
0.704 | -0.107 | -1 | 0.795 |
YANK2 |
0.704 | -0.090 | 2 | 0.382 |
MATK |
0.704 | -0.104 | -1 | 0.741 |
LYN |
0.703 | -0.142 | 3 | 0.819 |
MUSK |
0.702 | -0.122 | 1 | 0.165 |
FGFR4 |
0.700 | -0.110 | -1 | 0.750 |
EPHA3 |
0.700 | -0.174 | 2 | 0.695 |
CSK |
0.698 | -0.158 | 2 | 0.735 |
EPHA8 |
0.698 | -0.138 | -1 | 0.762 |
EPHA5 |
0.694 | -0.170 | 2 | 0.698 |
ERBB4 |
0.692 | -0.106 | 1 | 0.184 |
PTK2 |
0.690 | -0.101 | -1 | 0.714 |
SYK |
0.688 | -0.121 | -1 | 0.706 |
IGF1R |
0.688 | -0.157 | 3 | 0.765 |
EPHA2 |
0.686 | -0.157 | -1 | 0.705 |
CK1G2 |
0.682 | -0.076 | -3 | 0.469 |
ZAP70 |
0.679 | -0.077 | -1 | 0.634 |
FES |
0.676 | -0.154 | -1 | 0.673 |